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Pharmaceuticals and personal care products (PPCPs) are a group of various chemicals, 
used for the bodies of humans and domestic animals and plants. Many PPCPs are highly 
bioactive and most are polar when present in the environment, usually occur at no more than 
trace concentrations. On the other hand, there has also been a growing interest in water reuse 
according to the lack of water resources and the advanced technologies for water treatment 
such as membrane treatment and advanced oxidation processes (AOPs). In Japan, the amount 
of reclaimed water in 2005 was about 200 million m3, which corresponds to just 1.4% of total 
effluent from wastewater treatment plant. Wastewater can be reclaimed and piped to 
individual households for uses such as toilet flushing, garden watering and washing of cars 
and outdoor surfaces. Therefore, the water reuse of wastewater treatment plant discharges can 
lead to an exposure of user to potential harmful constituents such as PPCPs. In the future, 
high quality treated water after conventional wastewater treatment will be needed for water 
reuse. According to the above background, the applicability of physicochemical processes 
such as UV-based processes (UV and UV/H2O2 processes) and O3-based processes (O3, 
O3/H2O2 and O3/UV processes) for the removal of PPCPs in secondary effluent was 
investigated in this study. 
Firstly, degradation characteristics of the 30 PPCPs detected often in the aquatic 
environment by UV-based processes were examined. Two types of UV lamps with different 
wavelength each other (UV/Lamp1 - 254nm, UV/Lamp2 - 254/185nm) were used for UV 
alone process. UV/Lamp2 was more effective for the PPCPs degradation than UV/Lamp1 
maybe due to the contribution of OH radicals formed from the photolysis of H2O molecular 
by the wavelength of 185nm. Photochemistry in the vacuum-ultraviolet (VUV) spectral 
domain (140~200nm) is of high applicatory interest in environmental techniques for the 
oxidative treatment of water. However, limited information on the application of the VUV 
spectral domain is still available. This study provided research data on the degradation of 
PPCPs, emerging contaminants and demonstrated the availability of the VUV spectral domain 
in the area of wastewater treatment.  
For UV/Lamp1 process, UV dose required for degrading 90% of initial concentration of 
each PPCP ranged from 38 mJ/cm2 to 5,644 mJ/cm2, indicating that for several PPCPs, very 
high UV dose will be needed for the effective removal. This means that considerable energy 
will be consumed for the effective PPCPs removal by UV/Lamp1 alone process. Contrarily, 
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for UV/Lamp1/H2O2 process, most of PPCPs were degraded by more than 90% at UV dose of 
691 mJ/cm2, showing that the addition of H2O2 during UV process can reduce the energy 
consumption.  
Based on the results, the removal performance of UV/Lamp1 and UV/Lamp1/H2O2 
processes for the PPCPs present in real secondary effluent was investigated using bench scale 
plant. Among the 38 PPCPs detected in secondary effluent, only 18 PPCPs were removed by 
more than 90% despite UV dose of 2,768 mJ/cm2, which was the highest UV dose introduced 
for UV/Lamp1 alone process. In contrast with UV/lamp1 process, UV dose of 923 mJ/cm2 
was required for the 90% removal of all the PPCPs when initial H2O2 concentration in tested 
water was 6.2 mg/L during UV/Lamp1 process. Energy consumption is a very critical point in 
designing water treatment facilities. This study showed that the combination of H2O2 with UV 
process contributed to the decrease of operating cost as well as the significant improvement of 
the PPCPs removal. 
Secondly, the removal potential of 30 PPCPs detected in aquatic environment with O3, 
O3/UV and O3/H2O2 processes was investigated through batch experiments. Rate constants of 
the 30 PPCPs increased with the increase of O3 feed rate. However, the degradations of the 30 
PPCPs to the amount of O3 consumed were more efficient at O3 feed rate of 0.3 mg/L/min 
than 0.6 mg/L/min probably due to the promoted reaction of O3 molecules with OH radicals 
by the supply of excess O3. The combination of UV or H2O2 with O3 process could improve 
the degradation rates of the PPCPs significantly, resulting in the reduction of required O3 dose. 
Consequently, it was considered that most of the PPCPs can be degraded easily by O3-based 
processes. On the other hand, most of the PPCPs were degraded by more than 90% at O3 
consumptions of 6.3 mg/L and 4.5 mg/L for O3 and O3/UV processes, respectively, when 
using tested water prepared by pure water spiked with the 30 PPCPs (initial H2O2 
concentration : 13.4~144.0 µg/L). However, O3 consumptions increased by 8.9 mg/L and 7.7 
mg/L for O3 and O3/UV processes when the PPCPs were spiked into biologically treated water. 
For O3 process, the addition of H2O2 promoted the degradation rates of almost all the PPCPs, 
whereas, it was found that the addition of excess H2O2 could cause a scavenging effect of OH 
radicals resulting in the decrease of PPCPs degradation rates. 
The removal performance of O3 and O3/UV processes for PPCPs in secondary effluent 
was investigated using bench scale plant. Among the 37 PPCPs, only 24 PPCPs including 
carbamazepine, crotamiton and diclofenac were removed by more than 90% even at O3 dose 
of 2 mg/L during O3 process. However, an increased O3 dose (6 mg/L) could lead to the 90% 
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removal for all the PPCPs except primidone (87%). Consequently, it is considered that O3 
dose of 6 mg/L can ensure the efficient removal of the investigated PPCPs for O3 alone 
process. For O3/UV process, most of PPCPs showed the removal efficiency of more than 90% 
by the combination of UV65W with O3 dose of 4 mg/L. An electrical energy of 1.09 kWh/m3 
was needed for the effective PPCPs removal by O3/UV process. This was compared with for 
O3 alone process (0.09 kWh/m3). As a consequence, a considerable electrical energy was 
required due to the application of UV lamps for O3/UV process.  
Finally, the applicability as technologies for the reclamation of secondary effluent of O3, 
UV/H2O2 and O3/UV processes was discussed. UV/H2O2 and O3/UV processes can be used as 
treatment options for various water reuses such as urban reuse, agricultural reuse, recreational 
reuse and potable reuse, with their superior disinfection effectiveness, decrease effect of 
ecological risk and no bromate formation potential as well as an effective PPCPs removal. In 
addition, an effective disinfection (4~5 log inactivation of total coliform) is expected when the 
investigated processes are applied for the effective removal of PPCPs in secondary effluent 
for water reuse. Therefore, the application of these processes for water reuse can bring the 
minimization or omission of the disinfection process. On the other hand, the formation 
potential of bromate is likely to be high at O3 dose of 6 mg/L that showed the effective PPCPs 
removal during O3 process. The combination of UV or H2O2 with O3 process is recommended 
to suppress bromate formation for direct and indirect potable reuses. UV/H2O2 process can be 
also a treatment option in terms of bromate suppression. 
These studies were performed mainly for investigating the reactivity of limited kinds of 
PPCPs with UV, O3 or OH radicals. This study focused on the effective removal of various 
PPCPs in real secondary effluent with UV- and O3-based processes. Moreover, appropriate 
process for water reuse of secondary effluent was proposed based on the energy consumption, 
the formation potential of disinfection by products (DBPs), disinfection effectiveness and 
decrease effect for ecological risk. Applicability of UV/H2O2, O3 and O3/UV processes for 
water reuse was confirmed through this study.  
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1         INTRODUCTION 
 
 
1.1 Research background 
The precautionary principle with regard to wastewater treatment implies an efficient 
removal of all potential harmful constituents. In recent years, there has been a growing 
concern regarding the occurrence of pharmaceuticals and personal care products (PPCPs) in 
the aquatic environment (Heberer et al., 2002; Smital et al., 2004). The PPCPs have been 
detected in samples from the aquatic environment such as river water, ground water and 
drinking water and the main source of them has been known as the effluent from wastewater 
treatment plants (Halling-Sørensen et al., 1998; Kanda et al., 2003). There are also several 
investigations showing that PPCPs are not eliminated during wastewater treatment and also 
not biodegraded in the environment (Ternes, 1998; Daughton et al., 1999; Nakada et al., 
2006; Okuda et al., 2007). 
On the other hand, there has also been a growing interest in water reuse according to the 
lack of water resources and the advanced technologies for water treatment such as membrane 
treatment and advanced oxidation processes (AOPs). It has been reported that the majority of 
states in U.S. have regulations regarding water reuse and reclaimed water use on a volume 
basis is growing at an estimated 15 percent per year (U.S EPA, 2004). In Japan, the amount of 
reclaimed water in 2005 was about 200 million ton, which corresponds to only 1.4% of total 
effluent from all the municipal wastewater treatment plants (The Ministry of Land, 
Infrastructure and Transport of Japan, 2005). 
Wastewater can be reclaimed and piped to individual households for uses such as toilet 
flushing, garden watering and washing of cars and outdoor surfaces. U.S.EPA suggests 
advanced water treatment facilities such as MBR and UV treatment in the guidelines for water 
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reuse for ensuring the safety from chemical constituents, whereas the guideline of Japan has 
not treated with it yet. At the present, the concentration of residual chlorine is being regulated 
by the Japanese guideline on the use of the reclaimed water for the microbiological safety of 
the reclaimed water. However, disinfection with chlorine does not lead to a general removal of 
PPCPs (Huber et al., 2005). Therefore, the water reuse of wastewater treatment plant 
discharges can lead to an exposure of user to potential harmful constituents such as PPCPs. In 
the future, high quality treated water after conventional wastewater treatment will be needed 
for water reuse. 
UV treatment, which is very popular for disinfection of potable water, lacks knowledge 
on applicability for the PPCPs removal in wastewater treatment system. Contrarily, recently 
several studies have demonstrated that O3 and AOPs are very effective for the oxidation of 
PPCPs in water treatment process (Huber et al., 2003; Ternes et al., 2003; Rosenfeldt et al., 
2006; Balcioglu et al., 2003). These processes are very promising for the removal of potential 
harmful constituents, microorganisms and viruses that may present in the reclaimed water. 
However, up to now, most of the studies on PPCPs degradation using these processes have 
been done to confirm the reactivity of PPCPs with O3, UV and OH radicals. In the future, in 
applying physicochemical processes such as UV-based processes (UV and UV/H2O2 
processes) and O3-based processes (O3, O3/H2O2 and O3/UV processes) for water reuse, it will 
be also necessary to take into consideration a required energy consumption and decrease 
effect of ecological risk as well as an effective PPCPs removal by the processes.  
 
1.2 Research objectives 
According to the above research background, detailed objectives of this research are as 
follows; 
1) To study the degradation characteristics of PPCPs by UV-based and O3-based 
processes, 
2) To investigate the removal performance of UV-based and O3-based processes for 
PPCPs in secondary effluent using a bench scale plant, 
and 3) To discuss the applicability of the investigated processes as water reuse 
technologies. 
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1.3 Research structure 
This dissertation consists of seven chapters. Fig. 1-1 shows the schematic diagram of 
research structure. Introduction of each chapter is as follows; 
In Chapter I, a research background, research objectives and research structure were 
described. In Chapter II, literature review was performed to obtain the knowledge on the 
PPCPs as an emerging contaminant, the world trend for water reuse and the potential of 
physicochemical processes such as UV-based and O3-based processes for PPCPs removal. 
In Chapter III, photodegradability of PPCPs with 2 types of UV lamps that emit at the 
wavelengths of 254 nm and 254 nm/185 nm, respectively, and the effect of H2O2 addition 
during UV process on the PPCPs degradation were studied in a laboratory scale plant. Tested 
waters spiked with 30 PPCPs, which were selected on the basis of consumption and 
environmental relevance, were used for batch UV treatment experiments. Degradation rate 
constants of the 30 PPCPs by UV and UV/H2O2 treatment were calculated, and UV doses 
required for the 90% removal of the 30 PPCPs in secondary effluent during UV and UV/H2O2 
processes were estimated.  
In Chapter IV, removal characteristics of the 30 PPCPs by O3, O3/UV and O3/H2O2 
processes were examined in the laboratory scale plant. Tested waters spiked with the 30 
PPCPs were used for semi-batch O3 process experiments. Degradation rate constants of the 30 
PPCPs by O3, O3/UV and O3/H2O2 treatment were calculated. O3 doses required for the 90% 
removal of the 30 PPCPs in secondary effluent during O3 and O3/UV processes were 
estimated. In Chapter V and VI, the operating factors such as UV dose, H2O2 addition, O3 
dose and UV combination for the removal of PPCPs by UV and O3 processes were 
investigated in a bench scale plant. Electrical energy and operating costs required for the 
effective removal of PPCPs in secondary effluent were also estimated for each process.  
In Chapter VII, the applicability of UV/H2O2, O3 and O3/UV processes as technologies 
for wastewater reuse considering the removal of PPCPs was discussed, based on energy 
consumption, disinfection effectiveness, the formation potential of by-products and decrease 
effectiveness of ecological risk as well as the removal effectiveness of PPCPs. 
In Chapter VIII, conclusions from this research and recommendations for further study 
were summarized.  
 4 





Laboratory scale investigation 
Photodegradation of PPCPs by 
UV-based processes 
Removal characteristics of PPCPs 
by O3-based processes 
- Tested water spiked with the 30 PPCPs 
(Batch experiments) 
- Determination of rate constants for UV 
and UV/H2O2 
- Estimation of UV dose for the effective 
removal of PPCPs in secondary effluent 
by UV-based processes 
- Tested water spiked with the 30 PPCPs 
(Semi-batch experiments) 
- Determination of rate constants for O3, 
O3/UV and O3/H2O2 
- Estimation of O3 dose for the effective 
removal of PPCPs in secondary effluent 
by O3-based processes 
[Chapter III] [Chapter IV] 
Bench scale investigation 
Performance of UV-based processes 
for PPCPs removal 
Performance of O3-based processes 
for PPCPs removal 
- Secondary effluent as tested water 
(Continuous experiments) 
- Effect of UV dose and H2O2 addition 
during UV process on the PPCPs removal 
- Estimation of electrical energy and 
operating cost for the effective PPCPs 
removal 
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operating cost for the effective PPCPs 
removal 
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reuse considering the PPCP removal 
- Discussion and evaluation based on the 
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2            LITERATURE REVIEW 
 
 
2.1 Introduction of PPCPs 
2.1.1 PPCPs and related knowledge 
2.1.1.1 Definition of PPCPs 
 “Not only is drug discovery important to the medical health of humankind, it is also an 
important component of our economic health.” “New chemical entities (NCEs) as 
therapeutics for human disease may become the “oil and gas” of the 21st century.” “As the 
world’s population increases and health problems expand accordingly, the need to discover 
new therapeutics will become even more pressing.” These were quoted from “Medicinal 
chemistry” written by Nogrady et al (2005) and, thus, the number of pharmaceuticals used by 
human is expected to increase continuously in the future, although the large number of 
pharmaceutical ingredients (>3,000) are registered now (Richardson et al., 2005).  
Pharmaceuticals and personal care products (PPCPs) are a group of various chemicals, 
used for the bodies of humans and domestic animals and plants. PPCPs consist of all drugs 
including the new genre of biologics, diagnostic agents, nutraceuticals, and other consumer 
chemicals such as fragrances and sun-screen agents (See Table 2-1). Many PPCPs are highly 
bioactive and most are polar when present in the environment, usually occur at no more than 
trace concentrations. PPCPs used in large amounts over the world have recently become a 
new environmental concern (Daughton et al., 1999; Ferrari et al, 2003) because of their high 
production level and their pharmacokinetical behavior during normal therapeutic use. One 
more reason is that a variety of PPCPs belonging to antibiotics, analgesics, lipids regulator 
agents, β-blockers and antiepileptics and so on have been detected in the aquatic environment. 
 
 8 
Table 2-1 Some chemical classified as PPCPs (Esplugas et al., 2007) 
 
Although the concentrations are generally at trace levels (ng/L to low µg/L) in the aquatic 
environment, it can be sufficient to induce toxic effects because all drug molecules are 
designed to interact with biological structures (e.g., biomembranes, the cell nucleus), 
biomolecules (e.g., lipoproteins, enzymes, nucleic acids) and other small molecules on their 
way “from the gums to the receptor” (Nogrady et al., 2005). 
On the other hand, Daughton (2004) has suggested that there may be as many as 6 




diclofenac, ibuprofen, ketoprofen, 
naproxen, 
Phenazone, indomethacine 
NSAIDs are the most used and abused drugs in the 
world today. All NSAIDs have analgesic, 
antipyretic and anti-inflammatory effect 
Antibiotics/antimicrobials Sulfonamides,fluoroquinolones, 
trimetoprim, hlortetracycline,  
erythromycin, lincomycin,  
oxytetracycline, tetracycline,  
roxithromycin, tylosin 
Antibiotics/antimicrobials are vital medicines for 
the treatment of bacterial infections in both humans 
and animals 
Antiepileptics Carbamazepine Antiepileptics are commonly used in medicine to 
stop, prevent, or control seizures (convulsions, 
partial seizures, generalized tonic-clonic seizures, 
etc.) 
Antihypertensives Bisoprolol, metoprolol, 
propranolol 
Antihypertensives are used to reduce the blood 
pressure in the arteries. It is difficult to prevent the 
hypertension, because a high blood pressure does 
not usually give signs or symptoms 
Antineoplastics Cyclophosphamide, ifosfamide Antineoplastics are commonly used in the treatment 
of various solid tumors, lymphomas, leukemias and 
in some autoimmune disorders such as rheumatoid 
arthritis 
Antiseptics Triclosan Antiseptics are chemical agents that slow or stop 
the growth of microorganisms (germs) on external 
surfaces of the body and help prevent infections. 
Antiseptics should be distinguished from antibiotics 
that destroy microorganisms inside the body, and 
from disinfectants, which destroy microorganisms 
found on inanimate (non-living) objects 
Contraceptives 7α-Ethynylestradiol Oral contraceptives are chemicals taken by mouth 




Albuterol Bronchodilators are medicines that help open the 
bronchial tubes (airways) of the lungs, allowing 
more air to flow through them 
Lipid regulators Clofibrate, bezafibrate Lipid regulators may be used to lower cholesterol 
and triglyceride (fat-like substances) levels in the 
blood 
Musks fragrances (synthetic) Nitromusks, galaxoline, tonalide,  
polycyclic musks,  
reduced metabolites of nitromusks 
Synthetic musk fragrances are commonly used in 
perfumery 
Anti-anxiety/hypnotic agents Diazepam Anti-anxiety/hypnotic agents are used to relieve 
anxiety, nervousness, and tension associated with 
anxiety disorders 
Sun screen agents Benzophenone, 
octylmethoxycinnamate, 
methylbenzylidene camphor 
Sun screen agents provide the protection against the 
harmful effects of the ultraviolet radiation coming 
from the sun 
X-ray contrast agents Diatrizoate, iopamidol, iopromide,  
iomepol 
Radiocontrast agents (or simply contrast agents) are 
compounds used to improve the visibility of 
internal bodily structures in an X-ray image 
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million PPCP substances commercially available worldwide and that the use of 
pharmaceuticals is increasing by 3%-4% by weight per annum. With increasing urbanization 
and associated commercial activities, and an increasing concern with personal care and health, 
the significance of PPCPs as a societal lifestyle cause of water pollution is likely to impose an 
increased risk. 
 
2.1.1.2 Research trends of PPCPs 
In U.S. many studies on the fate and transport of PPCPs in the aquatic environment, 
assessment of potential ecological effects and potential human health effects and so on have 
been done since 1990s. Especially, in STAR project started in 2001, studies on the occurrence 
and the fate of PPCPs in groundwater, drinking water, sewage treatment facilities and coastal 
waters, and effects of some PPCPs such as fluoroquinolone antibacterial agents in aquatic 
ecosystems have been investigated very widely and this project will also continue until 2010. 
Apart from the STAR project, U.S. EPA is carrying out a wide range of research for PPCPs 
management in the environment and in particular, PPCPs are considered in a research on the 
persistent contaminants from wastewater discharges during drinking water treatment. 
For Europe, 3 big projects on PPCPs called REMPHARMAWATER, ERAVMIS and 
POSEIDON, respectively, were done between 2000 and 2004. REMPHARMAWATER project 
was performed mainly for assessing the presence of PPCPs in wastewaters and sludges of 
municipal sewage treatment plants (STPs), the ecotoxicity of PPCPs found in STP effluents 
with respect to living organisms such as algae and invertebrates and fish, and the possibility 
of removing the PPCPs in STP effluents by means of integrated biological processes or AOP 
techniques. The objective of ERAVMIS project was to develop approaches for assessing the 
environmental impact of veterinary medicines released to the environment through the 
spreading of manure, slurry and sludge. Finally, for POSEIDON project, to develop a strategy 
to assess and improve the removal of PPCPs in wastewater and drinking water and, to 
perform environmental risk assessments (ERAs) for selected PPCPs were main objectives. 
The above three studies provided the first data to enable the assessment of the presence and 
effects of PPCPs in the environment at the European level. They also proposed solutions for 
PPCPs removal from wastewater (e.g. AOPs or sunlight). Furthermore, they have 
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demonstrated that microbial populations appear to change due to exposure to antibiotics.  
At the present in Europe, KNAPPE (Knowledge and Need Assessment on Pharmaceutical 
Products in Environmental Waters) project is in progress aiming at identification of the 
relevant priority actions to be taken in order to reduce presence, impacts and risk of 
pharmaceutical products in environmental waters. Regulatory approaches and prevention 
action will be also likely to be implemented.  
 
2.1.1.3 Methods for PPCPs determination 
About 3,000 different compounds are used as constituents of medicinal products in 
human and veterinary medicine and, therefore, it appears to be nearly impossible to develop 
analytical methods for all the PPCPs. Actually, analytical methods have only been developed 
for a very small subset of compounds (~150) in environmental matrices (Richardson et al., 
2005). Several methods have been developed for the determination of PPCPs in the lower 
ng/L range using solid phase extraction (SPE), derivatization, detection and confirmation by 
GC/MS (gas chromatography / mass spectrometry), GC/MS/MS, HPLC/MS 
(high-performance liquid chromatography coupled to mass spectrometry) and particularly 
tandem mass spectrometry (HPLC/MS/MS) and a wide range of PPCPs can be determined 
down to the lower ng/L range.  
Ternes et al (2001) have reported that a multi-analytical method which consists of SPE 
using 500mg RP-C18 (Merck), followed by methylation of carboxylic groups with 
diazomethane, acetylation of phenolic hydroxyl groups with acetanhydride / triethylamine 
(1:1, v/v) and determination by GC/MS was applied for the quantification of acidic drugs (e.g. 
antiphlogistics, lipid regulators), and their recoveries frequently exceeded 80% and standard 
deviations varied between 5% and 26%. Kanda et al (2003) have used GC/MS for the 
determination of musks, aspirin, clofibric acid, ibuprofen and triclosan in sewage treatment 
works, and the LOD (Limit of detection) of below 10 ng/L for each PPCP determined by 
GC/MS was attained. They have also carried out LC/MS analysis for fluvoxamine 
quantification and the LOD of 24ng/L was obtained.  
Many PPCPs have been detected in aqueous samples with LC/MS/MS, predominantly in 
the positive ion mode with ESI. A multicompound LC ESI-MS/MS method was developed by 
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Vanderford et al (2003), which enabled the determination of 27 compounds, including various 
pharmaceuticals, pesticides, steroids and personal care products. Hirsch et al (1998) 
determined the concentration of 18 antibiotics such as penicillins, tetracyclines, sulfonamides 
and macrolide antibiotics with LC/MS/MS. In the study, lyophilizaiton and SPE for 
pretreatment processes were also compared and, recoveries using SPE had a tendency to be 
slightly lower than for the lyophilization procedure. When using the freeze-drying enrichment 
step, LOQs (Limits of quantification) of the antibiotics were 50 ng/L for the tetracyclines and 
20 ng/L for all others, and the results were largely independent of the kind of water matrices. 
Okuda et al (2007) also have reported on the removal efficiency of 66 pharmaceuticals during 
wastewater treatment based on PPCPs quatification method with SPE-LC/MS/MS. In the 
study, they mentioned that limit of quantification for 66 pharmaceuticals ranged from 11 ng/L 
to 140 ng/L. 
 
2.1.1.4 Ecological effects of PPCPs 
Recently, PPCPs were identified as an emerging class of potential pollutants for the 
aquatic environment. In addition, Halling-Sørensen et al (1998) have reported that PPCPs 
may pose an environmental threat, as they have been designed to have a physiological effect 
on humans or animals, and an additional concern regarding the environmental impact of 
PPCPs is the fact that many of these compounds have been designed to be lipophilic and 
biologically persistent in order for them to pass through membranes and to remain active until 
their curing function has been performed.  
Potential risks associated with releases of PPCPs into the aquatic environment have 
become an increasingly important issue for environmental regulators and the pharmaceuticals 
industry (Jørgensen et al., 2000). Exposure of aquatic wildlife to human pharmaceuticals is 
most likely to occur from sewage treatment plants. Ferrari et al (2003) have investigated 
ecotoxicological impact of carbamazepine, clofibric acid and diclofenac found in treated 
wastewaters using bacteria, algae, invertebrates and fish. In their study, the risk was estimated 
by the PEC (predicted environmental concentration)/PNEC (predicted no-effect 
concentrations) ratio and the MEC (measured environmental concentration)/PNEC ratio. The 
result demonstrated that carbamazepine seemed the most dangerous tested compound for the 
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aquatic environments. They also suggested that among different keys for the hazard and risk 
assessment of pharmaceuticals, chronic effect studies seem to be highly adequate and the use 
of appropriate removal technologies in STPs should be an adequate approach for limiting 
aquatic risk.  
A study has been done to examine the cytotoxic and oxidative effects of PPCPs such as 
caffeine, ibuprofen, naproxen, oxytetracycline, novobiocin, carbamazepine gemfibrozil, 
bezafibrate, trimethoprim, sulfamethoxazole and sulfapyridine and other wastewater-related 
products such as estradiol-17β, nonylphenol and cholesterol with primary cultures of rainbow 
trout hepatocytes (Gagne et al., 2006). Primary cultures of rainbow trout hepatocytes were 
exposed to various drugs identified in the municipal effluent for 48h at 15°C. They suggested 
that the basic redox properties of PPCPs could influence oxidative metabolism in liver cells 
and lead to oxidative damage, indicating that the PPCPs have the potential to produce a toxic 
response in aquatic organisms.  
On the other hand, chronic aquatic toxicity tests have been adopted in the most recent 
draft of environmental risk assessment guidance document for human pharmaceuticals 
produced by the European Medicines Agency (EMEA, 2005) in support of Directive 
2001/83/EC (EC, 2001). In contrast to acute toxicity tests, which often use mortality as the 
only measured effect, chronic tests usually include additional measures of effect such as 
growth or reproduction (Crane et al., 2006). Little is known about chronic effect of most 
pharmaceuticals, although an increasing amount of information is becoming available on the 
effects of antimicrobial substances. Several authors have measured alterations in microbial 
assemblages after exposure to antibiotics at concentrations similar to those found in hospital 
wastewaters (Al-Ahmad et al., 1999; Kummerer et al., 2000). Ash et al (2002) found 
evidence of resistance to imipenem and the beta-lactams ampicillin, cefotaxime and 
ceftazidime in bacteria cultured from water samples taken from UV streams. 
However, it does not seem to be clear to decide whether PPCPs pose a significant threat 
to the aquatic environment. The most practical current solution to this problem will be to test 
the acute and chronic toxicity of a range of model substances, representative of the range of 
modes of action of human pharmaceuticals, on a representative range of aquatic organisms. 
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2.1.2 Sources and degradation of PPCPs in the aquatic environment 
In contrast to other pollutants, PPCPs are present in the environment directly because of 
their frequent use by individuals dispersed throughout the community or concentrated in 
medical centers and hospitals (Halling-Sørensen et al., 1998). Disposal of unused PPCPs can 
also be a route to the environment either through disposal to sewer via the toilet or drain, or to 
landfill in domestic refuse or as special waste by waste contractors. Other sources of PPCPs 
will be landfill leachates, manufacturing residues and agriculture applying large amounts of 
PPCPs as veterinary drugs and feed additives in livestock breeding (Heberer, 2002). 
On the other hand, PPCPs have been detected in samples from all aquatic environment 
such as sewage effluent, river water, ground water and drinking water. It has been reported 
that many PPCPs occurred in ground water and drinking water samples from water works 
using bank filtration, artificial ground water recharge or downstream from STPs (Heberer et 
al., 1997). Daughton et al. (1999) have reported that most of PPCPs were disposed or 
discharged into the aquatic environment via sewage treatment plants and wet-weather runoff. 
Many of the pharmaceuticals applied in human medical care are not completely eliminated in 
the human body. They are excreted by the state only slightly transformed or even unchanged 
and mostly conjugated to polar molecules. These conjugates can easily be cleaved during 
sewage treatment and the original PPCPs will then be released into the aquatic environment 
mostly by effluents from STPs (Heberer, 2002). There are several investigations showed that 
PPCPs are not eliminated during wastewater treatment and also not biodegraded in the 
environment (Ternes, 1998; Daughton et al., 1999; Nakada et al., 2006; Okuda et al., 2007).  
Antiphlogistics, betablockers, lipid regulators, antibiotics, antiepileptics, estrogens and 
iodinated X-ray contrast media as well as personal care products such as musk fragrances are 
discharged into receiving waters due to their incomplete removal in municipal sewage 
treatment plants. Obviously, the currently applied wastewater treatment techniques are 
inappropriate to remove significantly those trace pollutants. Therefore, more enhanced 
technologies such as ozonation, advanced oxidation processes (AOPs) or membrane filtration 
may be crucial for the future. In drinking water treatment, it has already been shown that 
ozonation and AOPs are very effective in oxidizing pharmaceuticals (Zwiener et al., 2000; 
Ternes et al., 2002). 
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2.1.3 Position of this research 
From literature review of this section, it can be known that a variety of PPCPs may be 
present in the aquatic environment. In addition, PPCPs can affect water quality and potentially 
impact drinking water supplies, ecosystem and human health if they are continuously 
introduced into the environment and are prevalent at low concentrations. Hence, it is 
necessary to treat the effluents containing PPCPs adequately before discharging them from 
STPs, a main source of PPCPs. These PPCPs are not completely removed by conventional 
activated sludge treatment. Very little information is still available because of the use of a 
great variety of PPCPs although there are several studies on the PPCPs removal with 
physicochemical processes such as O3, UV, AOPs, chlorination, activated carbon adsorption 
and membrane treatment. Therefore, the removal potential of UV-based (UV and UV/H2O2) 
and O3-based (O3, O3/H2O2 and O3/UV) processes for the 30 PPCPs, which were selected 
based on consumption and environmental relevance, was examined in Chapter III and IV of 
this dissertation. 
 
2.2 Circumstances for water demand and reuse 
2.2.1 Overview of water reuse  
The demand for water will increase with the dramatic increase of the world urban 
population by the year 2020 (See Fig. 2-1). However, available water resources have been 
already limited in many areas of the world and, therefore, water reuse and reclamation will be 
necessary for extending available water resources. In addition, there has also been a growing 
interest in water reuse according to the advanced technologies for water treatment such as 
membrane treatment and advanced oxidation processes (AOPs). 
Water reuse is a relatively new market, though growing rapidly, and already supplying 
just under 0.2% of total water abstraction. With a forecast annual growth rate of 14%, it is 
predicted to outstrip desalination by 2020 (Pearce, 2008). Wastewater treatment normally 
consists of a biological treatment stage, known as conventional activated sludge and 
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clarification process. If followed by filtration, e.g. by a sand filter, the treatment is known as 
tertiary treatment. Historically, 70% of reused wastewater has only been treated to a 
secondary or tertiary standard, which would only be suitable for agricultural use in less 
developed parts of the world (Pearce, 2008). To be considered for reintroduction to the 
drinking water supply chain, and for most industrial uses, wastewater normally requires a 
further level of treatment. 
 
Fig. 2-1 Estimated and Projected Urban Population in the World (U.S. EPA, 2004) 
 
2.2.2 Technologies for water reuse 
U.S. EPA suggests wastewater treatment processes, reclaimed water quality, monitoring, 
and setback distances for various types of water reuse. Suggested guidelines include the 
following categories: urban reuse, restricted access area irrigation, agricultural reuse, 
recreational impoundments and landscape impoundments, construction uses, industrial reuse, 
environmental reuse, groundwater recharge and indirect potable reuse. Fig. 2-2 and 2-3 show 
the types of reuse occurring in California and Florida, respectively, accounting for the 
majority of the water reuse in the U.S. 
On the other hand, one of the most critical objectives in water reuse is to ensure that 
public health protection is not threatened by the use of reclaimed water. Public health 
protection can be achieved by (1) reducing or eliminating concentrations of pathogenic 
bacteria, parasites, and enteric viruses in the reclaimed water, (2) controlling chemical 
constituents in reclaimed water, and/ or (3) limiting public exposure (contact, inhalation, 
ingestion) to reclaimed water. The most commonly used disinfectant for eliminating 
pathogens is chlorine. O3 and UV are also promising disinfection alternatives used at 
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wastewater treatment plants. However, U.S. EPA suggests disinfection effectiveness and 
reliability, capital costs, operating and maintenance costs, and potential adverse effects when 
evaluating such disinfection alternatives.  
 
Fig. 2-2 California water reuse by type (Total 358 mgd) (U.S. EPA, 2004) 
 
 
Fig. 2-3 Florida water reuse by type (Total 584 mgd) (U.S. EPA, 2004) 
 
The chemical constituents potentially present in municipal wastewater are a major 
concern when reclaimed water is used for potable reuse. Several studies (Purdom et al., 1994; 
Harries et al., 1997) demonstrated that chemicals in wastewater effluent caused male fish to 
exhibit female characteristics, resulting in a great concern with respect to water reuse. 
Therefore, advanced wastewater treatment beyond traditional secondary treatment should be 
applied especially if high quality reclaimed water such as for urban landscaping, food crops 
eaten raw, contact recreation, many industrial applications and so on is needed. Advanced 
wastewater treatments include filtration, UV treatment, coagulation-sedimentation, carbon 
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adsorption and membrane processes. 
Stackelberg et al. (2004) conducted a study on the persistence of pharmaceutical 
compounds and other organic wastewater contaminants using a conventional drinking water 
treatment plant consisting of flocculation-sedimentation-GAC (granular activated carbon) 
filtration process. In their study, 34 out of 106 organic contaminants were detected in more 
than 10% of the 24 water samples collected at a drinking water treatment facility. The 34 
compounds included prescription and non-prescription drugs and their metabolites, fragrance 
compounds, cosmetic compounds and a solvent. Consequently, they suggested the 34 
compounds removal through conventional water treatment processes. There are several 
studies using nanofiltration and/or ultrafiltration membranes for PPCPs retention (Nghiem et 
al., 2005; Yoon et al., 2006). Retention of trace organics by membranes highly depends on the 
compound’s physicochemical properties, the solution chemistry and the membrane retention 
behavior still poorly understood.  
Low PPCPs removal in wastewater treatment process has been already reported by 
several researchers (Nakada et al., 2006; Okuda et al., 2007). In addition, potential risks of 
PPCPs into the aquatic environment have become an increasingly important issue for 
environmental regulators and the pharmaceuticals industry as mentioned above. Therefore, 
the issue on PPCPs as an emerging contaminant is also likely to grow in succession in the area 
of water reuse.  
 
2.2.3 Position of this research 
In the literature review mentioned above, it can be found that much more attentions will 
be paid on the reuse of secondary effluent of municipal wastewater in the future because of 
the shortage of water resources. With respect to the increase of water reuse, it will also 
become very important to consider the health assessment of pathogenic microorganisms, 
chemical constituents and endocrine disrupters for the reuse of secondary effluent. 
Chlorination is the most widely used for the disinfection of pathogenic microorganisms. 
Whereas, filtration, UV treatment, coagulation-sedimentation, carbon adsorption and 
membrane processes are suggested for the removal of chemical constituents in the guidelines 
for water reuse (U.S. EPA, 2004). However, as discussed above, it is thought that the removal 
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of PPCPs by the suggested processes will not be so effective. 
Therefore, in this study the removal efficiency of O3-based processes (O3 and O3/UV) 
and UV-based processes (UV and UV/H2O2) for PPCPs present originally in secondary 
effluent was investigated in order to evaluate the applicability as processes for water reuse. 
On the other hand, energy-saving treatment processes are recommended for the reduction of 
operating cost. It is very difficult to compare processes from different papers because the cost 
analyses are often based on different assumptions and, consequently, they can lead to very 
different operating costs. However, comparison of the operating cost associated with different 
processes is a subject of major importance. Therefore, this study estimated the electrical 
energy and operating costs required for the effective PPCPs removal by 4 processes (UV, 
UV/H2O2, O3 and O3/UV) using the same secondary effluent and the same assumptions. The 
results were described in Chapter V.  
 
2.3 Removal of PPCPs by UV-based and O3-based processes 
2.3.1 UV-based processes 
Ultraviolet (UV) is an effective disinfectant in water and is used widely for this purpose 
in many countries. The portion of the UV radiation band that is most effective for inactivating 
microorganisms is between about 220 and 320 nm. UV disinfection is generally more 
effective than chlorine for inactivation of most viruses, spores and cysts. However, UV does 
not show a good oxidation power of organic compounds when it is used alone. UV/H2O2 
process, one of UV-based processes, has been shown to degrade 99.9% of various 
contaminants including benzene (Weir et al., 1987), trichloroethene (Weir and Sundstrom, 
1993), pesticides (Beltran et al., 1993) and acetone (Stefan et al., 1996) although the rates of 
parent compound transformation differ widely. 
UV/H2O2 process used UV radiation to cleave the O-O bond in H2O2 and generate the 
OH radical (Glaze et al., 1987). The OH radical can then be scavenged by an organic 
compound to oxidize the organic, recombine with other hydroxyl species to reform H2O2 or 
initiate a radical chain degradation of H2O2 in the series of reactions shown below (Glaze et 
al., 1987): 
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OHOHOH hv ⋅+⋅→22    (1) 
⋅+→+⋅ 2222 HOOHOHOH   (2) 
OHOOHOHHO ⋅++→+⋅ 22222  (3) 
22222 OOHHO +→⋅    (4) 
 
OH radicals commonly attack organic molecules by abstracting a hydrogen atom frome 
the molecule (Clarke and Knowles, 1982). There are several studies on the degradation of 
PPCPs by UV and/or UV/H2O2 processes. Table 2.2 shows the results of UV-based processes 
used to degrade PPCPs in aqueous samples and sewage effluents. As known in Table 2.2, UV 
process was combined with H2O2, TiO2 or Fenton due to its poor removal potential for PPCPs. 
On the other hand, most of these studies were carried out at laboratory scale, and only a few 
PPCPs have been investigated on the degradation by UV, UV/H2O2 or UV/TiO2 processes. As 
mentioned before, PPCPs are a various group of chemicals and tens of PPCPs have been 
detected in the aquatic environment. This means that much more studies on the PPCPs 
removal are necessary to be done. 
 
2.3.2 O3-based processes 
The structure of O3 has been described as a resonance hybrid of the four canonical forms. 
Table 2.3 shows some important properties of O3. The main reasons for the use of O3 are 
disinfection and oxidation such as taste and odor control, decolorization, elimination of 
micropollutants and so on. Similar to other disinfectants such as chlorine or chlorine dioxide 
for water treatment, O3 is unstable in water, and undergoes reactions with some water matrix 
components. However, the O3 is decomposed, forming OH radicals which are the strongest 
oxidants in water (Staehelin et al., 1985). While disinfection occurs dominantly through O3, 
oxidation processes may occur through both oxidants, O3 and OH radicals (Langlais et al., 
1991). O3 reacts with a large number of inorganic and organic compounds. The fact that rate 
constants for the reaction with O3 range over several orders of magnitude demonstrates that 
O3 is a very selective oxidant. With respect to organic compounds, O3 is particularly reactive 
toward phenols, amines, compounds exhibiting C=C double bonds, and activated aromatic 
compounds.  
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Table 2-2 Results of PPCPs degradation by UV-based processes 
 











UV Low pressure lamp (254 nm); C0 
= 20 and 50 mg L−1; T=20˚C; pH 
7.5; Tr = 30 min 
Normal UV dose (30 mJ cm−2) used in 
water treatment plants were not enough 
to remove antibiotics. By using UV 
dose of 3.0 J cm−2, antibiotic removals 
between 50% and 80% were reached  
Adams et al. (2002) 
2003 Clofibric acid Aqueous 
solution 
UV/H2O2 Low pressure lamp (17W, 254 
nm); C0 = 1.0 mmol L−1; CH2O2 = 
1.0 mol L−1; pH 5; Tr=60min 
Almost complete removal of clofibric 
acid in 60 min with small 
mineralization 
Andreozzi et al.  
(2003) 
2004 Carbamazepine Doubly 
distilled water 
UV/H2O2 Low pressure lamp (254 nm); C0 
=20µmol L−1; CH2O2 = 5.0 mmol 
L−1; pH 5; Tr = 4 min 
100% removal of carbamazepine in 4 
min of treatment with a 35% removal 
of TOC. Intermediates formed in the 
oxidation were more toxic than the 
original pharmaceutical 
Vogna et al. 
(2004) 
2004 Diclofenac Doubly 
distilled water 
UV/H2O2 Low pressure lamp (17W, 254 
nm); I0 = 2.7µEinstein s−1; C0 = 
1.0µmol L−1; CH2O2 = 0.1 or 1.0 
mol L−1; pH 7.0 
100% removal of diclofenac with a 
complete release of chlorine by using 
H2O2/UV. Almost 40% of chlorine 
formed chlorate ions 
Vogna et al. 
(2004_ 




Photocatalysis TiO2 in suspension; solar 
simulator (1kW Xe lamp) 
Efficient removal degree was reached 
by using photocatalysis 
Doll and Frimmel 
(2005) 
2005 Antibiotic (amoxiline) Aqueous 
solution 
UV/H2O2 Low pressure lamp (254 W); C0 = 
0.5 mmol L−1 
The kinetic constant for the direct 
attack depends strongly in the pH of 
the solutions. UV/H2O2 was used to 
evaluate the constant for the OH 
radical attack to the amoxicillin 
molecule at pH 5.5. Kinetic constant 
obtained kOH,AM = 3.93 nmol L−1 s−1 
Andreozzi et al. 
(2005) 





Low pressure lamp; UV= 0–600 
mJ cm−2; CH2O2 = 25 − 50 mg L−1; 
C0 =6µmol L−1; pH (UV) = 6 pH 
(photo-Fenton) = 3.5 
UV provides small degradation 
compared to UV/H2O2. Photo-Fenton 
gives 20% higher removal than Fenton 
Shemer et al. 
(2006) 




Photocatalysis TiO2 was dosed at a rate of 
1.5gL−1; C0 =10mgL−1 
The system had a high removal rate of 
over 90% 
Areerachakul et al. 
(2007) 
2007 Sulfonylurea herbicide Milli Q water Photocalatalysis Light source HPK 125W Philips 
(365 nm); C0 = 25, 15, 10 and 
5mgL−1 
The degradation rate was strongly 
affected by the TiO2 amount and the 
light flux. More than 20 intermediates 
were unambiguously identified 




Table 2-3 Selected properties of O3 
 
O3-based AOPs are applied to oxidize O3-resistant compounds too, such as pesticides and 
chlorinated solvents such as tri- and tetrachloroethene, by OH radicals. OH radical is a 
powerful and non-selective oxidant. It reacts very fast with various inorganic and organic 
components of the water matrix. Therefore, OH radicals can also contribute to the oxidation 
of micropollutants. However, their efficiency is most often limited by the scavenging effect of 
the water matrix. In O3-based AOPs, the formation of OH radicals during O3 process is 
accelerated by increasing the pH of the water, by dosing H2O2, or by the application of UV 
irradiation. This can ensure a faster oxidation of compounds that do not exhibit an appreciable 
reactivity with O3 directly. 
However, it has to be emphasized that the application of AOPs does not increase the 
overall oxidation capacity of O3 process. The main advantage of O3-based AOPs is a shorter 
reaction time which allows the application of higher O3 dose without causing excess O3 
concentrations at the outlet of a reactor (von Gunten, 2003). There are relatively many studies 
on the degradation of PPCPs by O3-based processes. Table 2.4 shows the results of O3-based 
processes used to degrade PPCPs in aqueous samples and sewage effluents. As known in 
Table 2.4, removals higher than 90% were reached for several PPCPs such as 
anti-inflammatories, antiepileptics and antibiotics. O3 process was the oxidation process most 
studied which gives a good expectative to be applied with success although some PPCPs seem 
to be a little more recalcitrant to the oxidation (clofibric acid and X-ray contrast agents).
Molecular weight 48.0g/mol Diffusion coefficient 1.7 × 10-9m2/s 
Melting point -193˚C UV absorption ε(258nm)=3,000/M/cm 
Boiling point -112˚C Instant odor threshold 40µg/m3 




Table 2-4 Results of PPCPs degradation by O3-based processes 
 
    
Year Compound Type of Water Process Operational conditions Results References 
2003 Clofibric acid Aqueous solution 
 
Ozonation Tr = 60 min; pH 2.0–6.0; C0 = 
1.0–1.5 mmol L−1; CO3 aqueous = 
1.0×10−5 mol L−1 
100% removal of clofibric acid was reached in 20 
min with 34% mineralization. 49% mineralization 
was reached in 60 min. No halogenocompounds 
were detected in the oxidation products 
Andreozzi et al. 
(2003) 







Milli Q, river 




CO3 = 0.1; 0.2; 0.5; 1.0 and 2.0mg 
L−1; C0 = 0.5µmol L−1; natural 
water properties: pH 7.2–7.9; 
COD= 0.8–3.7 mg L−1; alcalinity 
= 0.7–5.8 mol L−1 HCO3− 
Ozone doses ranging from 0.2 up 0.5 mg L−1 were 
observed with 97% removal of all compounds. 
Removal of bezafibrate was lower  
Huber et al. 
(2003) 
2003 Iodinated X-ray contrast 
media 
antibiotics, betablockers, 
antiphlogistics, lipid regulator 
metabolites, antiepileptics and 
estrogens 
DWTP effluent Ozonation 
 
CO3 = 5, 10, 15 mg L−1; effluent 
properties: pH 7.2; 
DOC=23mgL−1; COD=30mgL−1; 
SST = 4.5 mg L−1 
Ozone doses ranging from 5 up to 15mg L−1 were 
necessary for complete removal of these 
compounds. The only exceptions were iodinated 
X-ray contrast media which were removed 
13–89% with ozone doses from 10 to 15 mg L−1, 
respectively 








pH 5.0; 5.5 and 6.0; 
scavenger = tert-butyl alcohol; 
C0 = 0.1 mmol L−1; CO3 
Aqueous = 0.1 mmol L−1 
100% of chlorine release was observed and 32% 
mineralization 
 
Vogna et al. 
(2004) 
2005 Antibiotic (amoxicillin) 
 
Aqueous solution Ozonation 
 
C0 = 0.5 mmol L−1; 
CO3 = 0.16 mmol L−1; pH 2.5–5.0 
Low mineralization and some by-products were 
identified 
Andreozzi et al. 
(2005) 
2006 Antibiotic (clarithromycin) 
 
Milli Q water Ozonation 
 
C0 = 0.1 mmol L−1; 
CO3 = 10 µmol L−1; T=20 ◦C 
Biological activity of clarithromycin was reduced 
after ozonation 
Lange et al. 
(2006) 
2007 Benzafibrate (lipid regulator) 
 
Distilled water Ozonation 
 
CO3 = 1µmol L−1; 
C0 = 0.2µmol L−1; pH 6 to 8 
The complete BZF abatement is achieved. 
However, only a small part of the substrate is 
mineralized 
Dantas et al. 
(2007) 




C0 = 4 and 400µmol L−1; 
CO3 = 20 mg L−1 
No significant influence of ozone pre-treatment 
was observed on PPCPs elimination except for 
carbamazepine 
Carballa et al. 
(2007) 
2007 Ibuprofen, bezafibrate,  
amoxicillin, sulfamethoxazole 
Pure water Ozonation C0 =10µmol L−1 In the ozone-Membrane Filtration hybrid 
experiments, the pre-ozonation was able to reduce 
the membrane fouling 




2.3.3    Position of this research 
As known above, up to now, most of studies on the removal potential of O3, UV and 
AOPs for PPCPs have been performed using laboratory scale investigation. However, 
considering tens of PPCPs detected in the aquatic environment, more practical approaches 
such as the expansion of target PPCPs and the magnification of experimental setup are also 
necessary for efficient PPCPs control. In this study, bench scale continuous O3-based and 
UV-based processes were operated for the removal of various PPCPs present originally in 
secondary effluent. Moreover, the practical approaches should include an integrated 
discussion on the disinfection effectiveness, decrease effect of ecological risk and the 
formation potential of by products as well as the PPCPs removal effectiveness and a saving of 
operating cost. In Chapter VI, the integrated discussion on the applicability of O3-based and 
UV-based processes into technologies for water reuse was done based on the results from this 
study and previous researches.  
 
2.4 Summary 
Chapter II made a literature review on PPCPs and their removal processes such as UV 
treatment, O3 and advanced oxidation processes (AOPs). The findings from this literature 
review were as follows; 
1) Very little information on the removal characteristics of PPCPs is still available 
although there are several studies on the PPCPs removal with physicochemical processes such 
as O3, UV, AOPs, chlorination, activated carbon adsorption and membrane treatment.  
2) Therefore, considering a variety of PPCPs detected in the aquatic environment, more 
practical approaches such as the expansion of target PPCPs and the magnification of 
experimental setup are also necessary for efficient PPCPs control. 
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3 PHOTODEGRADATION OF PHARMACEUTICALS AND 





There are a great variety of pharmaceuticals and personal care products (PPCPs) for 
human and veterinary health in the medical field. Among these PPCPs, it has been reported 
that tens of PPCPs including antibiotic clarithromycin and anti-inflammatory agent diclofenac 
were detected in the range of ng/L to µg/L order from the effluent of sewage treatment plant 
and river water (Thomas, 2002; Tvrtko et al., 2004; Nakada et al., 2007; Okuda et al., 2008). 
However, much more PPCPs may exist in the aquatic environment, because it is estimated 
that the number of PPCPs being used in the medical field exceeds 3,000 (Richardson et al., 
2005). Therefore, limitation of PPCPs reduction in water treatment plants could cause their 
contamination in the water environment, resulting in recent emerging concerns of the safety of 
drinking water, wastewater reclaimed and reuse, and aquatic ecosystems.  
UV treatment, which is becoming popular for disinfection of potable water, lacks 
knowledge on applicability for the PPCPs removal in wastewater treatment system. However, 
recently many studies on the removal of various organic materials such as 
N-nitrosodimethylamine (NDMA), pharmaceuticals, hydrocarbons and water soluble fraction 
of crude oil with UV treatment have been done because UV treatment does not form 
byproducts. Moreover, it has been known to an effective process for degrading organic 
matters especially when it is combined with O3 or H2O2 (Ziolli et al., 2003; Blatchley III et al., 
2007; Mascolo et al., 2007; Plumlee et al., 2008; Canonica et al., 2008). NDMA, one of 
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several N-nitrosamines classified as human carcinogens, is a disinfection byproduct formed 
from the chlorination and chloramination of drinking water and wastewater. It has been 
reported that UV treatment of NDMA resulted in removals of 43% - 66% in advanced 
processes consisting of disinfection by chlorination, microfiltration, RO (reverse osmosis) and 
an ultraviolet-hydrogen peroxide advanced oxidation system (Plumlee et al., 2008). This 
study suggested that UV irradiation in combination with RO treatment and, in some cases, 
blending will allow operators to reliably maintain the residual NDMA below the 10 ng/L 
Califonia drinking water notification level. 
There is some information on the removal of PPCPs in real sewage water using UV 
treatment (Andreozzi et al., 2003; Doll et al., 2003; Lopez et al., 2003). Lopez et al. (2003) 
have studied on the UV and UV/H2O2 degradations of pharmaceutical intermediates in 
aqueous solution. They found that two pharmaceutical intermediates 
(5-methyl-1,3,4-thiadiazole-2-methylthio and 5-methyl-1,3,4-thiadiazole-2thiol) degradation 
by photo-oxidation was always faster than degradation by direct photodegradation, and that 
during direct photodegradation, a lower substrate initial concentration led to a faster and more 
efficient degradation. Vogna et al. (2004a) have conducted a study on diclofenac oxidation 
with UV/H2O2 and ozone, and showed that both ozonation and UV/H2O2 systems proved to 
be effective in inducing diclofenac degradation. In other study, they reported that UV/H2O2 
process could degrade carbamazepine very effectively, while UV alone process was not 
effective for reducing carbamazepine concentration (Vogna et al., 2004b). A study on the 
potential effectiveness of UV and UV/AOP (Advanced Oxidation Process) as drinking water 
remediation technologies for PhACs (Pharmaceutically Active Compounds) found most 
commonly in surface waters has been done (Pereira et al, 2007). In the study, for 6 PhACs 
such as carbamazepine, naproxen, clofibric acid, iohexol, ciprofloxacin and ketoprofen, their 
removal from surface water during UV and UV/H2O2 treatments was evaluated using 
fundamental photodegradation parameters in laboratory-grade water for all targeted PhACs. 
The model developed in their study predicted the experimental UV removals.  
Canonica et al. (2008) evaluated the extent of degradation of four selected 
pharmaceuticals such as 17α-ethinylestradiol (EE2), diclofenac, sulfamethoxazole and 
iopromide in UV drinking water treatment for disinfection purposes. At the UV-C (254 nm) 
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drinking water disinfection fluence of 400J/m2, the degree of depletion of the select 
pharmaceuticals at pH 7.0 in pure water was 0.4% for EE2, 27% for diclofenac, 15% for 
sulfamethoxazole, and 15% for iopromide. 
Several studies on PPCPs degradation in UV and UV/H2O2 processes have been carried 
out as described above. However, limited PPCPs have been investigated in those studies, 
despite a great variety of PPCPs in the aquatic environment. The aim of this research is to 
examine the photodegradation characteristics of PPCPs detected often in the aquatic 
environment with UV treatment. Moreover, the effectiveness of H2O2 addition for PPCPs 
degradation during UV treatment was investigated. Finally, UV doses required for the 
effective removal of each PPCP were estimated. This information is useful for expecting the 
removal potential of UV process for various PPCPs in water and wastewater treatment plant.  
The structure of this chapter is indicated in Fig. 3-1. 
 
Fig. 3-1 Structure of this chapter 
 
3.2 Materials and methods 
3.2.1 Selected PPCPs 
A list of 30 PPCPs was selected for this study based on consumption and environmental 
relevance. The name and use of the selected PPCPs are shown in Table 3-1. The PPCPs 
consist mainly of analgesics, antiarrhythmia agents, antibiotics and bronchiodilators. Anti-itch 
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drugs, anticonvulsants, antineoplastic agents, insect repellents, carbadox (antiparasitic agent) 
intermediates and NMDA (N-methyl d-aspartate) receptor antagonists are also included. Most 
of the PPCPs have been detected in the river water and/or effluent from sewage treatment 
plants in Japan (Okuda et al., 2008). Twenty-eight of the PPCPs were obtained from Wako, 
Japan; levofloxacin (Fluka) and ceftiofur (Hayasijyunyaku, Japan) were the exceptions. The 
concentrations of stock solutions of the PPCPs ranged from about 100-1,000 mg/L and were 
prepared with methanol or acetone due to their low solubility in water and stored at 4°C. The 
molecular weights, octanol-water partition coefficients (log Kow) and pKas of the PPCPs 
ranged from about 151.165 (acetaminophen) to 747.964 (clarithromycin), -1.30 (tetracycline) 
to 5.12 (mefenamic acid), and 1.40 (antipyrine) to 9.42 (propranolol), respectively.  
 
Table 3-1 Selected 30 PPCPs 
No. Name of PPCPs Use Molecular Formula Molecular
weight Log Kow pKa
Water solubility
(mg/L, @25℃)
1 Acetaminophen C8H9NO2 151.165 0.46 9.38 14,000
2 Antipyrine C11H12N2O 188.230 0.38 1.40 51,900
3 Diclofenac C14H11Cl2NO2 296.153 4.51 4.15 2.37
4 Ethenzamide C9H11NO2 165.192 0.77 - -
5 Fenoprofen C15H14O3 242.274 3.90 7.30 -
6 Indomethacin C19H16ClNO4 357.793 4.27 4.50 0.937
7 Isopropylantipyrine C14H18N2O 230.311 1.94 - 3,000,000
8 Ketoprofen C16H14O3 254.285 3.12 4.45 51
9 Mefenamic acid C15H15NO2 241.290 5.12 4.20 20
10 Naproxen  C14H14O3 230.263 3.18 4.15 15.9
11 Disopyramide C21H29N3O 339.483 2.58 - 44.9
12 Metoprolol C15H25NO3 267.369 - - -
13 Propranolol C16H21NO2 259.349 3.48 9.42 61.7
14 Ceftiofur C19H17N5O7S3 523.553 - - -
15 Chlorotetracycline C22H23ClN2O8 478.885 -0.62 3.30 630
16 Clarithromycin C38H69NO13 747.964 3.16 8.99 0.342
17 Oxytetracycline C22H24N2O9 460.439 -0.90 3.27 313
18 Sulfadimethoxine C12H14N4O4S 310.328 1.63 - 343
19 Sulfadimidin C12H14N4O2S 278.330 0.89 7.59 1,500
20 Sulfamethoxazole C10H11N3O3S 253.276 0.89 - 610
21 Sulfamonomethoxine C11H12N4O3S 280.302 0.70 - 4,030
22 Tetracycline C22H24N2O8 444.440 -1.30 3.30 231
23 Carbamazepine Anticonvulsant C15H12N2O 236.274 2.45 - 17.7
24 Crotamiton Anti-itch drug C13H17NO 203.285 2.73 - -
25 Cyclophosphamide Antineoplastic agents C7H15Cl2N2O2P 261.089 0.63 - 40,000
26 Clenbuterol C12H18Cl2N2O 277.195 2.00 - -
27 Theophylline C7H8N4O2 180.167 -0.02 8.81 7,360
28 2-QCA Carbadox(Antiparasitic
agents) intermediate C9H6N2O2 174.159 - - -
29 DEET Insect repellents C12H17NO 191.274 2.18 - 912






- : No data 
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3.2.2 Water used in the experiments 
Test water was prepared by spiking the stock solutions of the 30 PPCPs into pure water 
(PW) purchased from Nisso Shoji Co., Ltd and biologically treated water (TW), respectively.  
Secondary effluent of sewage treatment plant was used for TW. TOC concentration of PW 
was below 50 µg/L, and the pH and DOC concentration of TW ranged 6.7 to 7.0 and 3.9 mg/L 
to 4.0 mg/L, respectively.  
 
3.2.3 Preparation of tested water 
In order to prepare the test water for UV and UV/H2O2 treatments, 2.2 ml of each stock 
solution was added to a 300 mL flask. Afterwards, the methanol and acetone used as solvents 
in the stock solutions were volatilized by an N2 gas purger with a flow rate of about 3-4L N2 
gas/min at 37°C to prevent them from absorbing UV energy and deteriorating the removal of 
the PPCPs during UV treatments. After this procedure, only the PPCPs remained adhered to 
the flask. The 30 PPCPs adhered to the flask were dissolved by adding an appropriate amount 
of PW to the flask and agitating with a magnetic stirrer. This solution was continuously 
agitated for at least 12 hours to allow the PPCPs to be sufficiently dissolved in the PW. After 
agitation, the solution was filtered with a 0.45 µm membrane filter to remove undissolved 
PPCP particles. The filtrate was adjusted to a final volume of 1 L with PW. Finally, 22 L of 
test water for each experiment was prepared by mixing the 1L solution with 21 L of PW or 
TW. For tested water spiked the 30 PPCPs into PW, the pH was adjusted to 7.0 with 
phosphate buffer solution of 1M manufactured by K2HPO4 and NaH2PO4 solution before 
experiments. TW used for preparing tested water was filtered by GF/C filter (Whatman) 
before use. The pH adjustment of tested water prepared by TW was not done. The initial 
concentrations of the 30 PPCPs in tested water ranged from 5 µg/L (clenbuterol) to 119 µg/L 
(propranolol). 
 
3.2.4 Experimental setup and conditions 
UV treatment was carried out using a cylindrical stainless reactor with an interior 
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diameter of 30 cm and a height of 108.7 cm (See Fig. 3-2). The test water was agitated 
continuously at a speed of 300 rpm with an agitator on top of the reactor during treatment 
experiments. A UV lamp was introduced into the reactor and kept separated from the tested 
water by UV sleeve. The temperature of the test water was maintained at 20°C by circulating 













Fig. 3-2 Batch reactor for UV and UV/H2O2 experiments 
 
An 8W low-pressure mercury lamp emitting at 254 nm (UV/Lamp1) was used, and the 
UV intensity was 0.384 mW/cm2. Additionally, the removal potential of a 10W low-pressure 
mercury lamp emitting at 254 and 185 nm (UV/Lamp2) for PPCPs was also ivestigated. The 
UV intensity of UV/Lamp2 was 0.388 mW/cm2. A UV lamp emitting at 254 nm is widely 
used for water disinfection because it is very effective for destroying DNA in microorganism. 
Generally, UV emitted at wavelengths of less than 200 nm photolyzes H2O molecular, and as 
a resulte, OH radicals and hydrogen ions form. The OH radicals can contribute to the 
oxidation of organic materials (Han et al., 2004).  
In order to investigate the removal potential of the 30 PPCPs, firstly, treatment 
experiments using UV/Lamp1 and UV/Lamp2 were done for tested waters spiked with the 30 
PPCPs into PW. Secondly, the effect of H2O2 addition on the PPCPs degradation during UV 
treatment was investigated only for UV/Lamp1. Initial H2O2 concentration in tested water was 
4.9 mg/L during UV/H2O2 treatment. Moreover, UV alone and UV/H2O2 treatment 
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experiments using UV/Lamp1 were carried out using tested waters spiked the 30 PPCPs into 
TW. For the UV/H2O2 treatment, initial H2O2 concentration was 6.1 mg/L. In these 
experiments, the contribution of OH radicals originated from the photodegradation of added 
H2O2 to the photocatalysis degradation of the 30 PPCPs was also compared with that of direct 
photodegradation. Degradation of the 30 PPCPs by H2O2 was investigated in a preliminary 
experiment. No significant variation in the concentration of the 30 PPCPs was observed. 
Experimental conditions are summarized in Table 3-2 
 
Table 3-2 Experimental conditions 
Tested water UV alone treatment UV/H2O2 treatment 
PW(pure water) + 30 PPCPs UV/Lamp1 (254nm), 
UV/Lamp2 (254/185nm) 
UV/Lamp1 + 
H2O2 4.9 mg/L 
TW(biologically treated water) 




H2O2 6.1 mg/L 
 
3.2.5 Analytical methods 
3.2.5.1 Measurement of PPCPs by LC/MS/MS 
Concentrations of the 30 PPCPs were measured simultaneously using an LC/MS/MS. An 
HPLC Alliance Waters2695 separation module was used for the LC and a Quattro micro API 
Tandem mass spectrometer was used for the MS/MS. The control of the LC/MS/MS system 
and treatment of the data acquired during the operation of LC/MS/MS were managed with 
MassLynxTM Software (Waters). For simultaneous quantification of the 30 PPCPs, a gradient 
elution analysis method by varying the polarity of mobile phase with time was adopted. 
Samples taken from the experiments using tested water spiked 30 PPCPs into PW were 
introduced directly to LC/MS/MS for PPCP quantification. Table 3-3 shows the measurement 
conditions of LC/MS/MS in details. 
The limit of detection (LOD) and limit of quantification (LOQ) for simultaneous analysis 
of the 30 PPCPs were determined by measuring solutions with a concentration in the 0 µg/L to 
100 µg/L range for individual PPCPs with LC/MS/MS. From values measured three times for 
each solution, the average value and standard deviation value for each PPCP were calculated 
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and then used for acquiring a variation coefficient, which is defined as the ratio of standard 
deviation value as compared to the average value. Based on the standard deviation (σ) of the 
solution with the lowest concentration and a variation coefficient of less than 20%, the LOD 
(3σ) and LOQ (10σ) were calculated. The LOQ ranged from 0.033 µg/L (oxytetracycline) to 
1.775 µg/L (acetaminophen) and the LOD ranged from 0.010 µg/L (oxytetracycline) to 0.533 
µg/L (acetaminophen). LOQ values were used for calculating the degradation rate of each 
PPCP in this study. Table 3-4 shows parent ion, product ion, cone voltage, collision energy, 
LOD and LOQ for each PPCP.  
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Table 3-4 Parent ion, product ion, cone voltage, collision energy, LOD and LOQ for each 
PPCP for LC/MS/MS analysis 











1 2-QCA 175.0 128.9 20 15 0.101 0.337
2 Acetaminophen 152.0 109.8 25 16 0.533 1.775
3 Antipyrine 189.1 76.7 30 35 0.179 0.597
4 Carbamazepine 237.1 194.0 25 20 0.390 1.299
5 Cetiofur 524.0 241.0 25 15 0.071 0.238
6 Chlorotetracycline 479.3 462.0 25 15 0.072 0.239
7 Clarithromycin 748.9 157.9 30 20 0.024 0.081
8 Clenbuterol 277.0 202.9 20 15 0.023 0.075
9 Crotamiton 204.1 68.7 30 20 0.046 0.152
10 Cycolphosphamide 261.0 139.8 25 20 0.122 0.407
11 DEET 192.1 118.8 25 15 0.065 0.216
12 Diclofenac 296.1 214.9 20 20 0.115 0.384
13 Disopyramide 340.2 239.0 20 15 0.014 0.047
14 Ethenzamide 166.0 148.9 15 10 0.031 0.102
15 Fenoprofen 243.1 196.9 15 10 0.474 1.579
16 Ifenprodil 326.2 308.1 30 20 0.010 0.032
17 Indomethacine 358.0 138.9 25 20 0.131 0.437
18 Isopropylantipyrine 231.1 184.9 20 15 0.073 0.243
19 Ketoprofen 255.1 209.0 25 15 0.056 0.188
20 Mefenamic acid 242.1 224.0 25 20 0.199 0.662
21 Metoprolol 268.2 115.9 30 20 0.092 0.306
22 Naproxen 231.1 188.9 35 20 0.145 0.485
23 Oxytetracycline 461.1 425.9 20 20 0.022 0.074
24 Propranolol 260.2 115.9 30 20 0.010 0.033
25 Sulfadimethoxine 311.0 155.9 30 20 0.128 0.427
26 Sulfadimizine 279.0 185.9 25 15 0.053 0.175
27 Sulfamethoxazole 254.0 155.9 25 15 0.119 0.396
28 Sulfamonomethoxine 281.0 155.9 25 15 0.069 0.229
29 Tetracycline 445.1 409.9 20 20 0.022 0.074
30 Theophylline 181.0 123.8 30 20 0.137 0.458
 
 
3.2.5.2 Pretreatment procedure of sample for LC/MS/MS analysis 
Samples taken from the experiments using tested water spiked 30 PPCPs into TW were 
introduced to LC/MS/MS after pretreatment using solid phase extraction (OasisHLBcartridge 
1cc/10mg P/N186000383, Waters). Firstly, a sample of 9ml taken from sampling port in outlet 
of each reactor was filtered with GF/B (pore size: 1.0µm) and then, EDTA and standard 
solution of 1ml with 90 µg/L concentrations of the 30 PPCPs were added to the filtrate. 
Afterwards, PPCPs in the filtrate were concentrated in Oasis HLB cartridge by the 
concentrator (Waters, Sep-Pak concentrator SPC-10). Oasis HLB cartridge conditioned in 
advance with 3ml methanol and 6ml distilled water was used for the concentration. After 
concentrating, the cartridge was dehydrated by pneumatic pump for 1 hr in order to avoid the 
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remaining of water in the cartridge, and PPCPs were eluted from the dehydrated cartridge 
with 2ml methanol. The eluted solution was volumed up to 10ml by a solution (Water:1% 
Formic acid = 7:1). This solution of 10ml was used for PPCPs quantification with 
LC/MS/MS. 
 
Fig. 3-3 Pretreatment procedure for LC/MS/MS measurement (For samples in TW) 
 
3.2.5.3 Recovery rates for 30 PPCPs in TW 
Table 3-5 shows recovery rates of each PPCP for LC/MS/MS analysis of the 30 PPCPs. 
Except for 2-QCA, acetaminophen, theophylline and mefenamic acid, good recovery rates of 
the 26 PPCPs were obtained (85% (ceftiofur) ~ 118% (carbamazepine)). The recovery rate of 
each PPCP was investigated by adding standard solution with 90 µg/L concentrations for the 
individual PPCPs into secondary effluent (n=3). The recovery rate was calculated by equation 
as follows; 
Recovery rate (%) = 100/)( ×− αXXa  
Xa : Measured concentration of a PPCP in sample added standard solution 
X : Measured concentration of a PPCP in sample 
α : Added PPCP concentration 
Solid phase extraction using Oasis HLB cartridge 
* Conditioning of cartridge (MeOH 3mL and pure water 6mL) 
* Pass sample of 10mL through cartridge with concentrator 
* Dehydration of cartridge 
* Elution (MeOH 2mL) 
Addition of EDTA 
Quantification by LC/MS/MS 
Collection of sample (9mL) 
Filtration with GF/B (1.0µm) 




Table 3-5 Recovery rates of the 30 PPCPs for LC/MS/MS measurement (n=3) 
No. PPCP Recovery rate(%) No. PPCP Recovery rate(%)
1 2-QCA 48 16 Ifenprodil 107
2 Acetaminophen 38 17 Indomethacin 99
3 Antipyrine 101 18 Isopropylantipyrine 103
4 Carbamazepine 118 19 Ketoprofen 109
5 Ceftiofur 85 20 Mefenamic acid 138
6 Chlorotetracycline 86 21 Metoprolol 102
7 Clarithromycin 86 22 Naproxen 104
8 Clenbuterol 103 23 Oxytetracyline 94
9 Crotamiton 106 24 Propranolol 107
10 Cyclophosphamide 99 25 Sulfadimethoxine 102
11 DEET 105 26 Sulfadimizine 113
12 Diclofenac 104 27 Sulfamethoxazole 103
13 Disopyramide 106 28 Sulfamonomethoxine 112
14 Ethenzamide 102 29 Tetracycline 89
15 Fenoprofen 101 30 Theophylline 66
 
 
3.3 Results and discussion 
3.3.1 Determination of molar extinction coefficient and quantum yield 
Generally, degradation rate of an organic material by photodegradation is affected by UV 
energy absorption and quantum yield of the organic material. UV energy absorption by an 
organic material is expressed as molar extinction coefficient, which is a measure of how 
strongly the organic material absorbs light at a given wavelength. Quantum yield represents 
the ratio of the total numbers of molecules of the compound degraded to the total number of 
photons absorbed by the solution due to the presence of compound. Therefore, the quantum 
yield is less than 1.0. Here, photodegradation is defined as a chemical reaction in which a 
chemical compound is broken down by photons. Photocatalysis is defined as the acceleration 
of a photoreaction in the presence of a catalyst such as H2O2.  
 
3.3.1.1 Measurement of molar extinction coefficient for the 30 PPCPs 
Molar extinction coefficients of the 30 PPCPs investigated in this study at a wavelength 
of 254 nm were shown in Table 3-6. The values were calculated from UV absorbance 
measured with tested solution of each PPCP with a concentration of 10 mg/L. UV 
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absorbances of clenbuterol and ceftiofur were measured at a concentration of 1 mg/L and for 
metoprolol and cyclophosphamide, tested solutions of 100 mg/L and 1,000 mg/L 
concentrations were used, respectively, due to their very low UV absorbances. The molar 
extinction coefficient of clarithromycin could not be measured because tested solution showed 
a very unstable UV absorbance at 254 nm. As shown from Table 3-6, molar extinction 
coefficients ranged from 9 /M/cm (cyclophosphamide) to 19,799 /M/cm (oxytetracycline). 
Molar extinction coefficients of 7 PPCPs such as oxytetracycline, chlorotetracycline, 
ketoprofen, indomethacin, ceftiofur, sulfamonomethoxine and theophylline were quite high 
more than 10,000 /M/cm. 
 
Table 3-6 Molar extinction coefficient and quantum yield for the investigated PPCPs 
PPCPs 
Molar extinction 
coefficient (ε, /M/cm) 
@254nm 
Quantum 
yeild (ø) PPCPs 
Molar extinction 




Oxytetracycline 19,799 0.0037 Mefenamic acid 4,633 0.0019 
Chlorotetracycline 18,868 0.0038 Acetaminophen 4,218 0.0043 
Ketoprofen 15,155 0.0724 Tetracycline 4,108 0.0098 
Indomethacin 14,848 0.0016 Naproxen 3,961 0.0061 
Ceftiofur 14,660 0.0208 2-QCA 3,623 0.0015 
Sulfadimethoxine 14,399 0.0045 Diclofenac 3,465 0.1131 
Theophyline 12,889 0.0002 Disopyramide 3,055 0.0342 
Sulfamonomethoxine 9,558 0.0172 DEET 1,205 0.0035 
Sulfadimidine 9,519 0.0040 Propranolol 856 0.0248 
Clenbuterol 7,484 0.0044 Fenoprofen 800 0.1348 
Sulfamethoxazole 7,345 0.0229 Ethenzamide 743 0.0059 
Isopropylantipyrine 7,255 0.0148 Ifenprodil 391 0.1241 
Antipyrine 6,626 0.0223 Metoprolol 235 0.0458 
Carbamazepine 6,072 0.0015 Cyclophosphamide 9 0.4242 
Crotamiton 4,777 0.0030 Clarithromycin No data No data 
 
On the contrary, 6 PPCPs such as propranolol, fenoprofen, ethenzaimde, ifenprodil, 
metoprolol and cyclophosphamide showed very low molar extinction coefficients of below 
1,000 /M/cm. Especially, the molar extinction coefficient of cyclophosphamide was 
considerably low compared to other PPCPs, implying that its photodegradation rate during 
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UV treatment can be very slow. On the other hand, tetracycline exhibited much lower molar 
extinction coefficient (4,108 /M/cm) than those of oxytetracycline (19,799 /M/cm) and 
chlorotetracycline (18,868 /M/cm) despite their similar chemical structures. This is compared 
with sulfonamides antibiotics such as sulfadimethoxine, sulfamonomethoxine, sulfadimidine 
and sulfamethoxazole showing similar molar extinction coefficients (7,345 /M/cm - 14,399 
/M/cm). Molar extinction coefficients of ketoprofen and carbamazepine were 15,155 /M/cm 
and 6,072 /M/cm, respectively and these values agreed very well with 15,450 /M/cm and 
6,070 /M/cm for ketoprofen and carbamazepine reported by Pereira et al (2007). The value of 
carbamazepine was also consistent very well with that (6,025 /M/cm) measured by Vogna et 
al (2004a). While, molar extinction coefficient of naproxen (3,961 /M/cm) obtained in this 
study was rather low due to unclear reason, comparing to 4,900 /M/cm reported by Vogna et 
al (2004a). 
 
3.3.1.2 Calculation of quantum yield for the 30 PPCPs 
Direct photodegradation rate of an organic compound i in the presence of other (N-1) 
substances that absorb UV radiation at a given wavelength depends on several factors such as 
UV intensity, I0, molar extinction coefficient, εi, reactor optical light path, L, quantum yields, 













εφ       (1) 
where fi, the fraction of total absorbed light which is absorbed by compound i, is 








/ εε         (2) 
Assuming that intermediate compounds do not absorb important fractions of UV 
radiation, fi is 1. It is essential to know the quantum yield of an organic compound in order to 
predict the photodegradation rate of the organic compound. There are several ways to 
determine the quantum yield. One of them is to carry out experiments on the direct 
photodegradation of the organic compound under the following condition. 
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1.03.2 <∑ iiCL ε         (3) 
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−=      (5) 
Therefore, quantum yield of an organic compound can be obtained if I0 and εi values are 
availble. On the other hand, H2O2 degradation arises from the absorption of incident radiation 
at 254 nm. The contribution of other incident radiations in H2O2 degradation is very negligible 
(Nicole et al., 1990). Fig. 3-4 shows the degradation of H2O2 with UV lamp (254 nm) used in 



















Fig. 3-4 Degradation of H2O2 at UV 254 nm  
 
The photodegradation rate of H2O2 can be described by an apparent first-order kinetic 





−=−       (6) 
H2O2: H2O2 concentration (M)    I0: UV intensity (Einstein/sec) 
ø: Quantum yield (1mol/photon)   ε: Molar extinction coefficient of H2O2 (18.6 /M/cm) 
L: Reactor optical light path (12.5cm)   V: Volume of reactor (22L) 
r: Reflexion coefficient values (1.75 for stainless steel wall) 
 









22 3.2]ln[ φε−=        (7) 
On the other hand, I0 can be obtained in equation (7). As a resulte, I0 of the UV lamp (254 
nm) used in this study was 1.9 E-04Einstein/L/sec. Substituting the I0 of the UV lamp and ε of 
each PPCP to equation (5), quantum yield (ø) of each PPCP can be calculated.  
Table 3-6 also shows quantum yield of each PPCP calculated from equation (5). Quantum 
yield for each PPCP ranged from 0.0002 (theophylline) to 0.4242 (cyclophosphamide). 
Quantum yield of theophylline was 0.0002, the lowest value among the quantum yields, 
whereas its molar extinction coefficient was so high (12,889 /M/cm). Quantum yields of 
oxytetracycline (0.0037), chlorotetracycline (0.0038) and indomethacine (0.0016) are not so 
high. On the contrarily, quantum yields of propranolol, fenoprofen, ifenprodil, metoprolol and 
cyclophophamide (0.0248 - 0.4242) are comparatively higher than the other PPCPs. These 
molecular extinction coefficients and quantum yields were used for discussing the 
photodegradability of the 30 PPCPs during UV and UV/H2O2 treatments. 
 
3.3.2 Photodegradability of PPCPs in PW with UV 
3.3.2.1 Determination of first-order rate constants of PPCPs for UV/Lamp1 and 
UV/Lamp2 
Fig. 3-5 and Fig. 3-6 illustrate the variations of logarithmic relative residual 
concentrations of the 30 PPCPs spiked into pure water (PW) for ten minute treatments with 
UV/Lamp1 and UV/Lamp2, respectively. When the tested water was irradiated with 
UV/Lamp1 and UV/Lamp2, the logarithmic relative residual concentrations of the 30 PPCPs 
decreased linearly with the time as shown in Fig. 3-5 and Fig. 3-6. 
Generally, when organic compounds absorbing UV are simultaneously present in water, 
assuming that UV absorbances by other organic compounds or intermediates formed during 
UV irradiation are negligible, the concentration decrease versus time of an organic material by 






−=−= εφ    (8) 
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C0: Initial concentration of an organic material (M) 
C: Concentration of an organic material (M) 
I0,254: UV intensity of UV/Lamp1 (Einstein/sec) 
ø254: Quantum yield of photodegradation for UV/Lamp1 (mol/photon) 
ε254: Molar extinction coefficient of an organic compound for UV/Lamp1 ( /M/cm) 
L: Reactor optical light path (cm) 

















































































































Fig. 3-5 Logarithmic relative residual concentrations of the 30 PPCPs spiked into PW during 
UV/Lamp1 treatment 
 
Concerning UV/Lamp2, OH radicals generated from the photodegradation of H2O with a 
wavelength of 185 nm as well as UV direct photodegradation with wavelengths 254 and 185 
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nm will involve the degradation of organic materials. Therefore, decreases in the 
concentrations of organic materials should be expressed as follows: 
tOHkLILI
C
CLog R ])[(  185185O,185 254254O,254
0
++−= εφεφ     
tk PWLampUV _2/−=    (9) 
 
I0: UV intensity (Einstein/sec) 
ø: Quantum yield of photodegradation (mol/photon) 
ε: Molar extinction coefficient of an organic material (/M/cm) 
L: Reactor optical light path (cm) 
kUV/Lamp2_PW: First-order rate constant for UV/Lamp2 (/sec) 
 
3.3.2.2 Classification of photodegradability of PPCPs for applied UV 
The first-order rate constant (k) for each PPCP makes it possible to compare the 
photodegradation effectiveness of UV for each PPCP when UV treatment was used to degrade 
the 30 PPCPs present in the test water. The k values of the 30 PPCPs obtained in the 
UV/Lamp1 and UV/Lamp2 treatment experiments were shown in Table 3-7.  
The k values (kUV/Lamp1_PW) ranged from 6.0 E-05/sec (theophylline) to 2.4 E-02/sec 
(ketoprofen). For UV/lamp2 treatment, the k values (kUV/Lamp2_PW) ranged from 3.4 E-04/sec 
(theophylline) to 2.7 E-02/sec (ketoprofen). As a result, the average k of the 30 PPCPs for 
UV/lamp2 was about 1.4 times higher than that for UV/Lamp1. 
The photodegradabilites of the 30 PPCPs investigated were compared by classifying into 
two groups: easily-degrading PPCPs with k ≥2.6 E-03/sec (equivalent to 90% degradation 
from the initial concentration within less than 15 min) and slowly-degrading PPCPs with k 
<6.4 E-04/sec (equivalent to 90% from the initial concentration after more than 1 hr) (See 
Table 3-7). Six PPCPs - ketoprofen, diclofenac, ceftiofur, sulfamethoxazole, 
sulfamonomethoxine and antipyrine - belonged to the category of easily-degrading PPCPs for 
UV/Lamp1. However, 10 PPCPs including isopropylantipyrine, disopyramide, ifenprodil and 
clenbuterol were classified as easily-degrading PPCPs for UV/Lamp2. On the other hand, 14 
and 6 PPCPs were classified as slowly-degrading PPCPs for UV/Lamp1 and UV/Lamp2, 
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respectively. Consequently, it can be known that UV/Lamp2 treatment will be more effective 































































































































Table 3-7 k values of the 30 PPCPs for UV/Lamp1 and UV/Lamp2 
Name of PPCPs Use k UV/Lamp1_PW(/sec) k UV/Lamp2_PW(/sec) Amide bond Amine bond
Ketoprofen Analgesic 2.4E-02 2.7E-02
Diclofenac Analgesic 8.4E-03 9.6E-03
○
Ceftiofur Antibiotics 6.6E-03 8.0E-03
○
Sulfamethoxazole Antibiotics 3.6E-03 4.1E-03 ○
Sulfamonomethoxine Antibiotics 3.5E-03 4.2E-03 ○
Antipyrine Analgesic 3.2E-03 3.1E-03
Fenoprofen Analgesic 2.3E-03 2.2E-03
Isopropylantipyrine Analgesic 2.3E-03 2.8E-03
Disopyramide Antiarrhythmic agents 2.2E-03 2.6E-03
○ ○
Oxytetracyline Antibiotics 1.6E-03 2.5E-03
○ ○
Chlorotetracycline Antibiotics 1.5E-03 2.1E-03 ○
Sulfadimethoxine Antibiotics 1.4E-03 2.1E-03 ○
Ifenprodil NMDA receptor antagonist 1.0E-03 3.2E-03
Tetracycline Antibiotics 8.6E-04 1.8E-03
○ ○
Sulfadimizine Antibiotics 8.1E-04 2.0E-03 ○
Clenbuterol Bronchodilator 7.1E-04 3.0E-03
○
Naproxen Analgesic 5.2E-04 1.2E-03
Indomethacin Analgesic 5.1E-04 1.2E-03
Propranolol Antiarrhythmic agents 4.6E-04 2.5E-03
○
Acetaminophen Analgesic 3.9E-04 1.8E-03
○
Crotamiton Anti-itch drug 3.1E-04 8.5E-04
○
Metoprolol Antiarrhythmic agents 2.3E-04 1.2E-03
○
Carbamazepine Anticonvulsant 2.0E-04 8.0E-04
○
Mefenamic acid Analgesic 1.9E-04 1.2E-03
○
Clarithromycin Antibiotics 1.8E-04 3.6E-04
2-QCA Carbadox intermediate 1.2E-04 6.0E-04
Ethenzamide Analgesic 9.5E-05 4.7E-04
○
DEET Insect repellents 9.2E-05 4.4E-04
○
Cyclophosphamide Antineoplastic agents 8.3E-05 4.0E-04
○ ○
Theophylline Bronchodilator 6.0E-05 3.4E-04
 
* Black: easily-degrading PPCPs,  Gray: slowly-degrading PPCPs 
 
On the other hand, the acidic drugs ketoprofen, diclofenac and ceftiofur exhibited 
particularly high k values, irrespective of the applied UV lamps, indicating that these can be 
degraded very easily by UV irradiation. Contrarily, clarithromycin (an antibiotic), 2-QCA (a 
carbadox intermediate), ethenzamide (an analgesic), DEET (an insect repellent), 
cyclophosphamide (an antineoplastic) and theophylline (a bronchodilator) were classified as 
slowly-degrading PPCPs, irrespective of the UV/Lamp used. The kUV/Lamp2_PW values of these 
PPCPs were still much lower than those of the others although the application of UV/Lamp2 
caused significant increases in their degradations. 
Among these PPCPs, enthenzamide, DEET and cyclophosphamide have amide bonds 
(RCONR2) in their chemical structures, indicating that PPCPs consisting of amide bonds 
cannot be photolyzed easily with UV. Besides these three PPCPs, compounds such as 
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disopyramide, oxytetracycline, chlorotetracycline, tetracycline, acetaminophen, crotamiton 
and carbamazepine also have amide bonds. Among these, only disopyramide was classified as 
a fast-degrading PPCP. Therefore, PPCPs with amide bonds can be expected to exhibit low 
photodegradability under UV light. Four of the PPCPs that photolyzed very easily under UV 
light - diclofenac, ceftiofur, sulfamethoxazole and sulfamonomethoxine - had amine bonds 
(RNH2, R2NH, R3N) in their chemical structures. However, the k values of the PPCPs with 
amine bonds were all quite different, indicating that the amine bond is not the main site 
attacked by UV energy during PPCP photodegradation. 
Alternatively, as mentioned above, the kUV/Lamp2_PW values were slightly higher than the 
kUV/Lamp1_PW values, indicating that the average kUV/Lamp2_PW value (3.1 E-03/sec) for the 30 
PPCPs was 1.4 times higher for UV/lamp2 than for UV/lamp1. This in turn indicates that, in 
addition to direct photodegradation by UV irradiation, OH radicals formed by the 
photodegradation of water under a wavelength of 185 nm contributed to the degradation of 
PPCPs during UV/Lamp2 treatment. Under irradiation with UV emitted at a wavelength of 
less than 200 nm, water is photolyzed into hydrogen atoms and hydroxyl radicals, and other 
oxidative species such as hydrogen peroxide are also probably formed simultaneously (Heit et 
al., 1998). During the photocatalysis degradation of water with vacuum ultraviolet (VUV), 
hydroxyl radicals and other oxidants are formed according to the following reactions: 
 
⋅+⋅→+ OHHVUVOH 2  
22OHOHOH →⋅+⋅  
⋅→+⋅ 22 HOOH  
 
Han et al (2004) investigated the photocatalytic decomposition and mineralization of 
4-chlorophenol, hydroquinone and 4-nitrophenol in an aqueous solution using two kinds of 
low-pressure mercury lamps: a UV lamp emitting light at 254 nm and a VUV lamp emitting 
light at both 254 and 185 nm. In the study, they found that, due to the contribution of the 
abundant and powerful oxidant, the OH radical, VUV irradiation performed the most efficient 
photocatalysis degradation of the organic materials. In this study, UV/Lamp2 also showed a 
better PPCPs photocatalysis degradation than UV/Lamp1. Therefore, the applicability of 
 49 
UV/Lamp2 is expected in the area of water treatment.  
 
3.3.3 Photodegradability of PPCPs in TW with UV/Lamp1 
Fig. 3-7 compares UV/Lamp1 photodegradation results obtained in experiments using 
tested waters spiked with 30 PPCPs into pure water (PW) and biologically treated water (TW). 
Antineoplastic agent cyclophosphamide was one of the PPCPs highly resistant for UV and, it 
was expected that only 5% of its initial concentration (64 µg/L) would be degraded during 
UV/Lamp1 treatment for 10 min. While, 88% photodegradation was expected from antibiotic 
sulfamonomethoxine, indicating that sulfamonomethoxine will be degraded very easily with 
UV/Lamp1. Thus, considerably different photodegradation rates for the 30 PPCPs were 













































Fig. 3-7 Concentration decrease for cyclophosphamide, sulfamonomethoxine and naproxen 
with UV/Lamp1  
(circle - PPCP in TW; rectangle - PPCP in PW) 
 
Table 3-8 shows first-order rate constants for the reaction of each PPCP with UV 
obtained using equation (2) and Fig. 3-7. kUV/Lamp1_PW and kUV/Lamp1_TW values for the 30 
PPCPs ranged from 6.0 E-05/sec (theophylline) to 2.4 E-02/sec (ketoprofen) and 1.8 E-04/sec 
(cyclophosphamide) to 2.2 E-02/sec (ketoprofen), respectively. Here, kUV/Lamp1_TW indicates 
first-order rate constant obtained in UV/Lamp1 treatment experiments using TW spiked with 
the 30 PPCPs. In this study, the difference between photodegradability in PW and in TW for a 
PPCP was evaluated using a ratio of kUV/Lamp1_PW value to kUV/Lamp1_TW value for each PPCP. It 
was defined that the photodegradability of a PPCP was not affected by other constituents in 
TW if kUV/Lamp1_PW/kUV/Lamp1_TW ratio ranges from 0.8 to 1.2 (for naproxen in Fig. 3-7) and, 
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however, the photodegradability was rather affected if kUV/Lamp1_PW/kUV/Lamp1_TW ratio 
corresponds to over 1.2 (for cyclophosphamide in Fig. 3-7) or below 0.8 (for 
sulfamonomethoxine in Fig. 3-7). The results are shown in Table 3-8. 
kUV/Lamp1_PW/kUV/Lamp1_TW ratios of 11 PPCPs such as ketoprofen, diclofenac, antipyrine, 
isopropylantipyrine, naproxen and indomethacin (analgesics), sulfamethoxazole (antibiotic), 
disopyramide, metoprolol and propranolol (antiarrhythmic agents), and crotamiton (antiitch 
drug) ranged from 0.8 to 1.2. This means that photodegradation rates of the 11 PPCPs will be 
less affected by UV energy consumption of other DOM (dissolved organic matter) in water. 
Moreover, the 9 PPCPs except indomethacin and naproxen showed quantum yields in the 
range of 0.0148 (isopropylantipyrine) to 0.1131 (diclofenac), which are higher than those of 
other PPCPs (Table 3-6). Therefore, it was expected that UV energy absorbed involved very 
effectively in degradation of the PPCPs.  
Photodegradability of 11 PPCPs including oxytetracycline, chlorotetracycline, 
tetracycline, sulfamonomethoxine, sulfadimethoxine and sulfadimidine (antibiotics), 
fenoprofen and acetaminophen (analgesics), anticonvulsant carbamazepine, NMDA receptor 
antagonist ifenprodil and bronchodilator clenbuterol reduced significantly when they were 
spiked into TW. This may be because UV energy absorbed to the 11 PPCPs decreased due to 
the consumption of UV energy by DOM in TW. Molar extinction coefficients of the 11 PPCPs 
ranged widely from 800 /M/cm to 19,799 /M/cm and, contrarily, quantum yields calculated 
for the 9 PPCPs except fenoprofen and sulfamonomethoxine were low to 0.0015 
(carbamazepine) - 0.0098 (tetracycline). Therefore, the interference of UV energy absorption 
of the PPCPs by other organic materials in water such as DOM might mainly cause low 
photodegradation of the PPCPs during UV treatment.  
Contrarily, ceftiofur and clarithromycin (antibiotics), mefenamic acid and ethenzamide 
(analgesics), carbadox intermediate 2-QCA, insect repellent DEET, antineoplastic agent 
cyclophosphamide and bronchodilator theophylline showed higher photodegradability when 
they were present in TW. This can be explained by an indirect production of radicals from 
reaction of UV with DOM in water. Doll et al (2003) have reported that NOM (natural 
organic matter) from Lake Hohloh in the southwest of Germany enhanced the photochemical 
degradation of carbamazepine, indicating that NOM can act as a precursor of reactive species. 
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Also, in sewage water, the degradation of these compounds could either decrease due to the 
competition with DOM for UV energy, or increase due to an indirect production of OH 
radicals from reaction of UV energy with DOM (Pereira et al., 2007). In this study, it can be 
also expected that reactive species were formed from organic materials in TW during UV 
treatment and promoted the degradation rates of the 8 PPCPs.  
 
Table 3-8 First-order rate constants for the reaction of each PPCP with UV/Lamp1 
PPCPs k UV/Lamp1_PW(/sec) R2 k UV/Lamp1_TW(/sec) R2 k UV/Lamp1_PW / k UV/Lamp1_TW ratio
Ketoprofen 2.4E-02 0.9933 2.2E-02 0.9867
Diclofenac 8.4E-03 0.9812 7.2E-03 0.9866
Sulfamethoxazole 3.6E-03 0.9759 3.1E-03 0.9837
Antipyrine 3.2E-03 0.9865 2.7E-03 0.9933
Isopropylantipyrine 2.3E-03 0.9818 2.0E-03 0.9925
Disopyramide 2.2E-03 0.9908 1.9E-03 0.9940
Naproxen 5.2E-04 0.9926 5.2E-04 0.9877
Indomethacin 5.1E-04 0.9553 4.6E-04 0.9528
Propranolol 4.6E-04 0.9708 3.9E-04 0.8200
Crotamiton 3.1E-04 0.9642 3.0E-04 0.9740
Metoprolol 2.3E-04 0.9259 2.2E-04 0.9519
Sulfamonomethoxine 3.5E-03 0.9753 2.5E-03 0.9832
Fenoprofen 2.3E-03 0.9982 1.7E-03 0.9953
Oxytetracyline 1.6E-03 0.9644 7.2E-04 0.9069
Chlorotetracycline 1.5E-03 0.9206 1.0E-03 0.8198
Sulfadimethoxine 1.4E-03 0.9936 1.1E-03 0.9867
Ifenprodil 1.0E-03 0.9871 5.7E-04 0.9963
Tetracycline 8.6E-04 0.9741 5.9E-04 0.9008
Sulfadimidine 8.1E-04 0.9937 5.6E-04 0.9797
Clenbuterol 7.1E-04 0.9812 3.7E-04 0.8717
Acetaminophen 3.9E-04 0.9939 3.1E-04 0.9709
Carbamazepine 2.0E-04 0.9750 1.6E-04 0.7787
Ceftiofur 6.6E-03 0.9598 8.5E-03 0.9579
Mefenamic acid 1.9E-04 0.9548 2.8E-04 0.9659
Clarithromycin 1.8E-04 0.9894 2.3E-04 0.8455
2-QCA 1.2E-04 0.9922 1.6E-04 0.9975
Ethenzamide 9.5E-05 0.8644 4.2E-04 0.9193
DEET 9.2E-05 0.9147 3.3E-04 0.7873
Cyclophosphamide 8.3E-05 0.8623 1.8E-04 0.7446






3.3.4 Discussion of PPCPs photodegradation based on chemical structure 
Photodegradation characteristics of sulfamethoxazole, diclofenac and cyclophosphamide 
with UV/Lamp1 were dicussed based on their chemical structures presented in Fig. 3-8. 
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Sulfamethoxazole degraded the most rapidly with UV/Lamp1 from among nine antibiotics 
investigated in this study. Analgesics diclofenac belonging to the group of nonsteroidal 
anti-inflammatory drugs (NSAIDs) has frequently been detected in aquatic environments in 
many conturies including Switzerland and Japan (Buser et al., 1998; Okuda et al., 2007). 
Among the 30 PPCPs, photodegradation of cyclophosphamide was highly resistant against 
UV treatment. In the aquatic environment, the presence of cyclophosphamide used to treat 
various types of cancer has not been reported, however, it can be discharged into an aquatic 
environment from hospitals where cyclophosphamide is likely to be used very often. 
 
           
<Sulfamethoxazole>     <Diclofenac>     <Cyclophosphamide> 
Fig. 3-8 Chemical structures of sulfamethoxazole, diclofenac and cyclophosphamide 
 
3.3.4.1 Photodegradation of sulfamethoxazole  
It has been known that sulfamethoxazole is a derivative of sulfanilamide (sulfamine) and 
has a strong antibacterial power and low side effects in human. In addition to 
sulfamethoxazole, three kinds of sulfanilamide derivatives such as sulfamonomethoxine, 
sulfadimethoxine and sulfadimidine were included in a list of 30 PPCPs investigated in this 
study with -SO2- group in their chemical structures. In particular, for antibiotics derived from 
sulfanilamide, only compounds with free amino groups in their chemical structures have 
antibacterial activity (Tanaka et al., 1992). In this study, which bond should be broken to 
invalidate their antibacterial activities during UV treatment was not investigated. However, 
some possible photodegradation reactions for UV treatment were discussed. When 
compounds with -SO2- group are photolyzed with UV, -SO2- groups can be separated from the 
compound by the breakage of bonds between -SO2- and its side atoms. These compounds can 
degrade through the breakage of C-S bonds during UV photodegradation (Sugimori, 1998). 
Besides these two types of photodegradations, a breakage reaction of the N-H bond that all 
sulfanilamide derivatives have is expected.  
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Among four kinds of sulfanilamide derivatives, sulfamethoxazole and 
sulfamonomethoxine showed relatively high kUV/Lamp1_PW values of 3.6 E-03/sec and 3.5 
E-03/sec, respectively. Conversely, kUV/Lamp1_PW values of sulfadimethoxine (1.4 E-03/sec) and 
sulfadimidine (8.1 E-04/sec) were low compared to sulfamethoxazole and 
sulfamonomethoxine. Generally, the photodegradation rates of compounds with similar 
chemical structures will also be similar because the same bond should be broken. However, 
photodegradation rates for four PPCPs derived from sulfanilamide were quite different, even 
though their chemical structures are very similar. This can be explained with the fact that 
other PPCPs which are simultaneously present in the tested water would affect 
photodegradations that would be similar, otherwise.  
 
3.3.4.2 Photodegradation of diclofenac  
NSAIDs diclofenac is a derivative of phenylacetic acid which is an organic compound 
containing a phenyl moiety and an acetic acid moiety. Diclofenac is also a carboxylic acid like 
most of the NSAIDs including ketoprofen, mefenamic acid, fenoprofen, naproxen and 
indomethacin (Nogrady and Weaver, 2005). Buser et al. (1998) have observed a significant 
elimination of diclofenac in the water of a natural lake in Switzerland, indicating that 
diclofenac degrades very easily during UV treatment.  
Degradation of aliphatic amines (RNH2, R2NH, R3N) by photo energy formed from short 
wavelengths is sometimes caused by the break of their C-N bonds, but most aliphatic amines 
mainly degrade by a breakage reaction of the N-H bond (Sugimori, 1998). Aromatic amines 
can also degrade in the same way and, therefore, diclofenac consisting of amino bonds of two 
benzene rings with Cl and RCOOH group, respectively, can degrade with UV 
photodegradation. On the other hand, it has been known that carboxylic acids would mainly 
degrade through the breakage of R-COOH bonds when they are photolyzed, which is similar 
to the photodegradation of aldehydes and ketones. However, the photoreactivity of derivatives 
from carboxylic acid is generally lower than that of aldehydes or ketones. For halogenated 
compounds, it has been known that the breakage of C-halogen atom bond could be caused by 
photodegradation (Sugimori, 1998). As a consequence, it is expected that degradation of 
diclofenac containing an amino group, carboxylic group and two chlorides in its chemical 
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structure as shown in Fig. 3-8 would result from the dehydrogenation of N-H bond, separation 
of -COOH from diclofenac molecular, and dechlorination of Cl from benzene ring.  
Vogna et al. (2004b) investigated the photodegradation of diclofenac under UV treatment 
with/without H2O2. They found that UV irradiation of diclofenac increased the concentration 
of chloride in tested water. This means that when diclofenac is photolyzed with UV, the 
separation of Cl from benzene rings occurs. Consequently, it can be said that dechlorination is 
one of diclofenac degradation procedures in its UV photodegradation.  
Among PPCPs investigated in this study, five kinds of PPCPs such as diclofenac, 
chlorotetracycline, clenbuterol, indomethacin and cyclophosphamide have C-halogen atom 
bonds in their chemical structures and for four PPCPs excluding cyclophosphamide, the 
halogen atom (Cl) is combined to benzene rings directly. Diclofenac was photolyzed rapidly 
(kUV/Lamp1_PW = 8.4 E-03/sec) during UV treatment, while the other PPCPs exhibited very low 
kUV/Lamp1_PW values (8.3 E-05/sec - 1.5 E-03/sec) compared to that of diclofenac. However, if 
the separation reaction of chloride from benzene ring occurs rapidly during UV 
photodegradation, chlorotetracycline, clenbuterol and indomethacin would be also degraded 
rapidly, similar to diclofenac. Therefore, it is considered that when diclofenac is photolyzed 
with UV, the dehydrogenation of N-H bond and separation reaction of -COOH from 
declofenac molecular would mainly be involved in the photodegradation of diclofenac.  
Actually, among seven PPCPs classified as easily-degrading PPCPs in UV/Lamp1 
treatment experiment, four PPCPs (diclofenac, ceftiofur, sulfamethoxazole, 
sulfamonomethoxine) have N-H bonds in their moleculars, indicating that the N-H bond may 
be broken easily by UV photodegradation. Moreover, three PPCPs (ketoprofen, diclofenac 
and ceftiofur) out of eight carboxylic acids such as 2-QCA, ceftiofur, diclofenac, fenoprofen, 
indomethacin, ketoprofen, mefenamic acid and naproxen included in a list of 30 PPCPs 
investigated in this study were classified as easily-degrading PPCPs. Consequently, it can be 
concluded that the dehydrogenation of N-H bond and breakage reaction of R-COOH can be 
considered as possible main reactions during diclofenac photodegradation with UV.  
 
3.3.4.3 Photodegradation of cyclophosphamide   
Amides (RCONR2) are generally photolyzed by the breakage of R-CO or CO-N bond. 
 55 
However, amides have the most stable of the carbonyl couplings due to their high resonance 
stabilization between the N-C and C-O bonds. DEET (N,N-diethyl-m-toluamide) which is the 
most common active ingredient in insect repellents and cyclophosphamide used to treat 
various types of cancer and some autoimmune disorders belong to amides. Among ten kinds 
of amides investigated in this study, six amides including DEET and cyclophosphamide were 
classified as slowly-degrading PPCPs in UV/Lamp1 treatment experiment (See Table 3-7), 
indicating that it would be difficult to degrade PPCPs with amide bond using UV 
photodegradation. In particular, cyclophosphamide showed the lowest photodegradation rate 
among PPCPs with amide bonds in their chemical structures. Moreover, cyclophosphamide 
has amide bonds and amine bonds in its chemical structure as shown in Fig. 3-8.  
 
3.3.5 The effect of H2O2 addition on the PPCPs degradation during UV treatment 
During UV/Lamp1 treatment, the effect of H2O2 addition on the photocatalysis 
degradations of 30 PPCPs was investigated. Tested water was prepared by spiking the 30 
PPCPs into pure water (PW) and biologically treated water (TW). The tested water 
temperature was kept constantly at 20°C and pH of tested water was adjusted to 7. Initial 
H2O2 concentrations in tested water are adjusted to 8.2 mg/L and 6.1 mg/L for experiments 
using PW and TW, respectively. Concentration decreases of individual PPCPs obtained in 
UV/Lamp1/H2O2 experiments were presented in Fig. 3-9 and 3-10, which show that 
logarithmic relative residual concentrations of all the PPCPs decreased linearly with time. For 
UV/Lamp1/H2O2, concentration decrease of an organic material with time is expressed as 
follows (Lopez et al., 2003):  
tktOHkLI
C
CLog R 2O2UV/lamp1/H 254254O,254
0
])[3.2( ′−=⋅+−= εφ
   (10) 
where kR and k'UV/Lamp1/H2O2 represent second order rate constant and pseudo first-order 
rate constant for UV/H2O2 treatment, respectively. Pseudo first-order rate constants of the 30 
PPCPs for UV/Lamp1/H2O2 treatments using PW (k'UV/Lamp1/H2O2_PW) and TW 
(k'UV/Lamp1/H2O2_TW) were calculated from equation (10). Table 3-9 shows pseudo first-order 
rate constants of the 30 PPCPs for UV/Lamp1/H2O2 treatments. 
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3.3.5.1 The effect of H2O2 addtion during UV/Lamp1 experiment using PW 
Higher photocatalysis degradations of the 30 PPCPs were observed when H2O2 was 
added during UV treatment, due to the production of the highly reactive OH radicals by H2O2 
photodegradation. kUV/Lamp1_PW values ranged from 2.2 E-02/sec (ketoprofen) to 6.0 E-05/sec 
(theophylline) (Table 3-9), while k'UV/Lamp1/H2O2_PW values from 2.5 E-02/sec (ketoprofen) to 
















































































































Fig. 3-9 Relative residual concentrations for the 30 PPCPs spiked into PW versus time during 
UV/Lamp1/H2O2 treatment 
 
An average value of all the PPCPs was 4.2 E-03/sec, which is 1.9 times higher than that 
(2.2 E-02/sec) of kUV/Lamp1_PW values obtained in experiment using only UV/Lamp1. In 
particular, it was observed that H2O2 addition was more effective in the photocatalysis 
degradation of PPCPs with low k values in UV treatment experiment. For example, k values 
of ethenzamide (kUV/Lamp1_PW: 9.5 E-05/sec), DEET (kUV/Lamp1_PW: 9.2 E-05/sec), theophylline 
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(kUV/Lamp1_PW : 6.0 E-05/sec) and cyclophosphamide (kUV/Lamp1_PW : 8.3 E-05/sec) increased by 
a factor of 12 to 29 when 8.2 mg/L H2O2 was added during UV treatment. In addition, 
k'UV/Lamp1/H2O2_PW values of carbamazepine, metoprolol, 2-QCA, clarithromycin and 
mefenamic acid that exhibited comparatively low kUV/Lamp1_PW values also increased 
significantly more than 10 times compared to their kUV/Lamp1_PW values. Contrarily, PPCPs 
degradable easily such as ketoprofen, ceftiofur and diclofenac showed the increase of k values 
by a factor of 1 to 3, and this result was compared with the PPCPs described above. Vogna et 
al. (2004b) have reported that diclofenac degradation was mainly caused by direct UV 
photodegradation during UV/H2O2 treatment, due to its very fast photodegradability. 
 
3.3.5.2 The effect of H2O2 addtion during UV/Lamp1 experiment using TW 
For experiments using 30 PPCPs in TW, kUV/Lamp1_TW values ranged from 1.6 E-04/sec 
(2-QCA) to 2.4 E-02/sec (ketoprofen) as shown in Table 3-8 and an average value was 2.1 
E-03/sec. However, k'UV/Lamp1/H2O2_TW values were in the range of 5.2 E-04/sec 
(cyclophosphamide) to 2.0 E-02/sec (ketoprofen) (average value : 2.8 E-03/sec), showing that 
the increase of k values was not so significant compared to experiments using PPCPs in PW. 
For experiments using TW, k values in UV/Lamp1/H2O2 treatment increased by a factor 
of 1 to 9 and, this is compared with the increase of 1 to 29 times in k values for experiments 
using PW. This may be due to the consumption of OH radicals by DOM and/or OH radicals 
scavengers such as HCO3- and CO32- in tested water prepared with biologically treated water. 
Nevertheless, k values of tetracycline, indomethacin, crotamiton, carbamazepine, mefenamic 
acid, metoprolol and 2-QCA increased more than 5 times by H2O2 addition, indicating that 
photocatalysis degradation rates of the PPCPs will be less affected by DOM and/or scavengers 
of OH radicals during UV/Lamp1/H2O2 treatment compared to other PPCPs. Overall, average 
k value for all the PPCPs investigated increased by a factor of 1.3 by H2O2 addition during 
UV/Lamp1 treatment. Therefore, the effectiveness of H2O2 addition for PPCPs removal 

















































































































Fig. 3-10 Relative residual concentrations for the 30 PPCPs spiked into TW versus time 




Table 3-9 Pseudo first-order rate constants of the 30 PPCPs for UV/Lamp1/H2O2 treatments 























Carbamazepine Anticonvulsant 2.6E-03 1.5E-03
Crotamiton Anti-itch drug 2.7E-03 1.5E-03
Cyclophosphamide Antineoplastic agents 9.8E-04 5.2E-04
Clenbuterol 2.2E-03 1.1E-03
Theophyline 1.7E-03 1.0E-03
2-QCA Carbadox intermediate 2.1E-03 1.2E-03










3.3.6 Estimation of UV dose for the effective PPCPs degradation 
Table 3-10 shows UV/Lamp1 irradiation time and dose required for 90% degradation of 
each PPCP. These were calculated from k values obtained in UV/Lamp1 and UV/Lamp1/H2O2 
treatment experiments using TW spiked with 30 PPCPs. UV/Lamp1 intensity of 0.384 
mW/cm2 was used for calculating UV dose introduced to tested water during each treatment. 
Firstly, for UV/Lamp1 alone treatment, UV irradiation time required for degrading each PPCP 
by 90% of initial concentration ranged from 1.6 min (ketoprofen) to 245.0 min (2-QCA) as 
shown in Table 3-10. It can be also known that more than 1 hour will be necessary for 90% 
degradation of 18 PPCPs including tetracycline, ifenprodil and sulfadimizine. For UV dose, 
38 mJ/cm2 to 5,644 mJ/cm2 will be required for 90% degradation of the 30 PPCPs during 
UV/Lamp1 treatment. Considering that UV dose required for typical disinfection in 
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wastewater treatment plant is in a range of 40 mJ/cm2 to 140 mJ/cm2, it can be said that 
considerable UV dose will be needed for degrading PPCPs effectively. Moreover, only 3 
PPCPs such as ketoprofen, ceftiofur and diclofenac can be degraded by more than 90% by 
only UV/Lamp1 treatment when UV dose of 140 mJ/cm2 was introduced. This also tells that 
most of PPCPs will not be removed sufficiently in UV disinfection process in wastewater 
treatment plant known to a main source for PPCPs discharge into aquatic environment. 
 
Table 3-10 UV irradiation time and dose required for the 90% degradation of each PPCP for 
UV/Lamp1 
PPCPs UV irradiation







Ketoprofen 1.6 38 1.9 45
Ceftiofur 4.5 104 No data No data
Diclofenac 5.3 123 4.9 113
Sulfamethoxazole 12.4 285 13.6 314
Antipyrine 14.2 328 12.7 293
Sulfamonomethoxine 15.5 358 11.3 261
Isopropylantipyrine 19.4 447 14.3 329
Disopyramide 20.1 463 15.1 348
Fenoprofen 22.7 522 12.7 292
Sulfadimethoxine 34.6 797 23.9 550
Chlorotetracycline 36.7 846 12.3 284
Oxytetracyline 50.9 1,174 13.5 310
Tetracycline 64.7 1,490 13.8 317
Ifenprodil 67.7 1,560 15.6 358
Sulfadimizine 68.7 1,584 24.3 561
Naproxen 73.3 1,690 18.9 434
Indomethacin 82.8 1,908 14.6 337
Ethenzamide 90.7 2,089 32.0 738
Propranolol 98.8 2,277 22.4 515
Clenbuterol 102.8 2,368 36.4 839
DEET 116.3 2,679 36.0 829
Acetaminophen 123.8 2,852 28.6 660
Crotamiton 126.5 2,915 26.1 602
Mefenamic acid 136.2 3,139 27.1 624
Clarithromycin 165.7 3,817 35.0 806
Metoprolol 171.8 3,959 28.5 657
Theophyline 195.1 4,496 38.4 884
Cyclophosphamide 225.7 5,201 73.6 1,695
Carbamazepine 235.0 5,413 26.3 605
2-QCA 245.0 5,644 31.5 727
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Unlike only UV/Lamp1 treatment, for UV/Lamp1/H2O2 treatment, all the PPCPs except 
7 PPCPs such as ethenzamide, clenbuterol, DEET, clarithromycin, theophylline, 
cyclophosphamide and 2-QCA were degraded by more than 90% by UV irradiation for 30 
min (UV dose : 691 mJ/cm2). It was also predicted that UV dose of 890 mJ/cm2 will be 
sufficient for 90% degradation of even the 6 PPCPs except cyclophosphamide. Antineoplastic 
agent cyclophosphamide turned out as the most resistant PPCP among 30 PPCPs because 
considerable UV dose of 1,695 mJ/cm2 was required for its 90% degradation in spite of H2O2 
addition during UV/Lamp1 treatment. As a consequence, it can be concluded that much more 
UV dose than that necessary for typical disinfection will be needed to degrade more than 90% 




Degradation characteristics of 30 PPCPs with UV and UV/H2O2 treatments were 
investigated using tested water prepared by spiking the 30 PPCPs simultaneously into pure 
water and secondary effluent. Each tested water was added into batch reactor with the 
effective volume of 22L and treated with UV or UV/H2O2. Two types of UV lamps were used; 
UV/Lamp1 emitting at the wavelength of 254nm, used for typical water disinfection, and 
UV/Lamp2 emitting at the wavelength of 254nm and 185nm. The findings from this study 
were as follows; 
1) At the UV wavelength of 254nm, molar extinction coefficients of the 30 PPCPs ranged 
from 9 /M/cm (cyclophosphamide) to 19,799 /M/cm (oxytetracycline), indicating that 
photodegradabilites of the PPCPs will be very different according to individual PPCPs.  
2) The concentration decrease of the 30 PPCPs with time followed 1st order kinetics, 
irrespective of UV lamps applied. Degradabilities of the 30 PPCPs were, therefore, classified 
and compared by 1st order rate constants. For UV/Lamp1 treatment, 6 PPCPs including 
ketoprofen and diclofenac and 14 PPCPs including theophylline, cyclophosphamide and 
DEET were classified as easily-degrading PPCPs (k≥2.6E-03 /sec) and slowly-degrading 
PPCPs (k<6.4E-04 /sec), respectively. On the other hand, 10 PPCPs and 6 PPCPs belonged to 
easily-degrading PPCPs and slowly-degrading PPCPs, respectively, for UV/Lamp2 treatment. 
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This result indicates that UV/Lamp2 was more effective for degrading PPCPs than 
UV/Lamp1. This might be due to the contribution of OH radicals formed during UV 
photodegradation of H2O molecular by the wavelength of 185nm to the PPCPs degradations. 
Consequently, the applicability of UV/Lamp2 for degrading PPCPs in water was implied.  
3) UV doses of 38 mJ/cm2 to 5,644 mJ/cm2 were needed for 90% degradation of the 30 
PPCPs in secondary effluent. These UV doses are much higher than those required for typical 
disinfection (40 mJ/cm2 ~ 140 mJ/cm2). It can be known that considerable UV dose will be 
required for the effective removal of PPCPs in secondary effluent.  
4) When the 30 PPCPs spiked into secondary effluent were treated with UV/Lamp1/H2O2, 
their degradation rates increased by a factor of about 1.3 comparing with those for UV/Lamp1. 
Especially, H2O2 addition improved significantly degradation rates of the PPCPs such as 
DEET and theophylline, which showed low photodegradation rates for UV/Lamp1 treatment. 
Considering that UV alone treatment is not so effective for the photodegradation of a lot of 
PPCPs, the combination of H2O2 with UV treatment will be a promising alternative treatment 
option for PPCPs removal.  
5) All the PPCPs except 7 PPCPs including cyclophosphamide and 2-QCA (727 mJ/cm2 ~ 
1,695 mJ/cm2) were degraded by more than 90% under UV dose of 691 mJ/cm2 (contact 
time : 30 min) during UV/lamp1/H2O2 treatment. As a consequence, it is considered that 
UV/H2O2 treatment can contribute to the reduction of energy consumption for the effective 




Andreozzi R., Raffaele M., Nicklas R., 2003, Pharmaceuticals in STP effluents and their solar 
photodegradation in aquatic environment, Chemosphere 50, 1319-1330 
Baxendale J.H., Wilson J.A., 1957, The photolysis of hydrogen peroxide at high light intensity, 
Trans. Faraday Soc. 53, 344 
Beltran F.J., Overjero G., Acedo B., 1993, Oxidation of atrazine in water by ultraviolet 
radiation combined with hydrogen peroxide, Water Res. 27, 1013-1021 
Blatchley III E.R., Shen C., Scheible O.K., Robinson J.P., Ragheb K., Bergstrom D.E., Rokjer 
 63 
D., 2007, Validation of large-scale, monochromatic UV disinfection systems for drinking 
water using dyed microspheres, Water Res., doi:10.1016/j.watres.2007.08.019 
Buser H.R., Poiger T., Muller M.D., 1998, Occurrence and fate of the pharmaceutical drug 
diclofenac in surface waters: rapid photodegradation in a lake, Environ Sci Technol. 32, 
3449-3456 
Cahill J.D., Furlong E.T., Burkhardt M.R., Kolpin D., Anderson LG, 2004, Determination of 
pharmaceutical compounds in surface-and ground-water samples by solid-phase extraction 
and high-performance liquid chromatography-electrospray ionization mass spectrometry, J 
Chromatogr A 1041, 171-180 
Canonica S., Meunier L., von Gunten U., 2008, Phototransformation of selected 
pharmaceuticals during UV treatment of drinking water, Water Res. 42, 121-128 
Doll T.E., Frimmel F.H., 2003, Fate of pharmaceuticals - photodegradation by simulated solar 
UV-light. Chemosphere 52, 1757-1769 
Fukunaga A., Nagao R., Yamashita N., Tanaka H., 2007, A risk assessment approach using 
reliability analysis for pharmaceuticals in discharge from sewage treatment plants, 5th IWA 
Specialised Conference on Assessment and Control of Micropollutants / Hazardous 
Substances in Water, DECHEMA e.V., Frankfurt/Main, Germany, 569 
Glaze W.H., Lay Y.S., Kang J.W., 1995, Advanced oxidation processes, a kinetic model for 
the oxidation of 1,2-dibromo-3-chloropropane in water by the combination of hydrogen 
peroxide and UV radiation, Ind. Eng. Chem. Res 34, 2314-2323 
Guittonneau S., Contribution a l’etude de la photooxydation de quelques micropollutants 
organochlores en solution aqueuse en presence de peroxide d’hydrogen. Comparison de 
systemes oxidants: H2O2/UV, O3/UV et O3/H2O2, These de docteur, University of Poitiers, 
France. 
Han W., Zhu W., Zhang P., Zhang Y., Li L., 2004, Photocatalytic degradation of phenols in 
aqueous solution under irradiation of 254 and 185 nm UV light, Catalysis today 90, 
319-324 
Heberer T., 2002, Occurrence, fate and removal of pharmaceutical residues in the aquatic 
environment: a review of recent research data, Toxicol Lett. 131, 5-17 
Heit G., Neuner A., Saugy P.Y., Braun A.M., 1998, Vacuum-UV (172 nm) Actinometry - The 
 64 
Quantum Yield of the Photolysis of Water, J Phys Chem A 102, 5551-5561 
Huber M.M., Ternes T.A., 2005, Oxidation of pharmaceuticals during water treatment with 
chlorine dioxide, Water Res. 39, 3607-3617 
Kobayashi Y., Yasojima M., Komori Y., Suzuki Y., Tanaka H., 2006, Removal Characteristics 
of Human Antibiotics during Wastewater Treatment in Japan, Water Practice and 
Technology doi10.2166/wpt.2006.059 
Lopez A., Anna B., Giuseppe M., John K., 2003, Kinetic investigation on UV and UV/H2O2 
degradations of pharmaceutical intermediates in aqueous solution, J Photochem Photobiol 
A: Chem. 156, 121-126 
Mascolo G., Ciannarella R., Balest L., Lopez A., 2007, Effectiveness of UV-based advanced 
oxidation processes for the remediation of hydrocarbon pollution in the groundwater: A 
laboratory investigation, J. Hazard. Mater., doi:10.1016/j.jhazmat.2007.07.120 
Michael C., 2004, Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, 
naproxen, and acetylsalicylic acid, Ecotox Environ Safe 59, 309-315 
Nakada N., Komori K., Suzuki Y., 2007, Occurrence of 70 pharmaceuticals and personal care 
products in Tone River basin in Japan, Wat Sci Tech. 56, 133-140 
Nghiem L.D., Schafer A.I., Elimelech M., 2005, Pharmaceutical Retention Mechanisms by 
Nanofiltration Membranes, Environ Sci Technol. 39, 7698-705 
Nicole I., Laat J.D., Dore M., Duguet J.P., Bonnel C., 1990, Use of UV radiation in water 
treatment: Measurement of photonic flux by hydrogen peroxide actinometry, Water Res. 24, 
157-168 
Nogrady T., Weaver D.F., Medicinal chemistry - A molecular and biochemical approach, 3rd 
ed, Oxford university press, 2005, p.525 
Okuda T., Kobayashi Y., Yamashita N., Tanaka H., 2007, Extraction of Pharmaceuticals from 
Activated Sludge and Behavior during Wastewater Treatment Process, Proceedings of 
Water Environment Federation/2007 Speciality Conference Series  Compounds of 
Emerging Concern - What is on the Horizen, 160-171 
Okuda T., Kobayashi Y., Nagao R., Yamashita N., Tanaka H., Tanaka S., Fuji S., Konishi C., 
Houwa I., 2008, Removal efficiency of 66 pharmaceuticals during wastewater treatment 
process in Japan, Wat Sci Tech. 57, 65-72 
 65 
Pereira V.J., Weinberg H.S., Linden K.G., Singer P.C., 2007, UV degradation kinetics and 
modeling of pharmaceutical compounds in laboratory grade and surface water via direct 
and indirect photolysis at 254 nm, Environ Sci Technol. 41, 1682-1688 
Plumlee M.H., Lopez-Mesas M., Heidlberger A., Ishida K.P., Reinhard M., 2008, 
N-nitrosodimethylamine (NDMA) removal by reverse osmosis and UV treatment and 
analysis via LC-MS/MS, Water Res. 42, 347-355 
Richardson S.D., Ternes T.A., 2005, Water Analysis: Emerging Contaminants and Current 
Issues, Anal.Chem. 77, 3807-3838 
Robinson P.R., Liu Q., Riddle A.M., Smith R.M., 2007, Modeling the impact of direct 
phototransformation on predicted environmental concentrations (PECs) of propranolol 
hydrochloride in UK and UV rivers, Chemosphere 66, 757-766 
Sugimori A., Organic photochemistry, 4th ed, Tokyo:Shokabo, 1998, 162-191 
Tanaka N., Nakamura S., Essentials of antibiotics, 4th ed, University of Tokyo press, 1992, 
355 
Thomas H., 2002, Occurrence, fate and removal of pharmaceutical residues in the aquatic 
environment: a review of recent research data, Toxicology Letters 131, 5-17 
Tvrtko S., Till L., Roverta S., Amro M.H., Rebecca L.V., David E., 2004, Emerging 
contaminants-pesticides, PPCPs, microbial degradation products and natural substances as 
inhibitors of multixenobiotic defense in aquatic organisms, Mutation Research 552, 
101-117 
Vogna D., Marotta R., Andreozzi R., Napolitano A., M.d’Ischia, 2004a, Kinetic and chemical 
assessment of the UV/H2O2 treatment of antiepileptic drug carbamazepine, Chemosphere 
54, 497-505 
Vogna D., Marotta R., Napolitano A., Andreozzi R., d’Ischia M., 2004b, Advanced oxidation 
of the pharmaceutical drug diclofenac with UV/H2O2 and ozone, Water Res. 38, 414-422 
Werner J.J., McNeill K., Arnold W.A., 2005, Environmental photodegradation of mefenamic 
acid, Chemosphere 58, 1339-1346 
Ziolli R.L., Jardim W.F., 2003, Photochemical transformations of water-soluble fraction 
(WSF) of crude oil in marine waters A comparison between photolysis and accelerated 
degradation with TiO2 using GC-MS and UVF, J. Photochem. Photobiol. 155, 243-252 
 66 
Zwiener C., Frimmel F.H., 2003, Short-term tests with a pilot sewage plant and biofilm 
reactors for the biological degradation of the pharmaceutical compounds clofibric acid, 






4 REMOVAL CHARACTERISTICS OF PHARMACEUTICALS 





Over the past few years, several studies have demonstrated that O3 was very effective for 
the oxidation of PPCPs in water treatment process. A study showed that compared to other 
important micropollutants such as MTBE and atrazine, several PPCPs (bezafibrate, 
carbamazepine, diazepam, diclofenac, ibuprofen, iopromide, sulfamethoxazole and 
roxithromycin) reacted about two to three times faster with OH radicals, concluding that O3 
treatment and AOPs are promising processes for an efficient removal of PPCPs in drinking 
waters (Huber et al., 2003). A pilot study using O3 treatment and UV-disinfection receiving 
effluent from a wastewater treatment plant has been reported that by applying 10-15 mgO3/L 
(contact time : 18 min), all the PPCPs investigated as well as musk fragrances and estrone 
were no longer detected (Ternes et al., 2003). However, it was also found that iodinated X-ray 
contrast media such as diatrizoate, iopamidol, iopromide and iomeprol were still detected in 
appreciable concentrations.  
During O3 treatment, organic compounds are oxidized by O3 molecules and OH radicals, 
which are formed as a consequence of O3 decay. When H2O2 is added during O3 treatment, the 
formation of OH radicals by the rapid decay of O3 will be more accelerated (Rosenfeldt et al., 
2006). O3 treatment for synthetic pharmaceutical wastewater containing two human 
antibiotics and a veterinary antibiotic has been studied to enhance the biodegradability of the 
pharmaceutical (Balcioglu and Otker, 2003). The study showed that although O3/H2O2 
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combination had no advantage for COD removal kinetics over the direct O3 application at pH 
7, the higher total removal rates of COD and UV254 were achieved by O3/H2O2 process once 
adjusted optimum H2O2 concentration. The combined O3/UV process has been widely studied 
due to a synergistic effect of several reactions such as direct UV photodegradation, direct O3 
treatment and OH radical oxidation. O3/UV process has been employed for removing the 
organic contaminants in wastewater, drinking water and industrial wastewater (Lau et al., 
2007; Zou and Zhu, 2007). 
As discussed above, O3 treatment can be used as a very effective process for PPCPs 
removal in water and wastewater treatment plants. Moreover, it is thought that O3/H2O2 and 
O3/UV treatment could improve their removals. However, the numbers of PPCPs investigated 
were limited although a great variety of PPCPs may occur in the environment. Therefore, the 
data on the degradation characteristics of those PPCPs will be needed when wastewater 
treatment plants are designed for preventing the pollution of PPCPs in the aquatic 
environment. The objective of this study was to investigate the degradation characteristic and 
the removal potential of various PPCPs detected in the aquatic environment with O3, O3/UV 
and O3/H2O2 treatments. Additionally, O3 consumption needed for the effective PPCPs 
degradation was estimated. Structure of the research of this chapter is shown in Fig 4-1. 
 
 
Fig. 4-1 Structure of this chapter 
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4.2 Methods and materials 
4.2.1 PPCPs investigated and preparation of tested water   
The 30 PPCPs used for this study were shown in Table 3-1. In order to examine the 
degradabilities of the 30 PPCPs with O3, O3/UV and O3/H2O2, tested water was prepared by 
spiking the 30 PPCPs into pure water (PW) obtained from Nisso shoji Co., Ltd and 
biologically treated water (TW) delivered from the same sewage treatment plant mentioned in 
Chapter III. TOC concentration in PW was below 50 µg/L, and the pH and DOC 
concentration of the TW ranged from 6.8 to 7.1 and 7.1 mg/L to 12.4 mg/L, respectively. TW 
used for preparing tested water was filtered by GF/C filter (Whatman) before use. 
The preparation procedure for tested water was the same as that for Chapter III. The 
initial concentrations of the 30 PPCPs in tested waters ranged from 4.7 µg/L (mefenamic acid) 
to 147.6 µg/L (sulfamonomethoxine).  
 
4.2.2 Experimental setup and conditions 
All the experiments were carried out using a cylindrical stainless reactor with an inside 
diameter of 30cm, a height of 108.7cm and an effective volume of 22L (Fig. 4-2). The 
temperature of tested water was maintained at 20°C by circulating hot water into a water 
jacket outside the reactor by a water circulator. The pH of tested waters spiked with the 30 
PPCPs into PW were adjusted to 7.0 with phosphate buffer solution of 1M prepared by 
K2HPO4 and NaH2PO4 solution before each experiment. The pH adjustment of tested water 
prepared by TW was not done. All the experiments started by sparging O3 gas continuously 
into the reactor filled with tested water. To confirm the potential of O3 treatment and O3-based 
AOPs for the PPCPs removal, we conducted 3 different treatment experiments such as O3 


















Fig. 4-2 Semi-batch reactor for O3, O3/H2O2 and O3/UV experiments 
 
4.2.2.1 Experimental conditions for O3 treatment  
For O3 treatment, firstly the effect of O3 feed rate on PPCPs degradation was investigated 
using tested water prepared by spiking the 30 PPCPs into PW. O3 feed rates investigated were 
0.15 mg/L/min, 0.3 mg/L/min and 0.6 mg/L/min, which were controlled by changing the 
concentration of O3 gas supplying to the reactor into 3.3 mg/L, 6.6 mg/L and 13.2 mg/L, 
respectively. Flow rate of O3 gas was maintained constantly to 1.0 L/min for all the 
experiments. Moreover, the degradation characteristic of PPCPs in real treated water by O3 
treatment was also investigated, and this experiment was performed by carrying out O3 
treatment (O3 feed rate : 0.6 mg/L/min) for the 30 PPCPs spiked into TW.  
 
Table 4-1 Experimental conditions 












UV 254nm - 





4.2.2.2 Experimental conditions for O3/UV treatment  
An 8W low pressure mercury lamp that emits at 254 nm and of which the intensity was 
0.384 mW/cm2 was used for O3/UV treatment. O3/UV treatment was done for tested water 
prepared by TW under O3 feed rates of 0.15 mg/L/min, 0.3 mg/L/min and 0.6 mg/L/min, 
respectively. The degradation of the 30 PPCPs in TW by O3/UV was investigated at an O3 
feed rate of 0.6 mg/L/min. 
 
4.2.2.3 Experimental conditions for O3/H2O2 treatment  
O3/H2O2 treatment was done by adding H2O2 solution into tested water before O3/H2O2 
treatment. Initial H2O2 concentrations of 2.3 mg/L and 11.2 mg/L in tested water prepared by 
PW were used, and O3 feed rate was 0.6 mg/L/min in both experiments.  
 
4.2.3 Analytical method 
The concentrations of the 30 PPCPs were measured simultaneously with LC/MS/MS. 
The measurement condition of LC/MS/MS, limit of detection (LOD) and limit of 
quantification (LOQ) were described in Chapter III. Dissolved O3 concentration was 
measured with indigo method (Bader et al., 1981) measuring the absorbance at 600 nm 
wavelength by a spectrophotometer (UV-16000, Shimadzu). DOC (dissolved organic carbon) 
concentration was measured with a TOC analyzer (TOC-5000A, Shimadzu) and calculated 
from the difference of TOC (total organic carbon) and IC (inorganic carbon). 
 
4.3 Results and discussion 
4.3.1 Determination of rate constants of PPCPs for O3, O3/UV and O3/H2O2 
treatments 
Generally, the degradation reaction of an organic compound with O3 in semi-batch 
reactor is expressed as equation (1):  
]][[][ 3OCkdt
Cd
=−      (1) 
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where, [C] is the concentration of the organic compound; [O3] is the concentration of 
dissolved O3; k is the rate constant. If O3 is not consumed by organic compounds etc, the 
increasing rate of dissolved O3 in semi-batch reactor is expressed as equation (2):  
][])[]([][ 333*33 OkOOakdt
Od
OL −−=      (2) 
where, [O3]* is the saturated concentration of dissolved O3, which is determined by the 
partial pressure and distribution coefficient of O3 gas; kLa is the volumetric overall mass 
transfer coefficient (/h); kO3 is the rate constant of O3 self decomposition (/h). As known in 
equation (2), when O3 gas is supplied to the reactor the concentration of dissolved O3 in the 
reactor increases with time. Moreover, if O3 gas is supplied continuously, finally the 
concentration of dissolved O3 will become constant ( ][])[]([ 333*3 OkOOak OL =− ). Therefore, 
equation (1) can be expressed as pseudo first-order reaction such as equation (3): 
][][ 3 Ckdt
Cd
O′=−    (3) 
where, k'O3 is affected by the concentration of dissolved O3 because k'O3 equals k[O3]. 
However, for experiments using the same reactor, k'O3 value can be used as an indicator for 
the reactivity of an organic compound with O3. By integrating equation (3), next equation is 
obtained.  
tkCC Ot 30 )/ln( ′=   (4) 
where, Ct is the concentration of an organic compound at the reaction time of t; C0 is the 
initial concentration of the organic compound. On the other hand, for O3/UV treatment, an 
organic compound is decayed by O3 molecules, direct UV photodegradation and OH radicals 
formed by UV photodegradation of O3. Therefore, the concentration decrease of the organic 
compound during O3/UV treatment can be expressed as equation (5): 
]])[[][(][ 03 COHkLIOkdt
Cd
R ⋅++=− φε    (5) 
Integrating equation (5) 
tktOHkLIOkCCLog UVORt /3030 ])[3.2][()/( ′=⋅++= φε   (6) 
where, L is reactor optical light path (cm); IO is UV intensity (Einstein/sec); ø is quantum 
yield (mol/photon); ε is the molar extinction coefficient of the organic compound (/M/cm); kR 
is the second order rate constant of OH radicals; [OH·] is the concentration of OH radicals.  
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For O3/H2O2 treatment, an organic compound will be degraded mainly by O3 molecules 
and OH radicals and the concentration decrease of an organic compound can be, therefore, 
expressed by equation (7): 
]])[[][(][ 3 COHkOkdt
Cd
R ⋅+=−    (7) 
Integrating equation (7), the following expression is obtained: 
tktOHkOkCCLog OHORt 22/330 ])[][()/( ′=⋅+=   (8) 
On the other hand, if ln (Ct/C0) of an organic compound decreases linearly with time, the 
degradation reaction of the compound by each treatment can be regarded as pseudo first-order 
reaction. This time, pseudo first-order rate constants (k'O3, k'O3/UV, k'O3/H2O2) for O3, O3/UV and 
O3/H2O2 can be obtained from the slopes of each straight line. 
y = -0.1583 x
R2 = 0.9820
y = -0.1024 x
R2 = 0.9770


















Fig. 4-3 Concentration decrease of DEET with time during O3, O3/UV and O3/H2O2 
treatments 
 
Fig. 4-3 shows the concentration decrease of DEET for the reaction time of 5 min during 
O3, O3/UV and O3/H2O2 treatments, which were conducted using tested water prepared by 
spiking 30 PPCPs simultaneously into PW. O3 was supplied to the reactor at an O3 feed rate of 
0.6 mg/L/min in all the experiments. O3/H2O2 treatment was done by supplying O3 to tested 
water with the initial concentration of H2O2 of 11.2 mg/L. The concentration of DEET 
decreased linearly with time in all the experiments and it can be, therefore, said that the 
degradation reactions of DEET with O3, O3/UV and O3/H2O2 follow pseudo first-order 
reaction. As shown in Fig. 4-3, k'O3 (pseudo first-order rate constant for O3) of DEET was 
0.1024 /min (1.7 E-03/sec), and k'O3/H2O2 was slightly enhanced by 0.1393 /min (2.3 E-03/sec) 
 74 
due to the contribution of OH radicals to the degradation of DEET. Moreover, it was observed 
that k'O3/UV increased by 0.1583 /min (2.6 E-03/sec) that thanks to the combination of UV with 
O3. On the other hand, the linear concentration decrease for the reaction time of 5 min was 
shown in all the PPCPs selected in this study, irrespective of applied processes and therefore, 
pseudo first-order rate constants of the 30 PPCPs for each process could be obtained. The 
pseudo first-order rate constants were used for investigating and comparing the degradability 
of each PPCP by applied processes and the effects of O3 feed rate, H2O2 addition and UV 
combination during O3 treatment on the degradation of the 30 PPCPs. 
 
4.3.2 Effect of O3 feed rate on PPCPs degradation during O3 treatment 
Fig. 4-4 compares pseudo first-order rate constants of the 30 PPCPs when different O3 
feed rates (0.15 mg/L/min, 0.3 mg/L/min and 0.6 mg/L/min) were used during O3 treatment. 
The experiments were carried out with tested water spiked the 30 PPCPs into PW. Pseudo 
first-order rate constants obtained in experiments performed by O3 feed rates of 0.15 
mg/L/min, 0.3 mg/L/min and 0.6 mg/L/min express as k'O3(0.15)_PW,  k'O3(0.3)_PW and k'O3(0.6)_PW, 
respectively.  k'O3(0.15)_PW values were in a low range of 1.4 E-04/sec (theophylline) to 6.0 
E-03/sec (mefenamic acid), while considerably high k'O3(0.3)_PW and k'O3(0.6)_PW values of 7.4 
E-04/sec (ethenzamide) to 1.5 E-02/sec (oxyteracycline) and 9.3 E-04/sec 
(cyclophosphamide) to 1.8 E-02/sec (mefenamic acid), respectively were obtained. Average 
rate constants of all the PPCPs for O3 feed rates of 0.15 mg/L/min, 0.3 mg/L/min and 0.6 
mg/L/min were also calculated as 1.2 E-03/sec, 3.3 E-03/sec and 4.7 E-03/sec, respectively, 
showing that high O3 dose led to fast PPCPs degradation. k'O3(0.15)_PW values of almost all 
PPCPs increased by a factor of more than 2 with the increased O3 feed rate (0.3 mg/L/min and 
0.6 mg/L/min).  
On the other hand, when tested water was treated with O3 feed rates of 0.15 mg/L/min, 
0.3 mg/L/min and 0.6 mg/L/min for the reaction time of 5 min, the amounts of O3 consumed 
per the volume of the reactor were 0.7 mg O3/L, 1.4 mg O3/L and 2.6 mg O3/L, respectively. 
Therefore, the ratio of average rate constant (/sec) to the amount of O3 consumed per the 
volume of the reactor (mg O3/L) was calculated to investigate the degradation efficiency for 
the PPCPs at each O3 feed rate based on the amount of O3 consumed during each treatment.  
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Fig. 4-4 k' values for the 30 PPCPs obtained during O3 treatment using different O3 feed rates 
 
The calculation showed that the value was highest in O3 feed rate of 0.3 mg/L/min (2.2 
E-03L/mg O3·sec), while 1.6 E-03L/mg O3·sec and 1.8 E-03L/mg O3·sec were obtained in O3 
feed rates of 0.15 mg/L/min and 0.6 mg/L/min, respectively. The values were calculated only 
for 28 PPCPs due to lacks of data for ceftiofur and chlorotetracyline. In water, O3 is decayed 
by chain reaction as equation (9) ~ (14). Especially, equation (14) is a fast reaction and causes 
O3 and OH radicals consumptions for waters with low scavenger (DOC, alkalinity) 
concentrations, resulting in the reduction of the oxidation capacity in the system (von Gunten, 
2003). In this study, the pH of all the tested waters was maintained at 7.0 by phosphate buffer 
solution. Therefore, the reason why the degradation efficiency of PPCPs to the amount of O3 
consumed for O3 feed rate of 0.6 mg/L/min was lower than for 0.3 mg/L/min may be that OH 
radicals and O3 were consumed faster by excess O3 which could be formed when relatively 
 76 
high O3 feed rate (0.6 mg/L/min) was used, resulting in low degradation efficiency of the 
PPCPs. This means that the appropriate O3 dose should be investigated first for the efficient 




    k = 70M-1s-1     (9) 
2223 OOOHHOO ++→+
−••−
 k = 2.8 × 106M-1s-1    (10) 
2323 OOOO +→+
−•−•
    k = 1.6 × 109M-1s-1      (11) 
23 OOHHO +→
••
         k = 1.4 × 105s-1         (12) 
−•−• +→+ OHOHOHO 2
    k = 108s-1         (13) 
223 OHOOOH +→+
••
     k = 1 × 108M-1s-1 ~ 2 × 109M-1s-1  (14) 
 
4.3.3 Degrdadation characteristics of PPCPs by O3 
When O3 was supplied by a feed rate of 0.6 mg/L/min, 3 PPCPs such as analgesic 
mefenamic acid and tetracycline antibiotics (oxytetracycline and tetracycline) showed the 
highest rate constants (1.8 E-02/sec, 1.6 E-02/sec and 1.6 E-02/sec, respectively) among the 
PPCPs, indicating that O3 will be very effective for their degradation. Contrarily, insect 
repellent DEET, carbadox intermediate 2-QCA and antineoplastic agent cyclophosphamide 
turned out to be very resistant for O3 from their very low rate constants (17 E-03/sec, 1.5 
E-03/sec and 9.3 E-04/sec, respectively). Here, O3 degradation characteristics of these several 
PPCPs was discussed. 
 
4.3.3.1 O3 degradation of tetracyclines 
Tetracyclines have been used as antibiotics for human and animal, and its consumption in 
the United States and Europe was estimated to 5,500tons/year in the mid-1990s (Chopra and 
Roberts, 2001). There are some studies on the fast degradation of tetracycline with O3. It has 
been reported that tetracycline reacted very quickly with O3, even though total organic carbon 
 77 
analyses revealed that it was not mineralized at all (Dalmazio et al., 2007). They proposed 
that during O3 treatment the C11a-C12 double bond of tetracycline was attacked by O3 and O3 
reaction at the C2-C3 double bond occurred by subsequent O3 attack (Fig. 4-5).  
Dodd et al (2006) have measured O3 and OH radical reaction kinetics for 14 antibacterial 
compounds from nine structural families. In their study, C11a-C12 double bond, C2-C3 
double bond and tertiary amine were proposed as expected sites of O3 attack, and they showed 
that tetracycline reacted rapidly with O3 in a wide range of pH. 3 kinds of tetracyclines 
(tetracycline, chlorotetracycline and oxytetracycline) with a similar chemical structure were 
included in a list of 30 PPCPs investigated, and all the tetracyclines showed  a similar 
degradation rate.  
 
 
Fig. 4-5 Chemical structure of tetracycline  
 
4.3.3.2 O3 degradation of DEET and cyclophosphamide 
Insect repellent DEET and antineoplastic agent cyclophosphamide were observed to be 
very resistant for O3. There seems to be no information on the O3 degradation of these PPCPs. 
Costanzo et al (2007) discussed a preliminary risk assessment for DEET in the aquatic 
environment based on its new and existing toxicity data, and showed that risk to aquatic biota 
at observed environmental concentrations is minimal. However, they suggested that further 
investigation on the risk should be done because it is detected in the aquatic environment very 
frequently.  
Cyclophosphamide is also known to a cytotoxic drug, which is a group of compounds 
used in chemotherapy which prevent or disrupt cell division. Steger-Hartmann et al (1997) 
assessed the biological degradability of cyclophosphamide using the Zahn-Wellens/EMPA test 
(OECD 302B) and a laboratory scale sewage treatment plant. In both test, cyclophosphamide 
showed very poor degradability and might, therefore, enter into the water cycle. This means 
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that additional processes following biological process will be necessary for ensuring high 
removal efficiency of cyclophosphamide, even though its effect on aquatic environment still 
remains unclear. On the other hand, Johnson et al (2008) have suggested that occurrence of 
cytotoxic drugs in water is not desirable because a mixture of cytotoxic drugs as well as a 
single cytotoxic drug can affect aquatic environment. 
 
       
Fig. 4-6 Chemical structures of DEET and cyclophosphamide 
 
4.3.3.3 O3 degradation of sulfonamides 
In this study, the degradation of 4 sulfonamides (sulfamethoxine, sulfadimizine, 
sulfamonomethoxine and sulfamethoxazole) with O3 was investigated. Sulfonamide 
compounds, derivatives from sulfanilamide (sulfamine), have been known to be more 
antibacterial than sulfanilamide and have a low risk of side effects (Tanaka and Nakamura, 
1992). Huber et al (2003) investigated the oxidation of PPCPs using conventional O3 
treatment and O3-based AOPs. The study showed that when O3 of 1 mg/L was utilized at pH 
7~8, half-life time of sulfamethoxazole was below 0.5sec, indicating that it is completely 
transformed during O3 treatment and O3-based AOPs. In addition, they expected the aromatic 
amino group as the main reaction site of O3 during O3 degradation of sulfamethoxazole. They 
also suggested that rate constants of all sulfonamides will be very similar to the rate constant 
(~2.5×106M-1s-1) of sulfamethoxazeol for O3 reaction because the reactive group (aromatic 
amine) is characteristic for all the compounds in sulfonamides group. In this study, 4 
sulfonamides showed almost same rate constants (3.5 E-03/sec ~ 4.0 E-03/sec) for O3 feed 
rates of 0.6 mg/L/min, although a rather wide range of rate constants were obtained for 0.15 




4.3.4 Effect of UV on PPCPs degradation during O3 treatment 
Fig. 4-7 compares pseudo first-order rate constants (k'O3(0.15)/UV_PW, k'O3(0.3)/UV_PW and 
k'O3(0.6)/UV_PW) of the 30 PPCPs for O3 treatment with/without UV under O3 feed rates of 0.15 
mg/L/min, 0.3 mg/L/min and 0.6 mg/L/min, respectively. Each symbol in Fig. 4-7 indicates 
corresponding PPCP investigated. The combination of UV during O3 treatment led to the 
distinct improvement of degradation rates of most of the PPCPs for 0.15 mg/L/min and 0.6 
mg/L/min. While, for O3 feed rate of 0.3 mg/L/min, UV addition could not improve the 
degradation of 14 PPCPs including mefenamic acid, tetracyclines, carbamazepine and 
cyclophosphamide. As known in Fig. 4-7, rate constants of 4 PPCPs such as mefenamic acid 
and tetracyclines (tetracycline, oxytetracycline, chlorotetracycline) increased or decreased 
slightly for all the O3/UV treatments compared to O3 treatments.  
It was also observed that among the 14 PPCPs, the increase of rate constants of the 10 
PPCPs such as carbamazepine and cyclophosphamide were relatively lower than for other 
PPCPs, irrespective of O3 feed rate during O3/UV treatments. Therefore, it can be expected 
that the 14 PPCPs would be degraded very fast with O3 than with OH radicals compared to 
other PPCPs. On the contrary, rate constants of several PPCPs such as ketoprofen, diclofenac, 
sulfamethoxazole and antipyrine increased considerably by UV addition during O3 treatment. 
Especially, ketoprofen and diclofenac showed much higher rate constants than for O3 
treatment, irrespective of O3 feed rate (Fig. 4-7). Chapter III showed that ketoprofen was 
degraded very easily with UV, and direct UV photodegradation mainly contributed to its 
degradation during UV/H2O2 treatment. In this study, it is, therefore, thought that direct UV 
photodegradation rather than OH radicals involved in such a fast ketoprofen degradation 
during O3/UV treatment.  
On the other hand, when O3 feed rates of 0.15 mg/L/min, 0.3 mg/L/min and 0.6 
mg/L/min were used during O3/UV treatment, O3 of 0.6 mg/L, 1.3 mg/L and 2.7 mg/L was 
consumed, respectively. The degradation efficiency of the 30 PPCPs for each treatment was 
compared based on the ratio of average rate constant (/sec) for all the PPCPs to the O3 
consumption per the volume of reactor (mg O3/L). As a result, during O3/UV treatment 6.9 
E-03L/mgO3·sec, 3.8 E-03L/mgO3·sec and 3.3 E-03L/mgO3·sec were obtained for O3 feed 
rates of 0.15 mg/L/min, 0.3 mg/L/min and 0.6 mg/L/min, respectively, showing the apparently 
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Fig. 4-7 Comparison of rate constants of the 30 PPCPs for O3 treatment with/without UV 




However, in contrast to O3 treatment, it was characteristic that the highest degradation 
efficiency was shown at O3 feed rate of 0.15 mg/L/min, indicating that required O3 dose can 
be reduced by the combination of UV during O3 treatment.  
 
4.3.5 Effect of H2O2 addition on PPCPs degradation during O3 treatment 
Fig. 4-8 compares rate constants of the 30 PPCPs for O3/H2O2 treatment with k'O3(0.6)_PW 
values obtained for O3 treatment using O3 feed rate of 0.6 mg/L/min. Tested water prepared by 
PW spiked with the 30 PPCPs was used for the experiments using O3/H2O2 treatment. Initial 
H2O2 concentrations in tested water were 2.3 mg/L and 11.2 mg/L, and therefore, rate 
constants obtained in the experiments were expressed by k'O3(0.6)/H2O2(2.3)_PW and 
k'O3(0.6)/H2O2(11.2)_PW, respectively. Here, the degradation rates of 28 PPCPs were discussed 




























Fig. 4-8 Comparison of rate constants of the 30 PPCPs for O3 treatment with/without H2O2 
addition 
 
As a result, the presence of initial H2O2 concentration of 2.3 mg/L during O3 treatment 
promoted the degradation rates of 26 PPCPs by 1.1 to 6.5 times of those for O3 treatment (Fig. 
4-8). This is due to the contribution of OH radicals formed by the reaction of equation (15), 
although very low rate constant (5.1 E-03/sec) was obtained in tetracycline. 
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2223 322 OOHOHO +⋅→+       (15) 
Contrarily, rate constants of only 17 PPCPs including clarithromycin and propranolol 
increased by 1.1 to 1.6 times of those for O3 treatment when initial H2O2 concentration of 11.2 
mg/L was used for O3 treatment. In particular, even slightly lower rate constants than for O3 
treatment were shown in 4 PPCPs such as cyclophosphamide, disopyramide, tetracycline and 
theophylline. Moreover, average rate constants of the 28 PPCPs for 2.3 mg/L and 11.2 mg/L 
were 6.2 E-03/sec and 5.1 E-03/sec, respectively. Consequently, high H2O2 concentration of 
11.2 mg/L did not cause higher degradation rates of PPCPs. This can be explained that OH 
radicals can be scavenged by H2O2 in water as equation (16) (von Gunten, 2003), leading to 
low degradation rate of target compounds.  
OHHOOHOH 2222 +→+⋅     (16) 
Therefore, it is considered that when high initial H2O2 concentration of 11.2 mg/L was 
added, OH radicals formed by the reaction of equation (15) were scavenged by excess H2O2 
added during O3 treatment, and as a consequent, lower rate constants than those for O3/H2O2 
treatment using initial H2O2 concentration of 2.3 mg/L were obtained. Finally, it can be 
concluded that it will be important to determine the appropriate H2O2 dose for O3 treatment in 
order to improve degradation rates of PPCPs by the addition of H2O2 during O3 treatment. 
 
4.3.6 O3 consumption required for 90% degradation of PPCPs during O3 and 
O3/UV treatments 
Table 4-2 shows O3 consumptions and relative residual concentration of each PPCP at 
reaction times of 5 min, 10 min, 20 min and 30 min during O3 treatment (O3 feed rate of 0.6 
mg/L/min). Here, the achievement of relative residual concentration of 0.1 (90% degradation) 
was used for investigating the potential of O3 treatment for the degradation of 30 PPCPs in 
TW. 
Firstly, it can be seen that the degradation rate of each PPCP increased with the 
increasing O3 consumption in both the cases, and O3 consumption with time was a little higher 
in tested water prepared by spiking the 30 PPCPs into TW due to DOM (dissolved organic 
matters) present originally in TW. For tested water using PW, when O3 of 6.3 mg/L was 
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consumed, relative residual concentrations of all the PPCPs decreased by less than 0.1 except 
chlorotetracycline. However, when using TW as tested water, relative residual concentration 
of chlorotetracycline was 0.1 at O3 consumption of 2.8 mg/L, indicating that this compound 
will be degraded very easily even by low O3 dose. 
 
Table 4-2 Variation of O3 consumptions and relative residual concentration of each PPCP with 
time during O3 treatment 
Tested water Pure water +30 PPCPs Treated water +30 PPCPs 
Used process O3 (0.6 mg/L/min) O3 (0.6 mg/L/min) 
Reaction time 5min 10min 20min 30min 5min 10min 20min 30min 
Consumed O3 2.6mg/L 4.2mg/L 6.3mg/L 7.9mg/L 2.8mg/L 4.6mg/L 7.0mg/L 8.9mg/L 
Isopropylantipyrine < 0.1 - - - 0.2 < 0.1 - - 
Mefenamic acid < 0.1 - - - < 0.1 - - - 
Indomethacin ≤ 0.1 < 0.1 - - 0.3 < 0.1 - - 
Acetaminophen 0.2 < 0.1 - - 0.4 < 0.1 - - 
Diclofenac ≤ 0.3 < 0.1 - - 0.5 < 0.1 - - 
Naproxen 0.3 < 0.1 - - 0.5 ≤ 0.1 < 0.1 - 
Antipyrine 0.5 0.1 < 0.1 - ≤ 0.7 0.4 < 0.1 - 
Ethenzamide 0.6 0.2 < 0.1 - 0.7 0.5 0.2 < 0.1 
Fenoprofen 0.5 0.2 < 0.1 - 0.7 0.4 0.1 < 0.1 
Ketoprofen 
Analgesic 
0.6 0.2 < 0.1 - 0.8 0.5 0.2 < 0.1 
Propranolol ≤ 0.4 < 0.1 - - 0.6 0.2 < 0.1 - 




≤ 0.6 ≤ 0.3 < 0.1 - 0.8 0.5 0.3 < 0.1 
Oxytetracyline < 0.1 - - - < 0.1 - - - 
Tetracycline < 0.1 - - - < 0.1 - - - 
Ceftiofur 0.2 < 0.1 - - 0.4 < 0.1 - - 
Sulfadimethoxine ≤ 0.3 < 0.1 - - 0.5 < 0.1 - - 
Sulfadimizine ≤ 0.3 < 0.1 - - 0.5 < 0.1 - - 
Sulfamethoxazole 0.3 < 0.1 - - 0.6 0.1 < 0.1 - 
Sulfamonomethoxine ≤ 0.4 < 0.1 - - 0.5 0.1 < 0.1 - 
Clarithromycin ≤ 0.6 ≤ 0.2 < 0.1 - 0.7 0.4 < 0.1 - 
Chlorotetracycline 
Antibiotics 
No data 0.1 < 0.1 - - 
Ifenprodil NMDA receptor 
antagonist 0.1 < 0.1 - - 0.4 < 0.1 - - 
Clenbuterol Bronchodilator 0.5 < 0.1 - - ≤ 0.7 0.4 < 0.1 - 
Theophylline Bronchodilator 0.4 < 0.1 - - ≤ 0.7 0.2 ≤ 0.2 ≤ 0.2 
Carbamazepine Anticonvulsant 0.4 < 0.1 - - 0.6 0.2 ≤ 0.2 ≤ 0.2 
Crotamiton Anti-itch drug 0.4 < 0.1 - - 0.6 0.3 < 0.1 - 
2-QCA Carbadox intermediate 0.6 0.3 < 0.1 - ≤ 0.7 ≤ 0.5 ≤ 0.2 < 0.1 
DEET Insect repellents  0.6 0.2 < 0.1 - 0.7 0.5 0.2 < 0.1 
Cyclophosphamide Antineoplastic 
agents 0.8 0.6 0.1 < 0.1 ≤ 0.8 0.7 0.5 0.3 
No. of PPCPs degraded by ≥ 90% 6 20 29 29 4 15 22 27 
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On the other hand, when using tested water prepared by TW, cyclophosphamide showed 
relative residual concentration of 0.3 in spite of O3 consumption of 8.9 mg/L. Therefore, more 
O3 dose will be required for ensuring 90% degradation of cyclophosphamide in real sewage 
treated water. Relative residual concentrations of carbamazepine and theophylline were 
indicated as less than 0.2 even at the O3 consumption of 8.9 mg/L because their peaks were 
not detected for LC/MS/MS analysis. However, it is expected that when more than 90% of 
them would be degraded at O3 consumption of 8.9 mg/L because their relative residual 
concentrations were 0.2 at O3 consumption of 4.6 mg/L.  
From these results, it can be known that O3 dose of less than 6.3 mg/L will be needed for 
degrading the 30 PPCPs with concentrations ranging of 13.4~144.0 µg/L by more than 90% if 
there is no component consuming O3 in the water such as drinking water. While, O3 dose of 
about 8.9 mg/L will be necessary for ensuring 90% degradation of PPCPs in biologically 
treated water with DOC concentration of 12.7 mg/L. However, less O3 dose may be required 
for ensuring the degradation efficiency obtained in semi-batch reactor because O3 reactors in 
water and wastewater treatment plants are operated by continuous flow type. 
Table 4-3 shows O3 consumption and relative residual concentration of individual PPCPs 
at each reaction time during O3/UV treatment using O3 feed rate of 0.6 mg/L/min. O3 
consumption for 30 min was rather higher than for O3 treatment due to direct UV 
photodegradation of O3 molecules, while the amounts of O3 consumed for 10 min were almost 
the same to for O3 treatment. Nevertheless, relative residual concentrations of less than 0.1 
were obtained in 28 PPCPs except cyclophosphamide and ceftiofur when using PW as tested 
water. This was compared with for O3 treatment that only 20 PPCPs showed relative residual 
concentration of less than 0.1. As known in Table 4-2 and Table 4-3, such a significant 
difference was not observed when using tested water prepared by TW, probably due to the 
consumption of OH radicals by scavengers such as DOM and alkalinity in TW. Consequently, 
it is considered that the improvement of PPCPs degradation by the combination of UV during 





Table 4-3 Variation of O3 consumptions and relative residual concentration of each PPCP with 
time during O3/UV treatment 
Tested water Pure water +30 PPCPs Treated water +30 PPCPs 
Used process O3 (0.6 mg/L/min)/UV O3 (0.6 mg/L/min)/UV 
Reaction time 5min 10min 20min 30min 5min 10min 20min 30min 
Consumed O3 2.7mg/L 4.5mg/L 7.4mg/L 10.6mg/L 2.6mg/L 4.5mg/L 7.7mg/L 10.6mg/L 
Antipyrine < 0.1 - - - 0.4 < 0.1 - - 
Diclofenac < 0.1 - - - < 0.1 - - - 
Indomethacin < 0.1 - - - 0.2 < 0.1 - - 
Isopropylantipyrine < 0.1 - - - 0.2 < 0.1 - - 
Ketoprofen < 0.1 - - - < 0.1 - - - 
Acetaminophen 0.1 < 0.1 - - 0.4 < 0.1 - - 
Fenoprofen 0.1 < 0.1 - - 0.4 ≤ 0.2 < 0.1 - 
Ethenzamide 0.5 < 0.1 - - 0.8 0.5 0.2 < 0.1 
Mefenamic acid ≤ 0.5 < 0.1 - - 0.1 < 0.1 - - 
Naproxen 
Analgesic 
≤ 0.2 < 0.1 - - ≤ 0.5 ≤ 0.2 < 0.1 - 
Disopyramide 0.2 < 0.1 - - 0.5 0.2 < 0.1 - 




0.5 < 0.1 - - 0.8 < 0.1 - - 
Chlorotetracycline < 0.1 - - - < 0.1 - - - 
Oxytetracyline < 0.1 - - - < 0.1 - - - 
Sulfadimethoxine < 0.1 - - - 0.4 ≤ 0.1 < 0.1 - 
Sulfamethoxazole < 0.1 - - - 0.3 < 0.1 - - 
Sulfamonomethoxine < 0.1 - - - 0.2 < 0.1 - - 
Tetracycline < 0.1 - - - < 0.1 < 0.1 - - 
Sulfadimizine 0.2 < 0.1 - - 0.4 0.1 < 0.1 - 
Clarithromycin ≤ 0.6 < 0.1 - - ≤ 0.7 ≤ 0.4 < 0.1 - 
Ceftiofur 
Antibiotics 
No data No data 
Ifenprodil NMDA receptor 
antagonist 0.1 < 0.1 - - 0.2 < 0.1 - - 
Clenbuterol Bronchodilator 0.2 < 0.1 - - 0.7 0.3 < 0.1 - 
Theophylline Bronchodilator 0.3 < 0.1 - - 0.6 0.2 < 0.1 - 
Carbamazepine Anticonvulsant 0.3 < 0.1 - - 0.6 0.3 < 0.1 - 
Crotamiton Anti-itch drug 0.3 < 0.1 - - 0.6 0.3 < 0.1 - 
DEET Insect repellents ≤ 0.5 < 0.1 - - ≤ 0.8 0.5 0.2 < 0.1 
2-QCA Carbadox intermediate 0.6 0.1 < 0.1 - ≤ 0.8 ≤ 0.6 0.3 < 0.1 
Cyclophosphamide Antineoplastic 
agents ≤ 0.7 ≤ 0.4 < 0.1 - 0.9 ≤ 0.8 ≤ 0.5 ≤ 0.3 






The effect of O3 feed rate and the addition of H2O2 or UV on the degradation rates of 30 
PPCPs was investigated during O3 treatment using semi-batch reactor. The concentration of 
each PPCP decreased linearly with time, indicating that their reactions with O3, O3/H2O2 and 
O3/UV follow pseudo 1st order kinetics. Therefore, the degradability of each PPCP was 
compared by pseudo 1st order rate constant.  
1) The degradabilities (pseudo 1st order rate constants) of individual PPCPs increased 
with the increased O3 feed rate (0.15 mg/L/min, 0.3 mg/L/min, 0.6 mg/L/min). However, the 
degradation efficiency (the ratio of pseudo 1st order rate constant (/sec) to the amount of O3 
consumed per the volume of the reactor (mgO3/L)) for the 30 PPCPs was the highest for O3 
feed rate of 0.3 mg/L/min (2.2E-03 L/mgO3·sec). This indicates that the introduction of high 
O3 concentration could not contribute to the improvement of the degradabilites per O3 
consumed although it improved the degradation rates of the PPCPs.  
2) The degradation rate of each PPCP increased considerably by the combination of UV 
with O3 treatment, and the lowest O3 feed rate of 0.15 mg/L/min showed the most efficiency 
PPCPs degradation (6.9E-03 L/mgO3·sec). This means that O3 dose required for the effective 
PPCP removal can be reduced for O3/UV treatment. On the other hand, the degradation rates 
of 14 PPCPs including mefenamic acid, tetracyclines, carbamazepine and cyclophosphamide 
did not improve so much during O3/UV treatment, implying that the PPCPs will react more 
easily with O3 than OH radicals.  
3) For O3/H2O2 treatment, initial H2O2 concentration of 2.3 mg/L and 11.2 mg/L was 
combined with O3 treatment (0.6 mg/L/min). As a result, H2O2 addition increased the 
degradation rates of 26 PPCPs by factors of 1.1 to 6.5 comparing with for O3 alone treatment. 
However, lower degradation rates showed when initial H2O2 concentration was 11.2 mg/L, 
maybe due to the scavenging effect of O3 and OH radicals by excess H2O2.  
4) Finally, O3 consumptions required for 90% degradation of each PPCP for O3 and 
O3/UV treatment were calculated. For O3 treatment, O3 consumption of 6.3 mg/L was 
necessary for 90% degradation of all the 30 PPCPs spiked into pure water. While, for O3/UV 
treatment, O3 consumption of 4.5 mg/L could achieve 90% degradation of each PPCP. On the 
other hand, comparatively high O3 consumptions of 8.9 mg/L and 7.7 mg/L were required for 
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O3 and O3/UV treatments carried out with tested water spiked with the 30 PPCPs, respectively. 
These O3 consumptions resulted from semi-batch experiments (initial dissolved ozone 
concentration in tested water = 0 mg/L), and less O3 consumption will be, therefore, needed 
for real O3 and O3/UV treatment facilities because real treatment facilities are operated by 
supplying continuously O3 gas into O3 and O3/UV reactors.  
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5 INVESTIGATION ON THE REMOVAL PERFORMANCE 
FOR PHARMACEUTICALS AND PERSONAL CARE 
PRODUCTS BY UV-BASED PROCESSES                   




A great variety of pharmaceuticals and personal care products (PPCPs) have been 
produced for human and veterinary health in the medical field. The environmental fate and 
effects of the PPCPs have been studied over the last few years. Cleuvers (2004) demonstrated 
that diclofenac, ibuprofen, naproxen and acetylsalicylic acid exhibit the stronger toxicities 
when they coexist in water than when they exist alone. This means that more studies are still 
needed to confirm the adverse effects of PPCPs on human health and ecosystem. On the other 
hand, much attention has been paid to the safety of tap water and treated wastewater because 
of the lack of water resources and water reuse. While, there is a growing concern regarding 
the occurrence of PPCPs in the aquatic environment (Heberer et al., 2002; Smital et al., 2004). 
These PPCPs have been detected in samples from all aquatic environment such as river water, 
ground water and drinking water and the main source of them has been known as the effluent 
from wastewater treatment plant (Halling-Sørensen et al., 1998; Kanda et al., 2003). There are 
also several investigations showing that PPCPs are not eliminated during wastewater 
treatment and also not biodegraded in the environment (Ternes, 1998; Daughton et al., 1999; 
Nakada et al., 2006; Okuda et al., 2008).  
On the other hand, there seems to be almost no studies on the removal of PPCPs in 
secondary effluent by UV and UV/H2O2 processes using demonstration scale plant. In this 
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study, therefore, the removal performance of UV and UV/H2O2 processes was investigated 
using bench scale plant. The experiments were carried out ,based on the results from Chapter 
III (UV dose required for the effective removal of the 30 PPCPs: 38 mJ/cm2 to 5,644 mJ/cm2 
for UV alone process). Moreover, the appropriate amount of H2O2 addition during UV process 
was investigated for the 90% removal of all the PPCPs detected in secondary effluent. Finally, 
energy consumption and operating costs were estimated for each process considering the 
effective PPCPs removal. The research structure of this chapter is shown in Fig. 5-1. 
 
Fig. 5-1 Structure of this chapter 
 
5.2 Methods and materials 
5.2.1 Experimental setup and operational conditions 
Experiment setup used in this study consists of three reactors (R1, R2 and R3) connected 
in series (Fig. 5-2). The effective volume and HRT (hydraulic retention time) of a reactor are 
35L and 5 min, respectively. Secondary effluent from sewage treatment plant was used after 
filtered by sand filtration as tested water during all the experiments. The pH of the tested 
water was 6.7, and DOC and UV254 ranged from 2.6 mg/L to 3.9 mg/L and 0.053 /cm to 0.064 
/cm, respectively.  
 
Design of continuous 
experimental setup, based on UV 
dose estimated in Chapter III 
Investigation of operational condition for 
the effective removal of PPCPs in 
secondary effluent by UV/H2O2 process 
Energy consumption and 
operating cost for the effective 
PPCPs removal 
Discussion on the relationship 


























Fig. 5-2 Experimental setup for UV and UV/H2O2 treatments 
 
In order to investigate UV dose and energy consumption for the effective removal of 
PPCPs in secondary effluent by UV and UV/H2O2 processes, 2 kinds of UV lamps that emit at 
the wavelength of 254 nm were used for experiments; a 65W low pressure mercury lamp with 
UV output of 21.8WUV (UV65W Lamp) and a 41W low pressure mercury lamp with UV output 
of 13.6WUV (UV41W Lamp). UV65W and UV41W lamps have the UV intensities of 1.025 
mW/cm2 and 0.639 mW/cm2, respectively. UV treatments with and without H2O2 addition 
were performed for each UV lamp. For UV treatments, all the 3 reactors were operated under 
UV irradiation, while only R1 was operated during UV/H2O2 treatments. The same 3 UV 
lamps were placed inside each reactor and air was supplied continuously from the bottom to 
each reactor at a flow rate of 0.5 L/min for efficient UV irradiation to tested water during all 
the experiments. The initial H2O2 concentrations in tested water were maintained to 1.1 mg/L, 
3.1 mg/L and 6.0 mgL for UV41W /H2O2 treatments, and 1.2 mg/L, 3.1 mg/L and 6.2 mg/L for 
UV65W /H2O2 treatments. 
Table 5-1 Operational conditions 
UV alone process UV/H2O2 process 
Applied UV lamp Operated reactor Initial H2O2 
concentration Operated reactor 












5.2.2 Pretreatment of sample for PPCPs quantification with LC/MS/MS  
Fig. 5-2 shows pretreatment procedure of each sample for PPCPs quantification with 
LC/MS/MS. Firstly, a sample of 1,000ml taken from sampling port in outlet of each reactor 
was filtered with GF/B (pore size: 1.0µm) and then, EDTA of 1g was added to the filtrate. 
Afterwards, PPCPs in the filtrate were concentrated in Oasis HLB cartridge (Waters, 
6cc/100mg) by the concentrator (Waters, Sep-Pak concentrator SPC-10). The Oasis HLB 
cartridge conditioned in advance with 3ml methanol and 6ml distilled water was used for the 
concentration. After concentrating, the cartridge was dehydrated by a pneumatic pump for 1 hr 
in order to avoid the remaining of water in the cartridge, and PPCPs were eluted from the 
dehydrated cartridge with 6ml methanol. The eluted solution was volatilized with N2 gas and 
then, dissolved again with 1ml mixed solution of 0.1% formic acid and methanol. This 
solution of 1ml was used for PPCPs quantification with LC/MS/MS.  
 
 
Fig. 5-3 Pretreatment procedure of sample for PPCPs quantification 
 
Solid phase extraction using Oasis HLB cartridge 
* Conditioning of cartridge (MeOH 3mL and pure water 6mL) 
* Pass sample of 1,000mL through cartridge with concentrator 
* Dehydration of cartridge 
* Elution (MeOH 6mL) 
Dissolve using solution (1ml) prepared with 
0.1% formic acid and MeOH (8:2) 
Addition of EDTA (1g) 
Quantification by LC/MS/MS 
Collection of sample (1,000mL) 
Filtration with GF/B (1.0µm) 
Volatilization of MeOH from eluted solution with N2 gas 
(0.3~0.4L N2/min @37°C) 
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5.2.3 Analytical methods  
The concentrations of PPCPs were measured simultaneously with UPLC/MS/MS. 
AQUITY UPLC (Waters) was used for UPLC and Quattro micro API Tandem mass 
spectrometer (Waters) for MS/MS. The control of UPLC/MS/MS system and the treatment of 
data acquired during operation of LC/MS/MS were managed by MassLynxTM Software 
(Waters). For simultaneous quantification of PPCPs, gradient elution analysis method by 
varying the polarity of mobile phase with time was adopted and 62 PPCPs could be quantified 
simultaneously by UPLC/MS/MS.  
Table 5-2 shows the measurement condition of UPLC/MS/MS in details, and ionization 
conditions, LODs (Limit Of Detections) and LOQs (Limit Of Quantifications) for the 62 
PPCPs are shown in Table 5-3. LODs and LOQs for simultaneous analysis of the PPCPs were 
determined by measuring standard solutions with the concentration of 0.5 µg/L, 1 µg/L, 5 
µg/L, 10 µg/L, 50 µg/L, 100 µg/L and 200 µg/L for individual PPCPs with UPLC/MS/MS. 
Using the concentrations obtained by measurements of 5 times for each standard solution, 
average value and standard deviation value for each PPCP were calculated. Afterwards, a 
variation coefficient, which is defined as a ratio of standard deviation value to average value, 
was calculated. Based on the standard deviation (σ) of standard solution at the lowest 
concentration with the variation coefficient of less than 20%, LOD (3σ) and LOQ (10σ) were 
calculated.  
DOC (dissolved organic carbon) concentration was measured with a TOC analyzer 
(TOC-5000A, Shimadzu) and calculated from the difference of TOC (total organic carbon) 
and IC (inorganic carbon). A spectrophotometer (UV-16000, Shimadzu) was used for 
measuring the absorbance at 254 nm (UV254). DMP (2,9-dimethyl-1,10-phenanthroline) 








Table 5-2 Measurement condition for LC/MS/MS analysis 
<UPLC：UPLC AQUITY>
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<MS/MS：Quattro micro API>
- Ionization：Electrospray Ionization(ESI)
- Spray Voltage：        0.5kV           3.5kV
- Source Temp.：       120℃           120℃





Table 5-3 Ionization conditions, LOD and LOQ for 62 PPCPs 













1 Azithromycin + 749.5 591.4 40 25 0.06 0.19
2 Clarithromycin + 748.9 157.9 30 20 0.18 0.61
3 Erythromycin + 734.5 158.1 18 26 0.14 0.46
4 Roxithromycin + 837.7 679.4 25 20 0.07 0.24
5 Tylosin + 916.5 174.0 45 40 0.07 0.23
6 Ciproflxacin + 332.2 231.0 25 35 0.31 1.02
7 Enrofloxacin + 360.2 245.2 30 26 0.05 0.16
8 Levofloxacin + 362.1 317.8 28 18 0.39 1.31
9 Norfloxacin + 320.1 276.0 28 18 0.15 0.51
10 Sulfadimethoxine + 311.0 155.8 28 22 0.06 0.21
11 Sulfadimidine + 279.0 185.7 24 18 0.10 0.34
12 Sulfamerazine + 265.2 155.9 25 18 0.20 0.66
13 Sulfamonomethoxine + 281.0 155.7 24 18 0.49 1.64
14 Ampicillin + 350.3 105.8 16 20 0.58 1.94
15 Benzylpenicillin Potassium + 335.0 289.0 34 25 1.04 6.47
16 Ceftiofur + 524.0 240.8 20 16 4.62 15.41
17 Oxytetracycline + 461.1 425.9 16 18 0.20 0.68
18 Tetracycline hydrochloride + 445.1 409.7 20 18 0.02 0.08
19 Diclazuril - 406.9 335.7 32 18 0.41 1.38
20 Nicarbazin - 301.0 136.8 18 12 0.21 0.69
21 Sulfamethoxazole + 254.0 155.9 25 15 0.16 0.55
22 Trimethoprim + 291.0 229.8 32 26 0.11 0.35
23 2-quinoxaline carboxylic acid + 175.0 128.9 20 15 0.31 1.03
24 Chloramphenicol - 320.9 151.7 24 14 0.35 1.17
25 Griseofulvin + 353.1 214.9 25 25 0.17 0.58
26 Lincomycin + 407.2 125.8 28 28 0.14 0.47
27 Novobiocin + 613.3 188.7 20 32 0.22 0.73
28 Salinomycin - 749.6 240.9 48 34 0.44 1.48
29 Tiamulin + 494.4 192.1 25 20 0.03 0.10
30 Acetaminophen + 152.0 109.8 25 16 0.25 0.84
31 Antipyrine + 189.1 76.7 30 35 0.11 0.36
32 Ethenzamide + 166.0 148.9 15 10 0.09 0.29
33 Fenoprofen + 243.0 196.9 12 12 0.56 1.87
34 Indomethacin + 357.8 138.9 20 18 0.20 0.65
35 Isopropylantipyrine + 231.0 188.8 32 22 0.04 0.13
36 Ketoprofen + 255.1 209.0 25 15 0.50 1.68
37 Mefenamic acid + 242.0 224.6 12 18 0.28 0.94
38 Naproxen + 231.0 184.7 16 16 0.26 0.88
39 Crotamiton + 204.1 68.7 30 20 0.07 0.24
40 Diclofenac sodium + 297.6 215.2 12 26 0.66 2.19
41 Carbamazepine + 237.1 194.0 25 20 0.05 0.16
42 Ifenprodil + 326.2 308.1 30 20 0.07 0.23
43 Primidone + 219.3 162.1 20 10 1.06 3.52
44 Atenolol + 267.1 189.8 28 18 0.41 1.38
45 Disopyramide + 340.2 239.0 20 15 0.06 0.19
46 Metoprolol + 268.2 115.9 30 20 0.12 0.42
47 Propranolol hydrochloride + 260.1 182.7 24 18 0.06 0.19
48 Diltiazem hydrochloride + 415.1 177.7 24 22 0.02 0.05
49 Dipyridamole + 505.3 384.9 50 42 0.04 0.13
50 Nalidixic acid + 233.3 215.1 35 14 0.09 0.30
51 Salbutamol + 240.3 148.0 18 20 0.32 1.05
52 Theophylline + 181.5 123.9 30 20 0.22 0.73
53 Bezafibrate + 362.0 316.0 20 14 0.35 1.16
54 Clenbuterol + 277.0 202.9 20 15 0.21 0.72
55 Caffeine + 195.0 137.7 28 18 0.14 0.48
56 Carbazochrome + 237.0 219.7 12 8 0.23 0.77
57 Clofibric acid - 213.1 126.9 20 13 0.13 0.42
58 Cyclophosphamide + 260.9 139.7 24 22 0.20 0.66
59 N,N-diethyl-m-toluamide + 192.1 118.8 25 15 0.03 0.11
60 Furosemide - 329.1 205.1 30 20 0.19 0.64
61 Pirenzepine + 352.1 112.7 26 22 1.04 3.47
62 Sulpiride + 342.0 213.7 32 32 0.02 0.05
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5.3 Results and discussion 
5.3.1 PPCPs detected in tested water 
38 PPCPs were detected in secondary effluent used for tested water in this study. Fig. 5-4 
shows average, maximum and minimum concentrations of the 38 PPCPs. As therapeutic 
classes, 11 kinds of antibiotics including clarithromycin and levofloxacin, 7 analgesics 
including ketoprofen and diclofenac and 4 antiarrhythmic agents such as disopyramide, 
atenolol, metoprolol and propranolol were mainly present in the tested water. A variety of 
PPCPs such as anticonvulsants (carbamazepine and primidone), 2 vasodilators (dipyridamole 
and diltiazem), diuretic (furosemide), antineoplastic agent (cyclophosphamide) and peptic 
ulcer drug (pirenzepine) were also present, showing that sewage treatment plant is a main 
source of PPCPs contaminants of aquatic environment. Among the 38 PPCPs, antibiotic 
clarithromycin showed the highest concentration of 481 ng/L. Subsequently, antiitch drug 
crotamiton, antipsychotic drug sulpiride, insect repellent DEET, antibiotic clarithromycin and 
levofloxacin and antiarrhythmic agent disopyramide exhibited high concentration of over 100 































































































































































































































































































Fig. 5-4 Average, maximum and minimum concentrations of 38 PPCPs detected in tested 
water 
 
Nakada et al (2006) have surveyed the occurrences of 6 analgesics, 2 phenolic antiseptics, 
4 amide pharmaceuticals, 3 phenolic endocrine disrupting chemicals and 3 natural estrogens 
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for influents and secondary effluents of 5 sewage treatment plants in Tokyo. They reported the 
occurrences of crotamiton, ketoprofen, carbamazepine and mefenamic acid as PPCPs detected 
from the tested water used in this study. Especially, they found that PPCPs with the highest 
concentration in secondary effluents was crotamiton (245 ng/L ~ 968 ng/L). In our study, 
crotamiton showed the second highest concentration ranging from 347 ng/L to 448 ng/L. 
Although the occurrence of the compound has not been reported in other countries, it has 
often been detected in several sewage treatment plants of Japan over the past few years. 
Okuda et al (2008) also reported the occurrence of crotamiton in influent and effluent of a 
sewage treatment plant in Japan, and concluded that biological treatment process could not 
remove the compound effectively, based on its low removal efficiency (30% or less) obtained 
in their survey.  
Heberer et al (2002) have reported that for analgesic diclofenac average concentrations 
ranging from 3.02 µg/L to 2.51 µg/L occurred in influents and effluents of sewage treatment 
plants in Berlin, Germany, indicating that the compound is one of the most concerning PPCPs 
in water cycle. Antibiotic sulfamethoxazole has been reported to be detected up to 410 ng/L in 
groundwater by Sacher et al (2001). The occurrences of sulfonamides antibiotics such as 
sulfamethoxazole and sulfadimethoxine in aquatic environment have been often reported by 
many researchers (Okuda et al., 2008; Holm et al., 1995). Anticonvulsant carbamazepine has 
been found in sewage and surface water very frequently (Ternes, 1998; Heberer et al., 2001). 
On the other hand, ethenzamide, naproxen and isopropylantipyrine (analgesics), propranolol 
(antiarrhythmic agent), sulfadimethoxine and ciprofloxacin (antibiotics), griseofulvin 
(antifungal drug), clofibric acid (lipid modifying agent), cyclophosphamide (antineoplastic 
agent) and chlorampenicol (antimicrobial drug) showed relatively low concentrations ranging 
from 1 ng/L to 10 ng/L compared to other PPCPs.  
 
5.3.2 PPCPs removal with UV41W lamp and H2O2 
In order to investigate the removal performance of UV and UV/H2O2 processes for the 38 
PPCPs, UV and UV/H2O2 processes experiments were first performed using UV41W lamp with 
a low output of 13.6WUV. In this study, a goal of 90% removal efficiency was set to compare 
the performance for PPCPs removal of each process.  Table 5-4 compares the removal 
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efficiency of each PPCP at contact times of 5 min (R1), 10 min (R1+R2) and 15 min 
(R1+R2+R3) during UV41W process. UV dose introduced to each reactor in this study was 575 
mJ/cm2, which is much higher than 40 mJ/cm2 to 140 mJ/cm2 required for typical disinfection 
(Pereira et al., 2007).  
It can be seen in Table 5-4 that many PPCPs were not removed effectively during UV41W 
process although their removal efficiencies increased slightly according to the increase of 
contact time. Especially, 15 PPCPs including cyclophosphamide (antineoplastic agent), DEET 
(insect repellent) and carbamazepine (anticonvulsant) showed low removal efficiency of 
below 50% despite the introduction of UV dose of 1,725 mJ/cm2. Mefenamic acid, 
ethenzamide, metoprolol, clarithromycin, carbamazepine, theophylline, cyclophosphamide 
and DEET known to be resistant for UV irradiation also belong to the 15 PPCPs (Kim et al., 
2008). 
Contrarily, diclofenac, isopropylantipyrine and ketoprofen (analgesics), sulfamethoxazole 
(antibiotic), diltiazem and dipyridamole (vasodilators) and clofibric acid (lipid modifying 
agent) were thought to be susceptible for UV irradiation compared to other PPCPs because 
they were removed by more than 90% even at UV dose of 575 mJ/cm2 (contact time : 5 min). 
It was demonstrated in Chapter III that several PPCPs such as ketoprofen and diclofenac can 
be degraded very easily with UV irradiation. However, considerable UV dose will be 
necessary for efficient PPCPs removal with UV41W process. 
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Table 5-4 Removal efficiency of individual PPCPs at each reactor during UV41W process 
UV41W process Use PPCPs 
R1 R2 R3 
Diclofenac > 98 > 98 > 98 
Ketoprofen 98  98  99  
Isopropylantipyrine > 95 > 95 > 95 
Naproxen 55  70  > 87 
Indomethacin 40  62  77  
Ethenzamide 13  21  29  
Analgesics 
Mefenamic acid 5  25  44  
Disopyramide 89  97  99  
Atenolol 36  35  57  
Propranolol 23  39  65  
Antiarrhythmic agents 
Metoprolol 21  29  42  
Sulfamethoxazole 93  98  99  
Ciprofloxacin > 89 > 89 > 89 
Nalidixic acid 78  97  > 99 
Sulfadimethoxine 75  90  94  
Levofloxacin 22  17  54  
Trimethoprim 19  23  34  
Lincomycin 19  34  42  
Clarithromycin 13  27  38  
Erythromycin 11  15  22  
Azithromycin 10  14  25  
Antibiotics 
Roxithromycin 9  15  25  
Diltiazem 96  100  100  
Dipyridamole 96  99  100  
Clofibric acid 93  > 97 > 97 
Chloramphenicol > 87 > 87 > 87 
Furosemide 79  96  100  
Ifenprodil 62  85  95  
Crotamiton 41  67  81  
Griseofulvin 40  60  78  
Bezafibrate 31  54  68  
Pirenzepine 28  48  51  
Sulpiride 15  19  29  
Carbamazepine 13  23  33  
Theophyline 10  16  22  
DEET 7  17  25  
Cyclophosphamide 2  13  11  
The others 




In order to accomplish 90% removal efficiencies for all the PPCPs, H2O2 solution was 
added during UV process. The different initial H2O2 concentrations (1.1 mg/L, 3.1 mg/L and 
6.0 mg/L) in tested water were used during UV41W process. The removal efficiencies of 
individual PPCPs at contact time of 5 min during UV41W and UV41W /H2O2 processes were 
indicated and compared in Table 5-5.  
The removal efficiency of each PPCP ranged from 1% (primidon) to >98% (diclofenac) 
during UV41W process, while drastic increase in the removal efficiency was observed when 
H2O2 was added (22% (theophylline) ~ 100% (diltiazem), 32% (theophylline) ~ 100% 
(diltiazem) and 73% (theophylline) ~ 100% (diltiazem) for 1.1 mg/L, 3.1 mg/L and 6.0 mg/L 
of initial H2O2 concentrations during UV41W process, respectively). In particular, it was shown 
that 7 PPCPs such as mefenamic acid, azithromycin, roxithromycin, theophylline, DEET, 
cyclophosphamide and primidon improved most remarkably in their removal efficiencies by 
the addition of H2O2.  
Consequently, it was expected that by the combination of H2O2 with UV process, more 
efficient PPCPs removal could be achieved at lower UV dose comparing to UV41W process. 
However, 90% removals for all the 38 PPCPs could not be achieved even by UV41W /H2O2 
process because 7 PPCPs such as azithromycin, erythromycin, primidon, chloramphenicol, 
naproxen, cyclophosphamide and theophylline showed the removal efficiencies of 88%, 87%, 
87%, >83%, >81%, 78% and 73%, respectively despite the combination of the initial H2O2 
concentration of 6.0 mg/L with UV41W process.  
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Table 5-5 Removal efficiency of each PPCP at contact time of 5 min during UV41W and 
UV41W /H2O2 processes 









Diclofenac > 98 > 98 > 98 > 98 
Ketoprofen 98  99  99  100  
Isopropylantipyrine > 95 > 95 > 94 > 95 
Naproxen 55  > 88 > 86 > 81 
Indomethacin 40  78  96  > 99 
Ethenzamide 13  66  94  > 97 
Analgesics 
Mefenamic acid 5  60  > 98 > 98 
Disopyramide 89  94  97  99  
Atenolol 36  70  92  98  
Propranolol 23  82  > 98 > 98 
Antiarrhythmic  
agents 
Metoprolol 21  65  88  97  
Sulfamethoxazole 93  94  97  98  
Ciprofloxacin > 89 > 89 > 90 > 91 
Nalidixic acid 78  90  > 99 > 99 
Sulfadimethoxine 75  81  91  96  
Levofloxacin 22  56  91  95  
Trimethoprim 19  63  87  95  
Lincomycin 19  73  94  98  
Clarithromycin 13  54  82  94  
Erythromycin 11  46  63  87  
Azithromycin 10  49  75  88  
Antibiotics 
Roxithromycin 9  52  78  93  
Diltiazem 96  100  100  100  
Dipyridamole 96  99  99  99  
Clofibric acid 93  96  96  > 97 
Chloramphenicol > 87 > 42 > 82 > 83 
Furosemide 79  92  97  100  
Ifenprodil 62  88  97  100  
Crotamiton 41  73  90  97  
Griseofulvin 40  63  > 97 > 97 
Bezafibrate 31  72  91  97  
Pirenzepine 28  65  86  93  
Sulpiride 15  45  76  94  
Carbamazepine 13  65  90  98  
Theophyline 10  22  32  73  
DEET 7  53  81  93  
Cyclophosphamide 2  26  58  78  
The others 
Primidon 1  56  77  87  
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5.3.3 PPCPs removal with UV65W lamp and H2O2 
UV65W lamp with a higher output of 21.8WUV was used aiming at the improvement of the 
PPCPs removal performance by the introduction of more much UV dose because 90% 
removals for all the PPCPs could not be achieved by UV41W and UV41W /H2O2 processes 
under the experiment conditions carried out in this study. Table 5-6 indicates the removal 
efficiency of individual PPCPs at each reactor during UV65W process. 
It can be known that only 17 PPCPs including diclofenac and ketoprofen (analgesics), 
disopyramide (antiarrhythmic agent), sulfamethoxazole and ciprofloxacin (antibiotics) and 
clofibric acid (lipid modifying agent) could be removed by more than 90% in spite of the 
introduction of UV dose of 2,768 mJ/cm2 (contact time : 15 min, R3). On the other hand, 11 
PPCPs such as ethenzamide, metoprolol, azithromycin, roxithromycin, erythromycin, DEET, 
carbamazepine, sulpiride, primidon, theophylline and cyclophosphamide showed the removal 
efficiency of less than 50%, indicating that the PPCPs would be very resistant for UV. This 
result is compared with that for UV41W process that removed 15 PPCPs by less than 50% at a 
contact time of 15 min. It was also observed that the removal efficiency of each PPCP 
increased slightly by the application of UV65W lamp comparing to UV41W process thanks to 
much UV dose used. However, considerable UV energy will still be needed for the efficient 
removal of a variety of PPCPs in secondary effluent. 
Table 5-7 compares the removal efficiency of each PPCPs during UV65W and UV65W 
/H2O2 processes. The initial H2O2 concentrations used for UV65W/H2O2 process were 1.2 mg/L, 
3.1 mg/L and 6.2 mg/L and the contact time was 5 min (R1) for all the experiments. The UV 
dose introduced for 5 min was 923 mJ/cm2. The removal efficiencies for UV65W/H2O2 
processes using the initial H2O2 concentration of 1.2 mg/L, 3.1 mg/L and 6.2 mg/L ranged 
from 31% (theophylline) to 100% (diltiazem), 63% (theophylline) to 100% (diltiazem) and 
>89% (naproxen) to 100% (diltiazem), respectively, showing that the removal efficiency 
improved significantly comparing to for UV41W /H2O2 process. On the other hand, during 
UV65W process 17 PPCPs and 32 PPCPs were removed by more than 90% when initial H2O2 
concentrations were 1.2 mg/L and 3.1 mg/L, respectively. Beside naproxen, all the 37 PPCPs 
detected in tested water could be removed by more than 90% for UV65W/H2O2 process using 
the initial H2O2 concentration of 6.2 mg/L. 
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Table 5-6 Removal efficiency of individual PPCPs at each reactor during UV65W process 
UV65W Use PPCP 
R1 R2 R3 
Diclofenac > 98 > 98 > 98 
Ketoprofen 97  99  99  
Isopropylantipyrine > 92 > 92 > 92 
Indomethacin 51  77  90  
Mefenamic acid 25  53  > 98 
Naproxen 22  > 71 > 71 
Analgesics 
Ethenzamide 21  33  44  
Disopyramide 94  99  99  
Propranolol 35  65  81  
Atenolol 31  46  59  
Antiarrhythmic  
agents 
Metoprolol 22  40  50  
Sulfamethoxazole 94  99  99  
Ciprofloxacin > 93 > 93 > 93 
Nalidixic acid 87  > 99 > 99 
Sulfadimethoxine 84  94  97  
Levofloxacin 30  51  76  
Lincomycin 22  38  57  
Clarithromycin 21  38  52  
Trimethoprim 20  34  52  
Azithromycin 11  19  38  
Roxithromycin 10  19  32  
Antibiotics 
Erythromycin 2  17  31  
Diltiazem 100 100 100 
Clofibric acid > 98 > 98 > 98 
Dipyridamole 98  98  100 
Chloramphenicol > 91 > 91 > 91 
Furosemide 86  98  100  
Ifenprodil 74  92  98  
Bezafibrate 54  73  86  
Crotamiton 50  80  90  
Griseofulvin 50  68  83  
Pirenzepine 21  52  67  
DEET 20  31  48  
Carbamazepine 17  31  45  
Sulpiride 16  28  38  
Primidon 13  27  41  
Theophyline 11  15  20  
The others 




Table 5-7 Removal efficiency of each PPCP at contact time of 5 min during UV65W and 
UV65W/H2O2 processes 





Diclofenac > 98 > 98 > 98 > 98 
Ketoprofen 97 99 > 99 > 99 
Isopropylantipyrine > 92 > 94 > 92 > 93 
Indomethacin 51 92 > 99 > 99 
Mefenamic acid 25 > 98 > 98 > 98 
Naproxen 22 > 80 > 86 > 89 
Analgesics 
Ethenzamide 21 83 > 98 > 98 
Disopyramide 94 98 99 100 
Propranolol 35 > 98 > 98 > 98 
Atenolol 31 90 98 > 98 
Antiarrhythmic 
agents 
Metoprolol 22 79 96 > 99 
Sulfamethoxazole 94 97 99 100 
Ciprofloxacin > 93 > 93 > 93 > 91 
Nalidixic acid 87 > 99 > 99 > 99 
Sulfadimethoxine 84 91 96 > 99 
Levofloxacin 30 82 94 99 
Lincomycin 22 84 97 > 98 
Clarithromycin 21 69 93 99 
Trimethoprim 20 79 94 100 
Azithromycin 11 64 84 97 
Roxithromycin 10 69 92 98 
Antibiotics 
Erythromycin 2 58 87 98 
Diltiazem 100 100 100 100 
Clofibric acid > 98 > 97 > 97 > 98 
Dipyridamole 98 98 98 98 
Chloramphenicol > 91 > 86 > 91 > 90 
Furosemide 86 98 > 99 > 99 
Ifenprodil 74 94 100 100 
Bezafibrate 54 88 97 > 99 
Crotamiton 50 86 96 99 
Griseofulvin 50 76 > 97 > 97 
Pirenzepine 21 66 92 > 98 
DEET 20 71 91 99 
Carbamazepine 17 81 96 100 
Sulpiride 16 60 93 98 
Primidon 13 70 86 95 
Theophyline 11 31 63 91 
The others 
Cyclophosphamide 6 50 79 > 93 
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5.3.4 The variation of SUVA during UV and UV/H2O2 processes for PPCPs 
removal 
Specific UV absorbance (SUVA) is the absorbance (/cm) of a sample at 254 nm 
normalized for dissolved organic carbon (DOC, mg/L), and has been known to be strongly 
correlated to the aromaticity percentage (Weishaar et al., 2003). The aromaticity content of a 
sample decreases along the cleavage of the aromatic rings by UV or UV/H2O2 process. All the 
PPCPs investigated in this study have aromatic ring in their chemical structures and, therefore, 
the decrease of SUVA can be related to the degradation of PPCPs.  
The removal efficiency of SUVA was 16% for UV41W process, while for UV41W /H2O2 
process using initial H2O2 concentrations of 1.1 mg/L, 3.1 mg/L and 6.0 mg/L, the SUVA 
decreased by 23%, 28% and 37%, respectively (Fig. 5-5). The SUVA of tested waters ranged 
from 0.014 L/mg·cm to 0.016 L/mg·cm for the experiments using UV65W lamp, which are a 
little less than for the experiments using UV41W lamp (0.021 L/mg·cm ~ 0.024 L/mg·cm). The 
difference in SUVA would be driven from different experiment days. For the experiments 
using UV65W lamp, SUVA decreased more significantly compared to for UV41W and UV41W 
/H2O2 processes, and the removal efficiencies were 15%, 29%, 41% and 52% for UV65W, 
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Fig. 5-5 The decrease of SUVA during UV and UV/H2O2 processes 
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On the other hand, the number of PPCPs removed by more than 90% increased linearly 
with the decrease of SUVA, irrespective of UV lamp applied (Fig. 5-6). The number of PPCPs 
with a removal efficiency of more than 90% increased from 7 to 37 as the removal efficiency 
of SUVA increased from 15% to 52%. It has been reported that SUVA of secondary effluent 
can be decreased by around 60% with ozonation (Kim, 2005). In this study, 37 PPCPs were 
removed by 90% when SUVA decreased by 52% and, therefore, it is considered that the 60% 
decrease of SUVA can ensure the high removal efficiency of a variety of PPCPs in secondary 
effluent. 
Fig. 5-7 shows the relation between the number of PPCPs removed by more than 90% 
and SUVA in treated water. It was observed that the number increased as SUVA decreased, 
irrespective of UV lamp applied. However, low SUVA is not necessarily likely to ensure the 
high removal efficiency of PPCPs. For example, SUVA was 0.014 L/mg·cm when 31 PPCPs 
were removed by more than 90% (UV41W process), while only 10 PPCPs were removed by 
more than 90% despite very low SUVA of 0.013 L/mg·cm in treated water (UV65W process). 
Therefore, it can be known that it will be difficult to expect the PPCPs removal from the 
decrease of SUVA in treated water. 
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Fig. 5-6 PPCPs removal according to the removal efficiency of SUVA 
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<UVHigh>
y = -5490.0428 x + 79.6182
R2 = 0.9628
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Fig. 5-7 PPCPs removal according to the decrease of SUVA 
 
5.3.5 Energy consumption and operating cost 
The cost evaluation of UV/H2O2 process was performed as the procedure described by 
Sutherland et al (2004) and Mascolo et al (2008). Cost caused by added H2O2 amount and 
electrical energy of UV used occupies most of the process cost for UV and UV/H2O2 
processes. Firstly, an electrical energy introduced can be calculated using the following 
general equation: 
Electrical energy (kWh/m3) = 1,000 × UV power (kW)/60 × flow (L/min) + electrical 
energy for H2O2 production (kWh/m3)   (1) 
Electrical energy for H2O2 production was calculated on the basis of CO2 amount 
generated for producting H2O2 (The Ministry of Economy, Trade and Industry, 2003). Fig. 5-8 
indicates the number of PPCPs removed by more than 90% according to electrical UV energy 
introduced during UV and UV/H2O2 processes. When UV alone was used, the number 
increased slightly with the increased electrical energy, irrespective of the applied UV lamp, 
and the increasing tendency in the number was almost the same. From these, it can be known 
that the removal effectiveness of PPCPs will increase linearly according to the increase of the 
introduced electrical energy. When the electrical energy of 1.56 kWh/m3, which is the 
maximum electrical energy introduced for UV alone process, was used, only 17 out of the 38 
PPCPs were removed by more than 90%. Therefore, it will be inevitable to introduce 
considerable electrical UV energy for the effective removal of a variety of PPCPs by UV 
alone process. 
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On the other hand, it was observed that the addition of H2O2 for UV process can result in 
the very effective PPCPs removal even at the introduction of low electrical energy. Moreover, 
the removal effectiveness increased with the increased initial H2O2 concentration when the 
same UV lamp was used, and in this study, 37 PPCPs could be removed by more than 90% 
when initial H2O2 concentration in tested water was 6.2 mg/L for UV65W process (consumed 
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Fig. 5-9 PPCPs removal performance according to estimated operating cost 
 
The operating cost of UV/H2O2 process can be calculated with using following equation 
(Mascolo et al., 2008); 
Operating cost = [EE/O × log (Ci/Cf) × unit cost of electrical energy] + H2O2 cost   (2) 
where the cost of lamp replacement was not considered. Electrical energy in equation (1) 
can be expressed as follow;  
Electrical energy (kWh/m3) =EE/O ×log (Ci/Cf)   (3) 
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where EE/O is the electrical energy necessary for one order removal of the investigated 
pollutant; Ci and Cf the initial and final concentration, respectively. Here, the log (Ci/Cf) was 
calculated to 1 because this study was focused on the 90% removal of the investigated PPCPs. 
Therefore, equation (2) can be expressed as follow; 
Operating cost = [Electrical energy (kWh/m3) × unit cost of electrical energy] + H2O2 
cost   (4) 
15 Yen/kWh and 151.3 Yen/kg were used for the unit cost of electrical energy and cost of 
H2O2, respectively. 
Fig. 5-9 shows the number of PPCPs removed by more than 90% and the operating cost 
calculated by equation (4) for each process. For UV alone process, it can be known that the 
PPCPs removal effectiveness to the increase of the operating cost did not improve so 
significantly despite the considerable increase of operating cost. Contrarily, for UV/H2O2 
process, the slight increase of operating cost caused by the H2O2 addition led to the significant 
improvement for the PPCPs removal performance. This time, the operating cost ranged from 
5.1 Yen/m3 to 6.1 Yen/m3 and 8.0 Yen/m3 to 9.1 Yen/m3 for UV41W /H2O2 and UV65W/H2O2 
processes, respectively. Therefore, it can be concluded that the combination of H2O2 with UV 
process will be much more cost-effective than UV alone process that will cause the high 
consumption of electrical UV energy for the 90% removal PPCPs.  
 
5.4 Summary 
The performance of UV and UV/H2O2 processes for the PPCPs removal was investigated 
using secondary effluent. In addition, operating costs required for the accomplishment of 
appropriate PPCPs removal by the applied processes were estimated.  
1) 38 PPCPs were detected in secondary effluent used for tested water in this study. The 
concentration ranged from 1 µg/L to 481 µg/L. As therapeutic classes, 11 antibiotics including 
clarithromycin and levefloxacin, 7 analgesics including ketoprofen and diclofenac and 4 
antiarrhythmic agents such as disopyramide, atenolol, metoprolol and propranolol were 
mainly present. Besides, various PPCPs such as anticonvulsants (carbamazepine, primidone), 
vasodilators (dipyridamole, diltiazem), diuretic (furosemide), antineoplastic agent 
(cyclophosphamide) and peptic ulcer drug (pirenzepine) were also present in secondary 
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effluent. The side effects of PPCPs on the aquatic environment and human body have not been 
known yet, however, PPCPs in water environment should be removed in aspect of 
precautionary principles. 
2) Only 17 of 38 PPCPs were removed by more than 90% despite UV dose of 2,768 
mJ/cm2 (contact time : 15 min) during UV process, showing that considerable UV dose will 
be required for the effective PPCPs removal by UV alone process. This also shows that it will 
be difficult to accomplish good PPCPs removals by typical UV disinfection process (UV 
dose : 40 mJ/cm2 ~ 140 mJ/cm2, contact time : a few secs).  
3) On the other hand, the PPCPs removal by UV alone process improved significantly by 
the combination of H2O2 with UV process. Except naproxen (>89%), 37 PPCPs were removed 
by more than 90% at the operational condition of UV dose of 923 mJ/cm2 (contact time : 5 
min) and initial H2O2 concentration of 6.2 mg/L. As a consequence, the combination of UV 
and H2O2 made it possible to reduce UV dose at least by more than 3 times comparing with 
for UV alone process.  
4) The number of PPCPs removed by more than 90% increased linearly with the 
increased removal efficiency of SUVA, irrespective of applied processes. On the other hand, 
the removal efficiency of SUVA was 52% at at the operational condition of UV dose of 923 
mJ/cm2 and initial H2O2 concentration of 6.2 mg/L. From these results, it was expected that 
SUVA removal of more than 50% ensures the effective removal of various PPCPs by UV or 
UV/H2O2 processes.  
5) Electrical energy required for the effective PPCPs removal by UV/H2O2 process was 
0.54 kW per 1 m3 target water (Operational condition : UV dose : 923 mJ/cm2, H2O2 : 6.2 
mg/L), showing that UV/H2O2 process can reduce energy consumption and operating cost 
considerably, comparing with UV alone process, and, therefore, be utilized as a treatment 
option for water reuse.  
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6 INVESTIGATION ON THE REMOVAL PERFORMANCE 
FOR PHARMACEUTICALS AND PERSONAL CARE 
PRODUCTS BY O3-BASED PROCESSES                   




Wastewater is generally treated in wastewater treatment plants (WWTPs) before it is 
discharged into receiving waters. Nevertheless, WWTPs is known as the main source of 
PPCPs in the aquatic environment (Halling-Sørensen et al., 1998; Kanda et al., 2003). If the 
consumption of PPCPs is not reduced, the improvement of WWTPs will be one of the options 
to prevent the release of the PPCPs into the aquatic environment. As mentioned before, 
conventional activated sludge treatment was shown to degrade PPCPs to various extents 
(Ternes, 1998; Daughton et al., 1999; Nakada et al., 2006; Okuda et al., 2008). Therefore, 
advanced treatment technologies have to be implemented to achieve further removal of PPCPs. 
O3 process has been shown to have a high potential for the removal of PPCPs in drinking 
water (Huber et al., 2003) and wastewater (Ternes, 2003). They reported that O3 doses ranging 
from 5 mg/L to 15 mg/L led to a complete degradation of most of the PPCPs except for 
iodinated X-ray contrast media.  
The combined O3/UV process has been widely studied due to a synergistic effect of 
several reactions such as direct UV photodegradation, direct O3 process and OH radical 
oxidation. O3/UV process has been employed for the removal of the organic contaminants in 
wastewater, drinking water and industrial wastewater (Lau et al., 2007; Zou et al., 2007). 
However, limited information is available on the effectiveness of O3/UV processes for PPCPs 
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removal although they have been known as very effective processes for PPCPs removal. 
In Chapter IV, most of the PPCPs were degraded by more than 90% at O3 consumptions 
of 6.3 mg/L and 4.5 mg/L for O3 and O3/UV treatments, respectively, when using tested water 
prepared by PW spiked with the 30 PPCPs, indicating that O3 dose can be reduced by the 
combination of UV during O3 treatment. Based on these results, in this study the removal 
performance of O3-based processes (O3 and O3/UV processes) for the PPCPs detected in 
secondary effluent was investigated using bench-scale experimental setup with a treatment 
capacity of 10m3/day. Moreover, electrical energy and operating cost required for an effective 
PPCPs removal by the applied processes were estimated. Research structure in this chapter is 
shown in Fig. 6-1. 
 
Fig. 6-1 Structure of this chapter 
 
6.2 Materials and methods 
6.2.1 Experimental setup 
Experiment setup consists of three reactors (Reactor 1 (R1), Reactor 2 (R2) and Reactor 
3 (R3)) connected in series (Fig. 6-2). In this study, only R1 and R2 were operated for all the 
experiments. The effective volume and hydraulic retention time (HRT) a reactor are 35L and 5 
min, respectively. In order to ensure stable flux state, UV irradiation and O3 injection, each 
process was operated more than 3 HRT before samples were taken.  
 
Design of continuous 
experimental setup, based on O3 
dose estimated in Chapter IV 
Investigation of operational condition for 
the effective removal of PPCPs in 
secondary effluent by O3 process 
Energy consumption and 
operating cost for the effective 
PPCPs removal 
Discussion on the relationship 




Investigation of operational condition for 
the effective removal of PPCPs in 





























Fig. 6-2 Experimental setup for O3-based processes 
 
To investigate the effectiveness of O3 process for PPCPs removal, treatment experiments 
using different O3 doses were performed. O3/UV process was carried out using different O3 
dose and UV lamps with different UV intensity.  
Table 6-1 shows the operational conditions investigated in this study. O3 process was 
performed at different O3 doses of 2 mg/L, 4 mg/L and 6 mg/L. The concentrations of injected 
O3 gas were 14 mg/L, 28 mg/L and 42 mg/L for O3 doses of 2 mg/L, 4 mg/L and 6 mg/L, 
respectively. O3 gas was injected to R1 and R2 at a rate of 0.5 L/min, respectively. For O3/UV 
process, 2 types of UV lamps (21.5 W and 65 W low pressure mercury UV lamps) were used. 
Here, 2 UV lamps (UV wavelength : 254 nm, Length of lamp : 1,556 mm) were described as 
UV21.5W lamp and UV65W lamp, respectively, and O3/UV process using these UV lamps were 
also as O3/UV21.5W process and O3/UV65W process. UV21.5W and UV65W lamps have UV output 
of 7.2 W and 21.8 W, and UV intensity of 0.339 mW/cm2 and 1.025 mW/cm2, respectively. 3 
UV lamps are placed inside each reactor and the same O3 doses (2 mg/L, 4 mg/L and 6 mg/L) 
with for O3 process were applied. O3, O3/UV21.5W and O3/UV65W processes were operated on 
different days. All the samples taken during O3-based processes were purged by N2 gas 
immediately after sampling in order to remove residual O3 in sample and stop the reaction of 




Table 6-1 Operational conditions 
O3 O3/UV21.5W O3/UV65W 
Run O3 dose Run O3 dose UV lamp Run O3 dose UV lamp 
Run1 2 mg/L Run4 2 mg/L Not used Run8 2 mg/L Not used 
Run2 4 mg/L Run5 2 mg/L R1, R2 Run9 2 mg/L R1, R2 
Run3 6 mg/L Run6 4 mg/L R1, R2 Run10 4 mg/L R1, R2 
- - Run7 6 mg/L R1, R2 Run11 6 mg/L R1, R2 
 
6.2.2 PPCPs investigated 
Secondary effluent was used as tested water in this study. The pH, DOC and UV254 of 
the tested water ranged from 6.5 to 6.8, 2.7 mg/L to 3.4 mg/L and 0.0514 /cm to 0.0779 /cm, 
respectively. 37, 35 and 38 PPCPs were detected in the tested water for O3, O3/UV21.5W and 
O3/UV65W processes, respectively.  
Table 6-2 The name and use of PPCPs detected in tested water 
No. PPCP Use No. PPCP Use 
1 Acetaminophen 21 Atenolol 
2 Diclofenac 22 Disopyramide 
3 Ethenzamide 23 Metoprolol 
4 Indomethacin 24 Propranolol 
Antiarrhythmic agent 
5 Isopropylantipyrine 25 Carbamazepine 
6 Ketoprofen 26 Primidone 
Anticonvulsant 
7 Mefenamic acid 27 Griseofulvin Antifungal drug 
8 Naproxen 
Analgesic 
28 Crotamiton Anti-itch drug 
9 Azithromycin 29 Chloramphenicol Antimicrobial drug 
10 Ciprofloxacin 30 Cyclophosphamide Antineoplastic agent 
11 Clarithromycin 31 Sulpiride Anti-psychotic drug  
12 Erythromycin 32 Clenbuterol 
13 Levofloxacin 33 Theophylline 
Bronchodilator 
14 Lincomycin 34 Furosemide Diuretic 
15 Nalidixic acid 35 DEET Insect repellent 
16 Roxithromycin 36 Bezafibrate 
17 Sulfadimethoxine 37 Clofibric acid 
Lipid modifying agent 
18 Sulfamerazine 38 Ifenprodil NMDA receptor antagonist 








The number of the PPCPs detected in the tested water during all the investigated 
treatments was 41 including eight analgesics, twelve antibiotics and four antiarrhythmic 
agents (Table 6-2).  
The concentrations of the detected PPCPs ranged from 2 ng/L (isopropylantipyrine) to 
402 ng/L (clarithromycin), 2 ng/L (isopropylantipyrine) to 774 ng/L (clarithromycin) and 1 
ng/L (isopropylantipyrine) to 503 ng/L (clarithromycin) for O3, O3/UV21.5W and O3/UV65W 
processes, respectively.  
 
6.2.3 Analytical methods 
The concentrations of the 30 PPCPs were measured simultaneously with LC/MS/MS. 
The measurement condition of LC/MS/MS, limit of detection (LOD) and limit of 
quantification (LOQ) were described in Chapter V. 
DOC (dissolved organic carbon) concentration was measured with a TOC analyzer 
(TOC-5000A, Shimadzu) and calculated from the difference of TOC (total organic carbon) 
and IC (inorganic carbon). Dissolved ozone concentration was measured with indigo method 
(Bader et al., 1981) measuring the absorbance at 600 nm wavelength by a spectrophotometer 
(UV-16000, Shimadzu). This spectrophotometer was also used for measuring the absorbance 











6.3 Results and discussion 
6.3.1 Effect of O3 dose on the PPCPs removal during O3 process 
The effect of O3 dose on the PPCPs removal in secondary effluent was investigated. The 
O3 doses used for O3 process were 2 mg/L, 4 mg/L and 6 mg/L. 37 PPCPs ranging from 2 
ng/L (isopropylantipyrine) to 402 ng/L (clarithromycin) in their concentration were detected 
in secondary effluent used as tested water. Table 6-3 shows removal efficiencies of the 37 
PPCPs during O3 process for 10 min (R1+R2) performed at each O3 dose. The removal 
efficiency of PPCPs decreased by less than limit of detection (LOD) after O3 treatment was 
calculated to 100%. 25 PPCPs including carbamazepine, crotamiton and diclofenac were 
removed by more than 90% even at O3 dose of 2 mg/L, showing that O3 was very effective for 
the PPCPs removal. It was also observed that the increase of O3 dose could achieve the 
effective PPCPs removal. 
Among 11 antibiotics (sulfadimethoxine, trimethoprim, erythromycin, lincomycin, 
roxithromycin, levofloxacin, sulfamethoxazole, azithromycin, ciprofloxacin, clarithromycin 
and nalidixic acid), 10 antibiotics beside nalidixic acid could be removed by more than 90%, 
irrespective of O3 dose. 3 antibiotics such as levofloxacin, ciprofloxacin and nalidixic acid 
belong to quinoline antibiotics, however, only nalidixic acid showed low removal efficiency 
of 66% at O3 dose of 2 mg/L although higher O3 dose (more than 4 mg/L) could remove the 
compound by more than 90%. Quinoline, a representative of Nitrogen-heterocyclic 
compounds has been known to be degraded more easily by OH radicals than by O3 (Wang et 
al., 2004). Therefore, advanced oxidation processes (AOPs) such as O3/UV and O3/H2O2 are 
also expected to ensure the efficient removal of the PPCP. Ketoprofen (analgesic), which has 
known to be degraded very easily by UV (Kim et al., 2008), also showed low removal 
efficiency of 73% at O3 dose of 2 mg/L. Except ketoprofen and nalidixic acid, atenolol, 
metoprolol and disopyramide (antiarrhythmic agent), bezafibrate and clofibric acid (lipid 
modifying agent), ethenzamide (analgesic), chloramphenicol (antimicrobial drug), DEET 
(insect repellent), griseofulvin (antifungal drug) and primidone (anticonvulsant) also showed 
less than 90% in their removal efficiency at low O3 dose of 2 mg/L.  
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Table 6-3 Removal efficiency of the 37 PPCPs for O3 process (Run1, Run 2 and Run3, contact 
time: 10min) 
No. Use PPCPs 
O3 dose : 2 mg/L 
(O3 consumption : 
1.6 mg/L) 
O3 dose : 4 mg/L 
(O3 consumption : 
3.0 mg/L) 
O3 dose : 6 mg/L 
(O3 consumption : 
4.4 mg/L) 
1 Indomethacin > 99  > 99  > 99  
2 Isopropylantipyrine > 98  > 97  > 97  
3 Diclofenac > 98  > 97  > 98  
4 Mefenamic acid > 98  > 98  > 98  
5 Naproxen > 86  > 83  > 89  
6 Ethenzamide 74  96  > 98  
7 
Analgesics 
Ketoprofen 73  91  97  
8 Propranolol > 98  > 98  > 98  
9 Atenolol 89  > 98  > 98  
10 Metoprolol 86  > 99  > 99  
11 
Antiarrhythmic agents 
Disopyramide 74  96  100  
12 Roxithromycin 100 98  100 
13 Erythromycin 100 100 100 
14 Trimethoprim 100 100 100 
15 Sulfadimethoxine 100 100 100 
16 Lincomycin > 99  > 99  > 99  
17 Levofloxacin 98  100 98  
18 Sulfamethoxazole 97  100 100 
19 Azithromycin 97  100 100 
20 Ciprofloxacin 93  > 97  > 95  
21 Clarithromycin 90  99  100 
22 
Antibiotics 
Nalidixic acid 66  96  > 99  
23 Carbamazepine 100 100 100 
24 
Anticonvulsant 
Primidone 51  85  87  
25 Antifungal drug Griseofulvin 62  86  > 98  
26 Anti-itch drug Crotamiton 100 100 100 
27 Antimicrobial drug Chloramphenicol 69  > 90  > 90  
28 Anti-psychotic drug  Sulpiride 100 100 100 
29 Bronchodilator Theophylline 96  > 99  99  
30 Diuretic Furosemide > 99  100 100 
31 Insect repellent DEET 67  88  93  
32 Lipid modifying agent Bezafibrate 83  99  100 
33 Lipid modifying agent Clofibric acid 74  84  > 97  
34 NMDA receptor antagonist Ifenprodil 97  100 100 
35 Peptic ulcer drug Pirenzepine > 96  > 96  > 95  
36 Dipyridamole 100 100 100 
37 
Vasodilator  
Diltiazem 100 100 100 
 
On the other hand, the removal efficiency of clofibric acid, chloramphenicol, DEET, 
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griseofulvin and primidone improved by more than 80% when O3 dose of 4 mg/L was applied. 
Moreover, all the PPCPs except primidone (87%) were removed by more than 90% at O3 dose 
of 6 mg/L. Consequently, it is considered that O3 dose of 6 mg/L can ensure the efficient 
removal of the investigated PPCPs for O3 alone process.  
Fig. 6-3 compares dissolved ozone and O3 consumption for each O3 process. As shown in 
Fig. 6-3, it was found that high O3 dose increased O3 consumption and dissolved ozone 
concentration. Dissolved ozone can react with bromide in water and lead to the formation of 
bromate (Wert et al., 2007). Bromate regulation is now being proposed at a maximum 
contaminant level of 10 µg/L in drinking water in U.S.EPA. Carcinogenesis of bromate has 
been found (Kurokawa et al., 1983) and, therefore, concerns on the control of bromate 
formation are increasing. In 2003, Japan has set the bromate regulation of 10 µg/L in drinking 
water (The Ministry of Health, Labour and Welfare, Japan, 2003a,b). Bromate has also been 
known to remain in the water once formed (von Gunten U., 2003b). Therefore, the formation 
potential of bromate should be considered especially when O3 alone process was applied. 
Moreover, it will be desirable that the ecological risk which can be caused by PPCPs 
intermediates formed during O3 process is investigated in order to ensure the effectiveness of 
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Fig. 6-3 Comparison of dissolved ozone and O3 consumption during O3 process 
 
6.3.2 Effect of UV21.5W addition on the PPCPs removal during O3 process 
Here, the effect of UV combination with O3 process on the PPCPs removal was 
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investigated. UV21.5W lamp was combined during O3 processes performed using O3 dose of 2 
mg/L, 4 mg/L and 6 mg/L. As a control experiment, O3 alone process was carried out at O3 
dose of 2 mg/L. In this study, 35 PPCPs were detected in tested water, and their 
concentrations ranged from 2 ng/L (isopropylantipyrine) to 774 ng/L (clarithromycin).  
 
6.3.2.1 O3 process 
Fig. 6-4 indicates the removal efficiency of the 35 PPCPs during O3 process at O3 dose of 
2 mg/L (contact time: 10 min). Rather low removal efficiency (11% (ethenzamide) ~ 100% 
(mefenamic acid)) was obtained comparing with the result (51% (primidone) ~ 100% 
(carbamazepine)) in 6.3.1 (O3 dose: 2 mg/L). The decreased removal efficiency might be 
caused by the difference in the quality of tested water. For O3 process in 6.3.1, specific UV 
absorbance (SUVA) was 0.018 L/mg·cm (DOC: 3.0 mg/L, UV254: 0.0546 /cm), while SUVA 
of 0.024 L/mg·cm (DOC: 3.2 mg/L, UV254: 0.0779 /cm) was shown in this experiment. High 
SUVA means that more O3-consuming organic materials are included in tested water. 
Moreover, the difference in water quality is also demonstrated by that O3 absorption rate 
(84%) in this experiment was rather higher than for the experiment (79%) in 6.3.1, and O3 
consumption (1.7mg/L) was also slightly higher than for 6.3.1 (1.6 mg/L). It is thought that 
the difference led to the decreased PPCPs removal efficiency (No. of PPCPs removed by more 
than 90% : 16 out of the 35 PPCPs) despite the same O3 dose of 2mg/L. 
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Fig. 6-4 Removal efficiency of the 35 PPCPs during O3 process (Run 4, contact time: 10 min) 
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6.3.2.2 O3/UV21.5W process 
Table 6-4 compares the removal efficiency of each PPCP during O3 process (Run 4) and 
O3/UV21.5W processes (Run 5, 6 and 7) for contact time of 10 min. UV dose introduced for 10 
min was 1,220 mJ/cm2. Each signal in Table 6-4 represents individual PPCPs. For O3/UV21.5W 
process at O3 dose of 2 mg/L, it was observed that the removal efficiency of many PPCPs was 
lower than even for O3 alone process. Several researchers have reported that PPCPs react very 
fast with O3 molecular (Huber et al., 2003). However, most of O3 molecular would be 
photolyzed by UV when low O3 dose is used, and low dissolved ozone concentration shown 
in Fig. 6-5 proves this fact. During O3/UV process organic materials are mainly degraded by 
OH radicals formed through UV photodegradation of O3 molecular and/or by direct UV 
photodegradation (JOA, 2004). However, OH radicals can be consumed easily by other 
organic materials and/or scavengers such as HCO3- and CO32- in water (von Gunten U., 
2003a). On the other hand, our previous study showed that a variety of PPCPs were quite 
resistant for UV photodegradation (Kim et al., 2008). Therefore, it is considered that a lower 
removal efficiency of many PPCPs during O3/UV21.5W process (O3 dose: 2 mg/L) than O3 
alone process might be caused by the consumption of OH radicals by scavengers.  
On the other hand, average removal efficiency of the 35 PPCPs was 74% (12% 
(ethenzamide) ~ 100% (diclofenac)) when UV21.5W was combined with O3 dose of 2 mg/L. 
While, the average removal efficiency increased significantly by 90% (64% (ethenzamide) ~ 
100% (diclofenac)) and 95% (77% (propranolol) ~ 100% (diclofenac)) as O3 dose increased 
by 4 mg/L and 6 mg/L, respectively. Several PPCPs such as sulfamerazine (>89%), 
propranolol (77%), ethenzamide (79%), primidone (84%), DEET (87%) and griseofulvin 
(88%) were still less than 90% in their removal efficiency in spite of the combination of 
UV21.5W and O3 dose of 6 mg/L. Ethenzamide and DEET showed low degradability for O3 
comparing with other PPCPs in Chapter IV. As a consequence, it is thought that more O3 dose 





Table 6-4 Removal efficiency of each PPCP during O3 process (Run 4) and O3/UV21.5W 
process(Run 5, 6 and 7) for contact time of 10 min 
No. PPCP 
O3 dose : 2mg/L 
(O3 consumption  
: 1.7 mg/L) 
O3 dose(2mg/L)/UV 
(O3 consumption  
: 1.7 mg/L) 
O3 dose(4mg/L)/UV 
(O3 consumption  
: 3.3 mg/L) 
O3 dose(6mg/L)/UV 
(O3 consumption  
: 4.9 mg/L) 
1 Indomethacin 100  99  100  100  
2 Mefenamic acid 100  100  100  100  
3 Crotamiton 100  88  100  100  
4 Dipyridamole 99  99  99  99  
5 Diclofenac 99  > 99  > 99  > 99  
6 Theophyline 98  95  96  97  
7 Carbamazepine 97  95  98  98  
8 Sulfadimethoxine 97  95  98  98  
9 Pirenzepine > 96  87  > 95  > 95  
10 Levofloxacin 95  87  98  97  
11 Acetaminophen > 95  83  88  95  
12 Trimethoprim 94  92  96  96  
13 Sulfamethoxazole 94  96  99  99  
14 Sulpiride 93  37  93  99  
15 Diltiazem 92  96  96  96  
16 Furosemide 91  95  98  98  
17 Sulfamerazine > 88  90  > 93  > 89  
18 Lincomycin 87  89  88  > 97  
19 Ifenprodil 85  97  98  97  
20 Azithromycin 80  68  91  97  
21 Propranolol 76  73  74  77  
22 Roxithromycin 76  59  91  97  
23 Clarithromycin 74  61  92  98  
24 Ciprofloxacin 66  59  > 95  > 94  
25 Isopropylantipyrine 60  > 98  > 98  > 98  
26 Ａtenolol 47  49  82  91  
27 Bezafibrate 47  57  87  96  
28 Naproxen 42  15  66  90  
29 Clenbuterol 38  81  86  92  
30 Metoprolol 34  21  79  91  
31 Ketoprofen 31  94  99  100  
32  Griseofulvin 29  66  74  88  
33 Primidone 15  19  71  84  
34 DEET 14  27  75  87  




6.3.2.3 Dissolved O3 and O3 consumption 
For O3 process at O3 dose of 2 mg/L, the combination of UV21.5W decreased dissolved 
ozone concentration (Fig. 6-5). While O3/UV21.5W process could not remove effectively 
organic materials including PPCPs in tested water. Removal efficiencies of SUVA were only 
40.4% and 42.2% for O3 and O3/UV21.5W processes (O3 dose: 2 mg/L), indicating that organic 
materials which are degradable by O3 or O3/UV still remained. It has been reported that SUVA 
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Fig. 6-6 O3 consumption during O3 (Run 4) and O3/UV21.5W (Run 5, 6 and 7) processes 
 
On the other hand, for O3/UV21.5W process, the increase of O3 dose led to the increased O3 
consumption (Fig. 6-6) and the improvement of the PPCPs removal (Table 6-4). However, the 
increased O3 dose caused the increase of dissolved ozone (Fig. 6-5) which can form bromate 
through the reaction with bromide. It has been reported that O3 dose of 2 mg/L resulted in the 
oxidation of approximately 40% of MTBE, and approximately 70% was oxidized by O3 dose 
of 4 mg/L, whereas bromate formation increased considerably when the O3 dose increased 
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(von Gunten, 2003b). The application of O3/H2O2 process can suppress the bromate formation 
by the reduction of HOBr with H2O2/HO2-. However, the presence of H2O2 during O3 process 
can not ensure the complete suppression of bromate formation due to the oxidation of bromide 
by O3 (von Gunten U., 2003b). Similarly, O3/UV process may also cause the bromate 
formation especially if high O3 dose is used. Therefore, sufficient O3 degradation will be 
necessary in applying O3/UV process, and for this, the appropriate combination of O3 dose 
and UV dose should be investigated. 
 
6.3.3 Effect of UV65W addition on the PPCPs removal during O3 process 
Although comparatively good PPCPs removal could be achieved by the O3/UV21.5W 
process at high O3 dose, residual dissolved O3 concentration increased by approximately 0.2 
mg/L when O3 dose was 6 mg/L. Therefore, UV65W lamp with a UV intensity of 1.025 
mW/cm2 was applied during O3 process in order to induce the decrease of residual dissolved 
ozone concentration as well as the effective PPCPs removal by enhancing the UV 
photodegradation effectiveness for O3. In this study, 38 PPCPs were detected in tested water, 
and their concentrations ranged from 1 ng/L (isopropylantipyrine) to 503 ng/L 
(clarithromycin). 
 
6.3.3.1 O3 process 
Fig. 6-7 indicates the removal efficiency of the 38 PPCPs during O3 alone process (Run 8, 
O3 dose: 2 mg/L, contact time: 10 min) carried out as a control experiment for O3/UV65W 
processes. Among the 38 PPCPs, the removal efficiency of more than 90% was obtained in 25 
PPCPs, similar to for O3 process (O3 dose: 2 mg/L) in 6.3.1. SUVA of the tested water was 
0.020 L/mg·cm (DOC: 2.9 mg/L, UV254: 0.0569 /cm), which is a little higher than for O3 
alone process using O3 dose of 2 mg/L in 6.3.1 (0.018 L/mg·cm). The removal efficiency of 
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Fig. 6-7 Removal efficiency of the 38 PPCPs during O3 process (Run 8, contact time: 10 min) 
 
6.3.3.2 O3/UV65W process 
Table 6-5 compares the removal efficiency of each PPCP during O3 process (Run 8) and 
O3/UV65W process (Run 9, 10 and 11) for contact time of 10 min. UV dose introduced for 10 
min was 1,846 mJ/cm2. A very effective and stable removal for the 38 PPCPs could be 
achieved, and this is compared with for O3/UV21.5W process (Table 6-4). However, similar to 
for O3/UV21.5W process, the combination of low O3 dose (2 mg/L) with UV65W could not 
improve the PPCPs removal so significantly comparing to for O3 process (Run 8).  
Contrarily, all the PPCPs except DEET (89%), primidone (86%), cyclophosphamide 
(86%) and chloramphenicol (>73%) showed the removal efficiency of more than 90% by the 
combination of UV65W with O3 dose of 4 mg/L. In addition, all the PPCPs were removed by 
almost 100% when O3 dose of 6 mg/L and UV65W were combined. As a consequence, it is 
considered that O3 dose of approximately 4mg/L will be needed for the effective PPCPs 








Table 6-5 Removal efficiency of each PPCP during O3 process (Run 8) and O3/UV65W process 
(Run 9, 10 and 11) for contact time of 10 min 
No. PPCPs 
O3 dose : 2mg/L 
(O3 consumption  
: 1.6 mg/L) 
O3 dose(2mg/L)/UV 
(O3 consumption  
: 1.8 mg/L) 
O3 dose(4mg/L)/UV 
(O3 consumption  
: 3.4 mg/L) 
O3 dose(6mg/L)/UV 
(O3 consumption  
: 5.3 mg/L) 
1 Crotamiton 100 98 100 100 
2 Dipyridamole 100 100 100 100 
3 Carbamazepine 100 97 100 100 
4 Diltiazem 100 100 100 100 
5 Furosemide 100 100 100 100 
6 Levofloxacin 100 92 98 100 
7 Trimethoprim 100 98 99 100 
8 Sulfadimethoxine 100 100 100 100 
9 Indomethacin > 99 > 99 > 99 > 99 
10 Theophylline 99 93 99 99 
11 Lincomycin > 99 > 99 > 99 > 99 
12 Azithromycin 98 86 99 99 
13 Sulpiride 98 68 97 99 
14 Mefenamic acid > 98 > 98 > 98 > 98 
15 Propranolol > 98 > 98 > 98 > 98 
16 Diclofenac > 98 > 98 > 97 > 97 
17 Clarithromycin 98 88 99 100 
18 Erythromycin 97 84 98 100 
19 Ifenprodil 97 100 100 100 
20 Pirenzepine > 96 93 > 98 > 97 
21 Isopropylantipyrine > 96 > 96 > 96 > 96 
22 Sulfamethoxazole 96 99 100 100 
23 Roxithromycin 96 84 98 99 
24 Ciprofloxacin > 95 > 91 > 90 > 87 
25 Naproxen > 81 > 86 > 90 > 88 
26 Nalidixic acid 77 > 99 > 99 > 99 
27 Metoprolol 76 81 96 > 99 
28 Bezafibrate 76 90 97 100 
29 Atenolol 74 73 93 > 99 
30 Ketoprofen 67 99 99 99 
31 Cyclophosphamide 67 56 86 > 88 
32 Chloramphenicol 65 > 88 > 73 > 89 
33 Ethenzamide 64 76 > 98 > 98 
34 Disopyramide 63 100 100 100 
35 Clofibric acid 57 > 97 > 98 > 98 
36 DEET 54 66 89 97 
37 Griseofulvin 47 73 > 97 > 97 
38 Primidone 45 58 86 > 95 
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6.3.3.3 Dissolved O3 and O3 consumption 
Fig. 6-8 and 6-9 show dissolved O3 concentration and O3 consumption for O3/UV65W 
process. Due to the effective O3 degradation of UV65W lamp, a concentration of residual 
dissolved O3 was very low (less than 0.06 mg/L) even when O3 dose of 6 mg/L was used 
during O3/UV65W process (Fig. 6-8). This was compared with 0.19 mg/L and 1.8 mg/L for 
O3/UV21.5W and O3 alone processes, respectively. Therefore, it is thought that the application 
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Fig. 6-8 Dissolved O3 concentration during O3 (Run 8) and O3/UV65W (Run 9, 10 and 11) 
processes 
 
On the other hand, it was expected that more O3 would be consumed during O3/UV65W 
process because higher UV intensity were used in this study. SUVAs were also almost the 
same (0.019 L/mg·cm ~ 0.024 L/mg·cm for O3/UV21.5W process, 0.019 L/mg·cm ~ 0.022 
L/mg·cm for O3/UV65W process). However, almost the same or a little more O3 was consumed 
despite much more effective PPCPs removal by O3/UV65W process comparing to for 
O3/UV21.5W process. Therefore, it can be expected that the direct UV photodegradation 
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Fig. 6-9 O3 consumption during O3 (Run 8) and O3/UV65W (Run 9, 10 and 11) processes 
 
6.3.4 Relationship between the PPCPs removal efficiency and SUVA decrease 
Specific UV absorbance (SUVA) is the absorbance (/cm) of a sample at 254 nm 
normalized for dissolved organic carbon (DOC, mg/L), and has been known to be strongly 
correlated to the aromaticity percentage (Weishaar et al., 2003). The decrease in SUVA 
demonstrates the decrease of a variety of aromatic compounds including PPCPs. 
Consequently, the higher SUVA in water will need more O3 demand.  
Fig. 6-10 shows the removal efficiency of SUVA and the number of PPCPs removed by 
more than 90% during each process. Initial SUVA in tested water ranged from 0.018 L/mg·cm 
to 0.024 L/mg·cm, and decreased by 0.007 L/mg·cm to 0.014 L/mg·cm with O3 and O3/UV 
processes for contact time of 10 min. As shown in Fig. 6-10, the removal efficiency of SUVA 
increased with the increase of O3 dose. The highest removal efficiency was approximately 
60±5% and obtained when O3 dose was 6 mg/L, irrespective of applied processes. The 
removal efficiency of SUVA for O3/UV process was a little more remarkable than for O3 
process. The difference might be led to the contribution of OH radicals, which are generally 
considered to react relatively unselectively with organic compounds, to the degradation of 
aromatic compounds.  
It was also observed that the number of PPCPs removed by more than 90% increased 
with the increase of removal efficiency in SUVA. For O3 and O3/UV65W processes, the 
removal efficiency of SUVA was more than 48% (O3 dose: more than 4 mg/L) when among 
the detected PPCPs, more than 30 PPCPs were removed by more than 90%. Therefore, it is 
thought that the removal efficiency of SUVA of more than 48% can ensure the effective 
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removal of a variety of PPCPs although the removal efficiencies of PPCPs are sometimes 
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Fig. 6-10 Decrease of SUVA and No. of PPCPs removed by more than 90% during each 
process 
 
6.3.5 Energy consumption and operating cost 
Electrical energy and operating cost required during O3 and O3/UV processes for the 
PPCPs removal were calculated. Firstly, 15 kWh (6kWh for equipment for oxygen supply, 
9kWh for O3 generator) was used for an electrical energy required for generating 1kg O3 gas. 
Power consumptions of the used UV lamps were 23.7 W and 72 W for UV21.5W and UV65W, 
respectively, considering a leeway of 10%. 15 Yen per electrical energy of 1 kWh was applied 
for the calculation of operating cost. Tables 6-6, 6-7 and 6-8 show calculated electrical energy, 
operating costs and the number of PPCPs removed by more than 90% obtained in O3 and 
O3/UV processes. For O3 alone process, average O3 dose of 6.7 mg/L has been used for the 
water reuse in sewage treatment plants in Japan (JS, 2004). In this study, 35 out of 37 PPCPs 
were removed by more than 90% when O3 dose of 6 mg/L was used. Consequently, it can be 
expected that most of PPCPs will be removed effectively at a level of O3 dose used for 
existing water reuse projects. An electrical energy of 0.09 kWh/m3 for O3 dose of 6 mg/L 
(contact time: 10 min) is expected to be required, and operating cost was calculated as 1.4 
Yen/m3 as shown in Table 6-6.  
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Table 6-6 Electrical energy and operating cost required for O3 process 
Applied process O3 alone 
2 mg/L  
(O3 consumption : 1.6mg/L) 
4 mg/L 
(O3 consumption : 3.0mg/L) 
6 mg/L 
(O3 consumption : 4.4mg/L) O3 dose 
R1 : 1mg/L R2 : 1mg/L R1 : 2mg/L R2 : 2mg/L R1 : 3mg/L R2 : 3mg/L 
Contact time (min) 5 min  10 min 5 min  10 min 5 min 10 min 
Electrical energy (kWh/m3) 0.02  0.03  0.03  0.06  0.05  0.09  
No. of PPCPs removed by ≥ 90% 
/ No. of detected PPCPs 15 / 34 24 / 37 22 / 37 32 / 37 29 / 37 35 / 37 
Operating cost (Yen/m3) 0.2  0.5  0.5  0.9  0.7  1.4  
 
Table 6-7 Electrical energy and operating cost required for O3/UV21.5W process 
Applied process O3/UV21.5W 
2 mg/L 
(O3 consumption : 1.7mg/L) 
4 mg/L 
(O3 consumption : 3.3mg/L) 
6 mg/L 
(O3 consumption : 4.9mg/L) O3 dose 
R1 : 1mg/L R2 : 1mg/L R1 : 2mg/L R2 : 2mg/L R1 : 3mg/L R2 : 3mg/L 
Contact time (min) 5 min  10 min 5 min  10 min 5 min 10 min 
Electrical energy for O3 (kWh/m3) 0.02  0.03  0.03  0.06  0.05  0.09  
Electrical energy for UV (kWh/m3) 0.17  0.34  0.17  0.34  0.17  0.34  
Total electrical energy (kWh/m3) 0.19  0.37  0.20  0.40  0.22  0.43  
No. of PPCPs removed by ≥ 90% 
/ No. of detected PPCPs 7 / 25 15 / 35 10 / 35 23 / 35 16 / 35 31 / 35 
Operating cost (Yen/m3) 2.8  5.6  3.0  6.0  3.2  6.5  
 
Table 6-8 Electrical energy and operating cost required for O3/UV65W process 
Applied process O3/UV65W 
2 mg/L 
(O3 consumption : 1.8mg/L) 
4 mg/L 
(O3 consumption : 3.4mg/L) 
6 mg/L 
(O3 consumption : 5.3mg/L) O3 dose 
R1 : 1mg/L R2 : 1mg/L R1 : 2mg/L R2 : 2mg/L R1 : 3mg/L R2 : 3mg/L 
Contact time (min) 5 min  10 min 5 min  10 min 5 min 10 min 
Electrical energy for O3 (kWh/m3) 0.02  0.03  0.03  0.06  0.05  0.09  
Electrical energy for UV (kWh/m3) 0.51  1.03  0.51  1.03  0.51  1.03  
Total electrical energy (kWh/m3) 0.53  1.06  0.54  1.09  0.56  1.12  
No. of PPCPs removed by ≥ 90% 
/ No. of detected PPCPs 15 / 38 24 / 38 24 / 38 34 / 38 27 / 38 35 / 38 
Operating cost (Yen/m3) 7.9  15.9  8.2  16.3  8.4  16.8  
 
On the other hand, for O3/UV21.5W, the required electrical energy increased considerably 
due to the combination of UV treatment. An electrical energy and operating cost ranged from 
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0.19 kWh/m3 to 0.43 kWh/m3 and 2.8 Yen/m3 to 6.5 Yen/m3, respectively during O3/UV21.5W 
for 10 min at O3 dose of 2 mg/L, 4 mg/L and 6 mg/L. Nevertheless, only 7 to 31 out of the 
detected PPCPs exhibited the removal efficiency of more than 90%. 
In contrast to O3/UV21.5W process, the removal efficiency of PPCPs increased 
significantly when UV65W was combined with O3 process. In particular, O3/UV65W process at 
O3 dose of 6 mg/L could remove 35 PPCPs by more than 90%. However, as seen in Table 6-8, 
a considerable electrical energy was required due to the application of UV lamps with high 
power consumption. From Table 6-8, it can be known that at least an electrical energy of 1.09 
kWh/m3 (O3 dose: 4 mg/L, contact time: 10 min) will be needed for the effective PPCPs 
removal by O3/UV process. It is obvious that O3/UV process leads to much more energy 
consumption than O3 process. However, the applicability of this process for the PPCPs 
removal should be investigated, considering several questions such as incomplete oxidation of 
organic materials by O3 and the formation of by-products, and the improvement of 
disinfection effectiveness by the introduction of UV as well as a required electrical energy. 
 
6.4 Summary 
The effectiveness of O3-based processes (O3 and O3/UV processes) for the removal 
performance of PPCPs using bench-scale experimental setup was investigated. 
1) 37 PPCPs were detected in secondary effluent used as tested water in this study. O3 
dose of 6 mg/L (O3 consumption : 4.4 mg/L) was required for 90% removal of all the PPCPs 
except primidone (87%) for O3 process. However, 24 PPCPs including carbamazepine, 
crotamiton and diclofenac were removed by more than 90% even at a low O3 dose of 2 mg/L 
(O3 consumption : 1.6 mg/L), indicating that O3 process can be used as a technology for the 
effective removal of various PPCPs in secondary effluent.  
2) For O3/UV process, two types of UV lamps (UV21.5W, UV65W) were combined with O3 
doses of 2 mg/L, 4mg/L and 6mg/L, respectively. As a result, all the detected PPCPs were 
removed by more than 90% when UV65W lamps and O3 dose of 6 mg/L (O3 consumption  : 
5.3 mg/L) were combined (Contact time : 10 min, UV dose : 1,846 mJ/cm2). On the other 
hand, all the PPCPs except DEET (89%), primidone (86%), cyclophosphamide (86%) and 
chloramphenicol (>73%) showed removal efficiencies of more than 90% even when UV65W 
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lamps and O3 dose of 4 mg/L (O3 consumption : 3.4 mg/L) were combined, showing that a lot 
of PPCPs can be removed effectively under this operational condition.  
3) For O3 and O3/UV65W processes using O3 dose of over 4 mg/L (O3 consumption : over 
3.4 mg/L), more than 30 PPCPs showed the removal efficiency of more than 90% when 
SUVA decreased by more than 48%. Similarly to UV-based processes, it was thought that 
about 50% decrease in SUVA could ensure the effective PPCPs removal.  
4) Electrical energy consumed for the effective PPCPs removal was 0.09 kWh/m3 for O3 
process (O3 dose : 6 mg/L). Whereas, O3/UV process (O3 dose : 4 mg/L, UV dose : 1,846 
mJ/cm2) needed comparatively high electrical energy of 1.09 kWh/m3. Consequently, it can be 
known that O3 process is more cost-effective process than O3/UV process in the removal 
performance of PPCPs. 
5) For O3 process, the formation of bromate regulated in drinking water as well as the 
removal performance of PPCPs should be also taken into consideration. Although O3/UV 
process needs high energy consumption, the process has several advantages such as the 
suppression of bromate formation and the additional disinfection effect by UV. It is, therefore, 
thought that O3/UV process cannot be excluded in applying as technology for water reuse.  
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7 DISCUSSION ON THE APPLICABILITY OF UV/H2O2, O3 
AND O3/UV PROCESSES AS TECHNOLOGIES FOR SEWAGE 
REUSE UNDER CONSIDERING THE REMOVAL OF 




The demand for water will increase with the dramatic increase of the world’s population 
by the year 2020 (U.S. EPA, 2004). However, available water resources have been already 
limited in many areas of the world and therefore, water reuse will be necessary for extending 
available water resources. It has been reported that the majority of states in U.S. have 
regulations regarding water reuse on a volume basis is growing at an estimated 15 percent per 
year (U.S. EPA, 2004). In Japan, the amount of reclaimed water in 2005 was about 200 
million m3, which corresponds to just 1.4% of total effluent from sewage treatment plants 
(STPs) (The Ministry of Land, Infrastructure and Transport of Japan, 2005). However, in 
recent years there has been a growing interest in water reuse according to the lack of water 
resources and the advanced technologies for water treatment such as membrane treatment and 
advanced oxidation processes (AOPs). The manual for the quality of water reclaimed from 
treated water of STP was prepared by the Ministry of Land, Infrastructure and Transport of 
Japan in April, 2005. Moreover, a committee for promoting the reuse of secondary effluent 
was organized in 2008. Table 7-1 shows application types and purposes of the water reclaimed 




Table 7-1 Application types and purposes of the reclaimed water 
Application type Purpose 
Urban reuse - Irrigation of public parks and recreation centers, athletic fields, school yards and 
playing fields, highway medians and shoulders, and landscaped areas surrounding 
public buildings and facilities 
- Irrigation of landscaped areas surrounding single-family and multi-family 
residences, general wash down, and other maintenance activities 
- Irrigation of landscaped areas surrounding commercial, office, and industrial 
developments 
- Irrigation of golf courses 
- Commercial uses such as vehicle washing facilities, laundry facilities, window 
washing, and mixing water for pesticides, herbicides, and liquid fertilizers 
- Ornamental landscape uses and decorative water features, such as fountains, 
reflecting pools, and waterfalls 
- Dust control and concrete production for construction projects 
- Fire protection through reclaimed water fire hydrants 
- Toilet and urinal flushing in commercial and industrial buildings 
Industrial reuse - Cooling water, boiler make-up water, industrial process water  
Agricultural reuse - Agricultural irrigation 
Environmental and  
Recreational reuse 
- Natural and Man-made Wetlands 
- Recreational and Aesthetic Impoundments 
- Stream Augmentation 
Groundwater recharge - Establishment of saltwater intrusion barriers in coastal aquifers 
- Provision of further treatment for future reuse 
- Augmentation of potable or nonpotable aquifers 
- Provision of storage of reclaimed water for subsequent retrieval and reuse 
- Control or prevention of ground subsidence 
Augmentation of  
potable supplies 
- Surface water augmentation and groundwater recharge for indirect potable reuse 
- Direct potable water reuse 
 
On the other hand, it will be very important to consider the health assessment of 
pathogenic microorganisms, chemical constituents and endocrine disrupters for the reuse of 
secondary effluent. Especially, the effect of the chemical constituents should be considered 
when reclaimed water is used for potable reuse, food crop irrigation or aquaculture. U.S. EPA 
suggests advanced water treatment facilities such as MBR and UV treatment in the guidelines 
for water reuse for ensuring the safety from chemical constituents, however, the guideline of 
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Japan has not treated with it yet. At the present, the concentration of residual chlorine is being 
regulated by the guideline on the use of the reclaimed water of Japan for the microbiological 
safety of the reclaimed water. 
Much attention has been paid to PPCPs (pharmaceuticals and personal care products) as a 
kind of chemical constituents for the past few years. The effective degradation with chlorine is 
limited on only a few PPCPs such as diclofenac, indomethacine and naproxen although it is 
quite good disinfectant (Energy, Environment and Sustainable Development, 2004). In 
addition, there are a variety of organic compounds including PPCPs in secondary effluent and, 
therefore, the formation potential of disinfection by products (DBPs) is concerned during 
chlorination. Therefore, alternative methods are necessary to be investigated for reducing a 
risk of the reclaimed water caused by chemical constituents as well as pathogenic 
microorganisms. Up to now, our research group has studied and reported the effectiveness of 
O3-based and UV-based processes for the PPCPs removal. 
The objective of this chapter was to suggest the applicability as a technology for the 
reclamation of secondary effluent of investigated processes. 
 
7.2 Methods 
When evaluating the applicability of a process for the reclaimed water, factors such as 
reliability, operating and maintenance costs, practicality, disinfection effectiveness and 
potential adverse effects should be considered. Here, in terms of energy consumption, 
disinfection effectiveness, the formation potential of DBPs and ecological risk decrease, 
UV/H2O2, O3 and O3/UV processes were evaluated in order to suggest an appropriate process 
for the reclamation of secondary effluent. Fig 7-1 shows proposed procedure of appropriate 




Fig. 7-1 Propose procedure of appropriate process for water reuse considering the PPCPs 
removal 
 
PPCPs removal and energy consumption The electrical energy consumed for a pollutant 
removal is a powerful scale-up parameter and a measure of the removal performance in a 
fixed volume of contaminated water as a function of the applied specific energy dose. 
Therefore, energies consumed for the processes investigated in this study were calculated 
based on operational conditions that showed an effective PPCPs removal for each process. 
Afterwards, the most energy-saving process for an effective PPCPs removal from secondary 
effluent was suggested. Moreover, the energy consumptions were compared with those for 
other pollutants reported in previous studies. In this investigation, UV process was not 
considered because removal efficiencies of most of PPCPs detected in secondary effluent 
were less than 90% in spite of considerable energy consumption (UV dose : 2,768 mJ/cm2 for 
UVHigh, 1,725 mJ/cm2 for UVLow) (Fig 7-2). 
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Fig. 7-2 Removal efficiency of the 38 PPCPs by UVHigh and UVLow treatments 
 
Disinfection effectiveness In urban settings, where there is a high potential for human 
exposure to reclaimed water used for landscape irrigation and toilet flushing etc, the reclaimed 
water must assure minimum health risk. The facilities producing secondary effluent can 
become water reclamation plants with the addition of enhanced disinfection processes. 
The guideline for water reuse of Japan requires that total coliform does not exceed 
1,000/100ml for urban and recreational reuse (a tentative regulation). Therefore, Residual 
chlorine is necessary for meeting this regulation when secondary effluent is reclaimed in 
Japan. In the California Title 22 criteria, average total coliform should be less than 2.2/100 ml 
or 23/100ml according to the application of reclaimed water (Table 7-2).  
 
Table 7-2 Regulations of coliform for the reclaimed water in California 
Application Total coliform 
Unrestricted urban reuse 
Agricultural reuse – Food crops 
Unrestricted recreational reuse 
Restricted recreational reuse 
2.2/100ml (Avg) 23/100ml (Max in 30days) 
Restricted urban reuse 
Agricultural reuse – Non-food crops 
23/100ml (Avg) 240/100ml (Max in 30days) 
Groundwater recharge 
Indirected potable reuse 
Case-by-case 
 
Groundwater recharge and indirect potable reuse are determined on a case-by-case basis. 
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The most common disinfectant is chlorine, however, O3 and UV can be also used at 
wastewater treatment plants as prominent disinfectants. Therefore, the disinfection 
performance as well as the effective PPCPs removal by the investigated processes was 
evaluated. 
 
By-products formation By-product which can be formed for the degradation of an 
organic compound is one of the most important issues in the area of physicochemical process 
using oxidants such as O3, H2O2 and UV. There are several cases that by products are more 
problematic than parent product. For example, several aldehydes including formaldehyde, 
acetaldehyde and trichloroacetaldehyde can be produced during ozonation (Richardson et al., 
2007). Formaldehyde has been known to induce gene mutation in bacteria, mammalian cells 
and in rat nasal epithelia in vivo although in vivo genotoxicity of formaldehyde is difficult to 
assess for humans due to its highly reactive nature (Richardson et al., 2007).  
Moreover, Chloroacetaldehyde has been shown to cause liver tumors in rodents (Daniel 
et al., 1992). Bromate (BrO3-) can also be produced primarily by ozonation when source 
waters contain high levels of bromide (Richardson S.D, 1998). It has been known that among 
the regulated DBPs (disinfection by products), bromate is most carcinogenic in laboratory 
animals (Muellner et al., 2007). On the other hand, advance oxidation processes (AOPs) such 
as UV/H2O2 and O3/UV are promising technologies for mineralizing organic compounds. 
However, intermediate AOPs result in the partial oxidation of organic compounds into more 
biodegradable compounds such as aldehydes and carboxylic acids (Tuhkanen, 2004). 
Therefore, rigorous treatment should be applied for the complete mineralization of organic 
compounds. Here, the formation potential of by-products was discussed based on the results 
from laboratory and bench scale experiments, and previous studies performed by other 
researchers. 
 
Ecological risk decrease Screening evaluation has been carrying out for determining the 
priority of compounds which require more investigations due to their relatively high 
ecological risks. Initial ecological risk assessment is widely used as a tool for the screening 
evaluation and in this assessment, the priority is determined by the ratio of predicted 
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environmental concentration (PEC) to predicted no effect concentration (PNEC), called by 
Hazard Ratio (H/R). In this study, concentrations of individual PPCPs before and after 
treatment by each process were used instead of PEC in calculating H/R. No observed effect 
concentration (NOEC) divided by assessment factor (100) was used as a PNEC of each PPCP. 
NOEC was obtained from algae growth inhibition test using Pseudokirchneriella subcapitata 
(Korshikov) F.Hindak (Fukunaga, 2008). In this study, H/R was defined as the ratio of the 
concentration of a PPCP at each reactor during each process to NOEC. Decrease effect for 
ecological risk by each process was assessed using the H/R. During each process 38 PPCPs 
were dectected in tested water, however, H/Rs were calculated only for 30 PPCPs of which 
NOECs were available (Table 7-3).  
 
Table 7-3 NOEC and PNEC for 30 PPCPs 
No. PPCP Use Formula Water solubility(mg/L) pKa NOEC(mg/L) PNEC(mg/L)
1 Diclofenac C14H11Cl2NO2 2.4E+00 4.15 6.25 6.3E-02
2 Indomethacin C19H16ClNO4 9.4E-01 4.5 50 5.0E-01
3 Isopropylantipyrine C14H18N2O 3.0E+06 - 1.56 1.6E-02
4 Ketoprofen C16H14O3 5.1E+01 4.45 0.0156 1.6E-04
5 Mefenamic acid C15H15NO2 2.0E+01 4.2 5 5.0E-02
6 Naproxen C14H14O3 1.6E+01 4.15 6.25 6.3E-02
7 Atenolol Antiarrhythmic agent C14H22N2O3 1.3E+04 9.6 6.25 6.3E-02
8 Azithromycin C38H72N2O12 7.1E+00 8.74 0.0156 1.6E-04
9 Chloramphenicol C11H12Cl2N2O5 2.5E+03 5.5 0.125 1.3E-03
10 Ciprofloxacin C17H18FN3O3 3.0E+04 6.09 2.5 2.5E-02
11 Clarithromycin C38H69NO13 3.4E-01 8.99 0.0156 1.6E-04
12 Erythromycin C37H67NO13 1.4E+00 8.88 0.0313 3.1E-04
13 Levofloxacin C18H20FN3O4 - 5.5, 8.0 0.625 6.3E-03
14 Lincomycin C18H34N2O6S 9.3E+02 7.6 0.00781 7.8E-05
15 Nalidixic acid C12H12N2O3 1.0E+02 8.6 25 2.5E-01
16 Sulfadimethoxine C12H14N4O4S 3.4E+02 - 0.625 6.3E-03
17 Sulfamethoxazole C10H11N3O3S 6.1E+02 5.94 0.156 1.6E-03
18 Trimethoprim C14H18N4O3 4.0E+02 7.12 6.25 6.3E-02
19 Carbamazepine C15H12N2O 1.8E+01 - 6.25 6.3E-02
20 Primidone C12H14N2O2 5.0E+02 - 12.5 1.3E-01
21 Crotamiton Anti-itch drug C13H17NO 5.5E+02 - 6.25 6.3E-02
22 Cyclophosphamide Antineoplastic agent C7H15Cl2N2O2P 4.0E+04 - 50 5.0E-01
23 Sulpiride Anti-psychotic drug C15H23N3O4S 2.3E+03 9.12 12.5 1.3E-01
24 Theophylline Bronchodilator C7H8N4O2 7.4E+03 8.81 50 5.0E-01
25 Diltiazem Calcium channel blockers C22H26N2O4S 4.7E+02 7.7 0.625 6.3E-03
26 DEET Insect repellent C12H17NO 9.1E+02 - 50 5.0E-01
27 Bezafibrate Lipid regulating agent C19H20ClNO4 3.4E-01 3.4 25 2.5E-01
28 Clofibric acid Lipid regulating agent C10H11ClO3 5.8E+02 - 25 2.5E-01
29 Pirenzepine Muscarinic receptor antagonists C19H21N5O2 1.7E+01 1.8,7.9 25 2.5E-01







7.3 Results and discussion 
7.3.1 Energy consumption for the effective PPCPs removal  
7.3.1.1 Energy consumption by UV/H2O2, O3 and O3/UV processes 
In this study, a goal of 90% removal efficiency was set to compare the performance for 
PPCPs removal of each process. For UV/H2O2 process, 90% removal of 37 PPCPs could be 
achieved when initial H2O2 concentration in tested water was 6.2 mg/L during UV treatment 
using 65 W low pressure mercury lamp with UV output of 21.8WUV (UV intensity of applied 
UV lamp : 1.025 mW/cm2). Introduced UV dose (UV intensity x contact time) was 923 
mJ/cm2. During O3 process, O3 dose of 6mg/L (Concentration of O3 gas : 42 mg/L, Flow rate 
of O3 gas : 1.0 L/min, Contact time : 10 min., O3 consumption : 4.4 mg/L) was necessary for 
90% removal of all the PPCPs except primidone (87%) and naproxen (>89%).  
For O3/UV process, most of the PPCPs were removed by more than 90% when UV dose 
of 1,846 mJ/cm2 was combined with O3 dose of 4 mg/L (Concentration of O3 gas : 28 mg/L, 
Flow rate of O3 gas : 1.0 L/min, Contact time : 10 min., O3 consumption : 3.4 mg/L). 90% 
removal could not be accomplished in cyclophosphamide, primidone, DEET and 
chloramphenicol, however, high removal efficiencies of 86%, 86%, 89% and >73%, 
respectively were obtained. Consequently, it can be known that the combination of UV 
treatment with O3 process caused the decrease of O3 dose, showing a similar removal 
performance for PPCPs.  
 The amount of energy consumed during the operation of each process for achieving 
90% removal was estimated. For the estimation, the electricity consumption of 72 W per UV 
lamp was used. The electricity consumption required for O3 generation of 1 kg was 15 kWh. 
The energy for supplying H2O2 solution to the reactor was not considered. As a result, the 
energies of 0.54 kWh/m3, 0.09 kWh/m3 and 1.09 kWh/m3 were consumed during UV/H2O2, 
O3 and O3/UV processes, respectively for the accomplishment of efficient PPCPs removal. 
Based on this result, it was found that UV/H2O2 and O3/UV processes would need quite high 
electricity consumptions by the introduction of UV, comparing to O3 process. Therefore, it can 
be concluded that among the investigated processes, O3 process will be the most advantageous 
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Fig. 7-3 Comparison of removal efficiency of PPCPs by each process 
 
7.3.1.2 Electrical energy required for the removal of other micropollutants 
Here, the energy consumptions of each process for PPCPs removal and for the removal of 
other micropollutants such as methyl-tert-butyl-eter (MTBE) and atrazine reported in previous 
studies were investigated and compared. Table 7-4 shows the energy consumption required for 
1Log removal of individual compounds by each process.  
Mascolo et al (2008) have performed a preliminary operation cost evaluation of 
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UV/H2O2 process for the remediation of groundwater polluted by MTBE, benzene, toluene, 
p-xylene, styrene and ethylbenzene using batch experiment. In the study, they showed that the 
electrical energy necessary for a one order magnitude of removal of the investigated pollutants 
was 2.8 kWh/m3. This corresponds to more than 5 times of the electrical energy (0.54 
kWh/m3) required for 90% removal of the PPCPs investigated in this study.  
 
Table 7-4 Energy consumption required for 1Log removal of each all the compound 
 
Sutherland et al (2004) have also reported that the electrical energy necessary for a one 
order removal (EE/O) of MTBE in groundwater samples by pilot scale UV/H2O2 process 
ranged from 1.2 to 8.6 kWh/m3. It was also known that EE/O values for other compounds are 
0.5-1.3 kWh/m3 for BTEX, 2.6-7.9 kWh/m3 for atrazine, and 0.5-1.6 kWh/m3 for 1,4-dioxane 
(Calgon carbon oxidation technologies, 1996). Comparing to the results from these previous 
studies, it can be known that efficient PPCPs removal by UV/H2O2 process can be achieved 
with relatively less energy consumption than other micropollutants. 
On the other hand, Wu and Ng (2008) have calculated EE/O values for the decolorization 
Energy consumption (kWh/m3) 
Compounds 
UV/H2O2 O3 O3/UV 











MTBE, bezene, toluene, 
p-xylene, styrene 
2.8 iii) 
(Groundwater) - - 
BTEX 0.5 ~ 1.3 
iv)
 
(Groundwater) - - 
Atrazine 2.6 ~ 7.9 
iv)
 
(Groundwater) - - 
1,4-dioxane 0.5 ~ 1.6 
iv)
 
(Groundwater) - - 






Iopromide - 0.3 
ii)
 
(Drinking water) - 
i) Sutherland et al. 2008 
ii) Sona et al., 2006 
iii) Mascolo et al., 2008 
iv) Calgon carbon oxidation technologies, 1996 
v) Wu and Ng, 2008 
 
 149 
of C.I. Reactive Red2, dye with the most commonly used anchor in batch experiments using 
O3, O3/H2O2 and O3/UV. They reported that for O3 process, at pH 7 EE/O value was 2.1 
kWh/m3 and, O3/UV process needed 2 times higher electrical energy (4.2 kWh/m3) than for 
O3 process. It can be known that the EE/O values are quite high comparing to 0.09 kWh/m3 
for O3 process and 1.09 kWh/m3 for O3/UV process obtained in this study although a rather 
high concentration of the compound was used for the experiment.  
Sona et al (2006) calculated the EE/O values for the removal of iopromide and MTBE in 
batch O3 and O3/UV experiments. The EE/O values for the compounds spiked in drinking 
water were 0.3 kWh/m3 and 1.0 kWh/m3 for iopromide and MTBE, respectively. Iopromide, a 
contrast medium has been known to be very stable compound, however, no contrast media 
were not contained in the investigated PPCPs in this study. Therefore, more electrical energy 
could be necessary than 0.09 kWh/m3 if considering the efficient removal of contrast media 
such as iopromide by O3 process. However, it can be known that iopromide needs less 
electrical energy than MTBE although it is a compound with very low degradability among 
PPCPs. From these results, it can be concluded that effective PPCPs removal can be achieved 
by the introduction of less electrical energy comparing to for other pollutants, irrespective of 
the investigated processes.  
 
7.3.2 The disinfection effectiveness during UV/H2O2, O3 and O3/UV processes 
7.3.2.1 UV/H2O2 process 
UV doses required for the effective PPCPs removal were compared with those for the 
removal of pathogenic microorganisms. Fig 7-4 shows UV doses required for the effective 
pathogenic microorganisms and PPCPs removal.  
In guidelines for sewer maintenance of Japan (2003), UV doses of 150-200 mJ/cm2, 
200-300 mJ/cm2 and 300-500 mJ/cm2 are recommended for 1log, 2log and 3log removal of 
total coliform in secondary effluent. Kruithof et al (2007) have investigated on the potential of 
UV/H2O2 process for organic contaminants control and primary disinfection using surface 
water. Under UV dose of 540 mJ/cm2 (about 0.5 kWh/m3) and H2O2 of 6 mg/L, pesticide 
(atrazine), N-Nitrosodimethylamine (NDMA), MTBE, dioxane, endocrine disruptor 
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(bisphenol A), microcystine and pharmaceuticals (diclofenac, ibuprofen) were removed by 
more than 80%. Moreover, 3log disinfection for Cryptosporidium and Giardia were obtained 
at the UV dose of less than 20 mJ/cm2 and no reinfection of protozoa was observed at the UV 
dose of more than 45 mJ/cm2. The highest UV dose for disinfection was 105 mJ/cm2 needed 
for the inactivation of spores of Sulphite Reducing Clostridia. This means that UV/H2O2 
process showed very good disinfection effectiveness under the operational condition for 
removing organic pollutants sufficiently.  
It can be known in Fig 7-4 that E.coli and cryptosporidium are inactivated very easily 
even by UV dose of 5-18 mJ/cm2 and 2-12 mJ/cm2, respectively (Hijnen et al., 2006). UV 
doses of 56-167 mJ/cm2 can remove by 1-3log of Adenovirus type 40, which is the most 
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Fig. 7-4 UV doses for the effective pathogenic microorganisms and PPCPs removal 
 
On the other hand, among 38 PPCPs, only 18 including diclofenac and 
isopropylantipyrine (analgesics), disopyramide (antiarrhythmic agent), ciprofloxacin and 
sulfamethoxazole (antibiotics) and clofibric acid (lipid modifying agent) could be removed by 
more than 90% in spite of the introduction of UV dose of 2,769 mJ/cm2 during UV alone 
process (contact time : 15 min). Contrarily, the combination of H2O2 with UV process resulted 
in the significant decrease of UV dose. All the detected PPCPs were removed by more than 
 151 
90% under UV dose of 923 mJ/cm2 when initial H2O2 concentration of 6.2 mg/L was used 
during UV process. The disinfection effective for total coliforms with UV increases linearly 
with the increased UV dose (Paraskeva and Graham, 2005). This shows that 5 log disinfection 
for total coliform can be obtained under the operational condition (UV dose : 923 mJ/cm2, 
Initial H2O2 concentration : 6.2 mg/L). 
 
7.3.2.2 O3 process 
O3 has been known to be a very effective disinfectant for advanced wastewater treatment 
plant effluent, and it can also inactivate viral and bacterial pathogens very rapidly (U.S. EPA, 
2004). Moreover, some toxic, mutagenic, or carcinogenic compounds found in wastewaters 
can be more readily biodegraded after ozonation. Coliform is often used for evaluating the 
disinfection effectiveness by a disinfectant and several researchers have studied on the 
inactivation of coliform by ozone (Farooq et al., 1983; Smeets et al., 2006). In general, total 
coliform of less than 3,000 /cm3 can be achieved at O3 dose of 5 mg/L for secondary effluent 
including low organic compounds and/or NO2- (Japan Sewage Works Association, 2003). 
Paraskeva and Graham (2005) examined the effect of three potential disinfection methods 
- ozonation, UV irradiation and microfiltration - on the removal of E. coli and total coliforms 
from a typical secondary municipal effluent. They showed that O3 doses of 1-1.5 mg/L, 2.5 
mg/L, 2.5-5 mg/L, 5-7.5 mg/L and 7.5-10 mg/L can ensure total coliforms reduction of 1log, 
2log, 3log, 4log and 5log, respectively. Moreover, their results strongly indicated that 
transferred ozone dose was the most important parameter in the ozone treatment, but contact 
time was not a critical parameter. According to the U.S. EPA (1986), most plants have been 
reported to operate at 10-15 min contact times. 
On the other hand, Xu et al. (2002) investigated wastewater disinfection by ozone at pilot 
scale on wastewater effluents. They found that O3 dose of 4.8 mg/L with 4 min HRT was 
enough for total inactivation of enteroviruses (>2.9 log inactivation). In this study, O3 dose 
required for an effective PPCPs removal in this study was 6 mg/L (O3 consumption : 4.4 
mg/L). This O3 dose will also guarantee effluent water quality standard (< 3,000 /cm3) for 
total coliform even though 4.4 mg/L is slightly lower than O3 dose (5 mg/L) using for the 
disinfection of secondary effluent in Japan. In addition, Fig 7-5 shows that O3 dose of 2.5 
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mg/L can inactivate total coliform of 2log. From this result, it is expected that total coliform 
inactivation required for the reclaimed water in Japan could be achieved with an effective 
PPCPs removal. On the other hand, O3 doses of 7.5-10 mg/L are necessary for inactivating 
total coliform of 5log (Paraskeva and Graham, 2005). Therefore, 3log disinfection for total 
coliform is expected for O3 alone process using O3 dose of 4.4 mg/L. However, it can be 
known that more than O3 dose of 5 mg/L will be needed for satisfying the guidelines on the 
reclaimed water in the California Title 22 criteria (4-5log disinfection). The installation of 
rapid sand filter or biofilter before O3 process is recommended because O3 demand increase 
due to the consumption of O3 by various constituents such as organic compounds or NO2- 
when secondary effluent is reclaimed (Japan Sewage Works Association, 2003). These 
















1.6mg/L (>1log for 25 PPCPs, O3 dose:2mg/L)
3mg/L (>1log for 32PPCPs, O3 dose:4mg/L)
4.4mg/L (>1log for 36PPCPs, O3 dose:6mg/L)
 
Fig. 7-5 O3 doses for the effective pathogenic microorganisms and PPCPs removal 
 
7.3.2.3 O3/UV process 
Information on the disinfection effectiveness of O3/UV process appears to be not 
sufficient because most of studies on the process have been conducted for the removal of 
organic compounds. Jung et al (2007) evaluated the effect of O3, UV, O3/UV, O3-UV and UV- 
O3 processes for the disinfection of Bacillus subtilis spores which have often been used as a 
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surrogate microorganism for Cryptosporidium parvum oocysts. They found that among the 
investigated five processes, O3/UV process showed the greatest synergistic effect in 
disinfecting Bacillus subtilis spores. This might be because the inactivation of Bacillus subtilis 
spores was affected by OH radicals as well as ozone and UV during O3/UV process.  OH 
radicals can play an important role in the inactivation of microorganisms, mainly due to the 
destruction of their cell membranes or walls (von Sonntag, 1986). Therefore, O3/UV process 
is expected to be more effective for disinfection than O3 process owing to the contribution of 
OH radicals formed by UV photodegradation of O3 to the inactivation of pathogenic 
microorganisms as well as the destruction of pathogenic microorganisms by direct UV 
irradiation. In this study, the effective PPCPs removal was achieved for O3/UV process using 
O3 dose of 4 mg/L (O3 consumption : 3.4 mg/L) and UV dose of 1,846 mJ/cm2. Considering 
the synergistic effect of O3/UV process for disinfection, it is thought that 5log disinfection for 
total coliform can be acquired with the operational condition.  
 
7.3.3 The formation of by-products by UV/H2O2, O3 and O3/UV processes 
7.3.3.1 The formation of by-products of PPCPs during each process 
Fig. 7-6 shows the profile of dissolved organic carbon (DOC) concentration with time 
when tested waters spiked with 30 PPCPs including analgesics, antiarrhythmia agents, 
antibiotics and brondiodilators were treated with UV/H2O2, O3 and O3/UV processes. The 
initial concentrations of the 30 PPCPs in tested water ranged from 5 µg/L to 119 µg/L. 
UV/H2O2 process was carried out using batch reactor with an effective volume of 22L and, 
UV lamp that emits at the wavelength of 254 nm and the initial H2O2 concentration of 4.9 
mg/L were used. O3 process was performed by semi-batch experiment supplying O3 gas to 
batch reactor continuously at O3 feed rate of 0.3 mg/L/min (Concentration of O3 gas : 
6.6mg/L, Flow rate of O3 gas : 1 L/min). O3/UV process was carried out using O3 feed rate of 
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Fig. 7-6 Profile of DOC concentration with time during each process 
 
It can be known in Fig. 7-6 that DOC concentration decreased very slightly during the 
reaction time of 30 min. However, most of PPCPs dereased by less than limit of detection 
(LOD) in their concentrations for 5-15 min, irrespective of applied processes. Therefore, it 
was expected that a variety of by products would be generated during the processes.  
 
7.3.3.2 The formation of bromate during each process 
Fig 7-7 shows the formation of bromate under O3 doses of 3 mg/L (O3 consumption : 2.2 
mg/L), 6 mg/L (O3 consumption : 3.9 mg/L) and 12 mg/L (O3 consumption : 7.0 mg/L) during 
O3 process using bench scale experimental setup. The contact time of each reactor is 5 min 
and O3 gas was supplied to Reactors 1 and 2 (O3 gas flow rate/reactor : 0.5 L/min). Bromide 
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Fig. 7-8 Profile of dissolved O3 during O3 process 
 
As shown in Fig. 7-7, bromate concentration increased with the increased O3 dose and 
contact time. Kim (2005) reported that bromate formation increased linearly as CT 
(concentration × contact time) value increased, and the formation rate of bromate was mainly 
affected by initial bromide concentration. On the other hand, it can be known that the 
formation potential of bromate will increase when dissolved O3 concentration is high (Fig. 
7-8) although the removal efficiency of PPCPs improved with the increase of O3 dose as 
mentioned before.  
Fig. 7-9 shows the profile of bromate during UV/H2O2, O3 and O3/UV processes. No 
bromate formation showed during UV process combined with H2O2 concentration of 8 mg/L. 
For O3 process, bromate concentrations in samples from reactor 1 and 2 increased by 1.4 µg/L 
and 4.4 µg/L, respectively, under O3 dose of 6 mg/L. Contrarily, bromate concentration in 
sample from reactor 2 decreased by 2.3 µg/L in O3/UV process although the same O3 dose of 
6 mg/L was applied. It was described in Chapter 6 that the PPCPs removal was improved by 
the combination of UV with O3 process. Dissolved O3 concentrations in reactor 1 and 2 were 
0.4 mg/L and 1.7 mg/L during O3 process, while for O3/UV process, dissolved O3 
concentration of about 0.1 mg/L was shown in both reactors because of the direct 
photodegradation of O3 molecular by UV irradiation. Thus, it can be concluded that bromate 































Fig. 7-9 Formation of bromate during UV/H2O2, O3, O3/UV processes 
 
7.3.3.3 Review on the formation of by-products during each process 
PPCPs may be transformed by a variety of water treatment processes during their release 
to the aquatic environment. Consequently, the aquatic environment may be exposed to a 
mixture of the parent PPCPs and any resulting transformation products. The increasing 
concern is the potential toxicity of the transformation products to humans through drinking 
water as well as aquatic organisms (Li et al., 2008). Here, the formation potential of by 
products during the degradation of PPCPs by UV/H2O2, O3 and O3/UV processes was 
discussed.  
Vogna et al (2004a) has investigated the oxidation of diclofenac, a widely used 
anti-inflammatory drug, with UV/H2O2 and O3 treatments. In their study, both UV/H2O2 and 
O3 turned out effective treatment methods for inducing diclofenac degradation. When tested 
water spiked with diclofenac of 0.001M was treated for 90 min by UV/H2O2 process, 
diclofenac showed the degree of mineralization of 39%, which was calculated by total organic 
carbon (TOC) abatement. O3 treatment showed slightly lower mineralization of 32% than for 
UV/H2O2 treatment for 90 min although diclofenac was degraded completely within 10 min. 
The degradation of carbamazepine with UV/H2O2 treatment was investigated in their other 
study (Vogna et al., 2004b). They found that TOC of about 35% was removed when 
carbamazepine in aqueous solution (2.0×10-2mM) was degraded completely for about 4 min, 
showing the formation of a series of acridine intermediates which are more toxic and 
hazardous than carbamazepine. 
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There seems to be relatively many studies on the degradation of pharmaceuticals with O3 
(Andreozzi et al., 2005; Lange et al., 2006; Dantas et al., 2007; Seitz et al., 2008; Dantas et 
al., 2008; Li et al., 2008). Andreozzi et al (2005) has studied and reported on the ozonation of 
amoxicillin (5.0×10-4M) added to aqueous solution which was saturated with ozone ([O3] = 
1.6×10-4M) previously. In the study, more than 90% of amoxicillin was converted during 
ozonation of 4 min, while very low TOC removal of 18.2% was observed for longer ozonation 
time of 20 min. As a consequent, they suggested that further investigations will be necessary 
to assess the ecotoxicities of the intermediates and products formed during ozonation of 
amoxicilline. 
Seitz et al (2008) found that for ozonation of iomeprol, a representative iodinated X-ray 
contrast medium, unknown by-products were formed and detected from the effluent of an 
ozone reactor in a full-scale water treatment works as well as their batch studies. Dantas et al 
(2008) also observed that after 15 min of ozonation (0.4g O3/L), the complete 
sulfamethoxazole abatement was almost achieved with just 10% of mineralization. From these 
previous studies, it can be known that it will be difficult to achieve the complete 
mineralization of PPCPs by ozonation. Dantas et al (2007) have assessed the biodegradability 
and acute toxicity of by products formed from ozonation of bezafibrate, a largely used lipid 
regulator. They demonstrated that ozonation is an appropriate process to improve the 
biodegradability and slow down the toxicity of water containing bezafibrate, based on the 
increased ratio of BOD5/COD by ozonation.  
There seems to be very few studies on the formation of by products during the 
degradation of PPCPs by O3/UV process. Gong et al (2007) have done O3 and O3/UV 
treatment experiments for the biotreated effluent of a municipal wastewater treatment in order 
to investigate the effects of O3 and O3/UV on organic fractions. Dissolved organic matter 
(DOM) was separated into four fractions: hydrophobic acids, non-acid hydrophobics, 
transphilics and hydrophilics. As a result, they observed that ozone was not effective for 
reducing dissolved oxygen carbon (DOC) due to its sequential reaction with aromatic 
hydrophobics, trasphilics and hydrophilics. Contrarily, O3/UV process was effective for 
removing all four DOM fractions.  
From these results, it is likely to be difficult to accomplish the complete mineralization of 
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PPCPs by UV/H2O2 and O3 process. There may be a great variety of PPCPs in the aquatic 
environment. This may be why it will be much more difficult work to consider the 
mineralization of all the PPCPs by wastewater treatment processes. Therefore, after and 
before treatment by the processes, risk assessment for treated water should be performed to 
investigate the effect of the treated water on the aquatic system and human health.  
 
7.3.3.4 Review on the formation and suppression of bromate during O3 process 
Adverse health consequences associated with the reuse of raw or improperly treated 
wastewater were well documented. As a consequence, water reuse regulations and guidelines 
are principally directed at public health protection, and generally are based on the control of 
both health significant microorganisms and chemical contaminants especially for indirect 
potable reuse applications. For indirect potable reuse, treated wastewater is mixed with 
surface and/or groundwater, and the mix typically receives additional treatment before 
entering the water distribution system.  
On the other hand, for O3 process, dissolved O3 can react with bromide in water and lead 
to the formation of bromate as mentioned above. Bromate is known to be carcinogenic and, 
therefore, concerns on the control of bromate formation are increasing. Bromate regulation is 
now being proposed at a maximum contaminant level of 10 µg/L in drinking water in 
U.S.EPA. In 2003, Japan has also set the bromate regulation of 10 µg/L in drinking water. 
Therefore, if considering indirect potable reuse applications, bromate is needed to be 
controlled during treatment of secondary effluent. 
Bromate can be formed when O3 dose exceeds the O3 demand of the water. Wert et al 
(2007) observed that at O3 doses above 3.1 mg/L, a linear relationship was obtained between 
bromate formation and O3 dose during bench- and pilot-scale testing. They also reported that 
bromate formation during O3/H2O2 treatment was due to residual O3. Kim (2005) 
demonstrated that more than 3log inactivation of total coliform and 90% removal of EDCs 
could be achieved when the ratio of O3 consumed to initial DOC concentration was set to 1.0 
during O3 process. Moreover, he observed that no bromate was formed under the operational 
condition. Bench scale experiments showed that for O3 process, the ratios of O3 consumed to 
initial DOC concentration were 0.5, 1.0 and 1.6 for O3 doses of 2 mg/L, 4 mg/L and 6 mg/L, 
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respectively (Chapter VI). It can be, therefore, said that O3 dose of 4 mg/L will be desirable in 
terms of the suppression of bromate formation. However, the effective removal of PPCPs 
detected in secondary effluent could be achieved under O3 dose of 6 mg/L. 
On the other hand, Kim (2005) reported that when the molar ratio of H2O2 added to O3 
consumed was over 0.5, dissolved O3 was completely suppressed, resulting in no bromate 
formation. Moreover, this study showed that O3/UV process could be an alternative treatment 
option for the control of bromate formation (7.3.3.2) and the effective PPCPs removal 
(Chapter VI).  
From these results, the formation potential of bromate caused by residual O3 can be 
pointed out as a defect of O3 process. Bromate formation for O3 process can be controlled by 
selecting appropriate O3 dose considered initial DOC concentration of the water. In this study, 
it was thought that the operational condition (O3 dose of 6 mg/L) which achieved an effective 
PPCPs removal could cause bromate formation because the ratio of O3 consumed to initial 
DOC concentration was over 1.0 and SUVA was less than 0.013L/mg·cm, suggested by Kim 
(2005). On the other hand, the combination of H2O2 or UV with O3 can ensure the suppression 
of bromate formation. Especially, this study demonstrated that O3/UV process could 
accomplish an effective removal of all the PPCPs detected in secondary effluent.  
 
7.3.4 Decrease effect for ecological risk by each process 
Figs. 7-10~13 show the variation of H/Rs of the 30 PPCPs by each process. Among the 
30 PPCPs, PPCPs that showed high H/R in tested water were clarithromycin (2.3~3.6), 
ketoprofen (0.4~0.8), azithromycin (0.4~0.6), erythromycin (0.2) and lincomycin (0.1~0.3). 
Clarithromycin was classified as a candidate compound that further assessment is required 
due to its very high H/R (5.7), which was calculated using PEC and PNEC. On the other hand, 
the sum of H/Rs of other 25 PPCPs ranged from 0.1 to 0.2, which is negligible comparing 
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Fig. 7-11 Variation of H/Rs of the 30 PPCPs by UV/H2O2 process 
 
For UV process (Fig. 7-10), H/R decreased gradually passing through each reactor (R1, 
R2 and R3). In particular, H/R of ketoprofen in tested water was 0.4, however, it decreased by 
almost 0 in R1 (contact time: 5 min), indicating that UV process can reduce the ecological risk 
caused by ketoprofen very fast. It was also observed that H/Rs of other 25 PPCPs decreased 
by almost 0 in R1. On the other hand, three macrolide antibiotics such as clarithromycin, 
azithromycin and erythromycin showed highly high H/Rs of 0.2 to 1.7 even after UV 
treatment for 15 min (R3, Introduced UV dose : 2,768 mJ/cm2). It is, therefore, thought that 
considerable UV dose will be needed to decrease the ecological risk caused by PPCPs by UV 
alone process.  
H/R in treated water from R1 was about 1.3 when initial H2O2 concentration of 1.2 mg/L 
was combined with UV process (Fig. 7-11). The addition of initial H2O2 concentrations of 3.1 
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mg/L and 6.2 mg/L during UV process could decrease the H/Rs by 0.3 and 0.1, respectively. 
In contrast to UV process, significant decrease effect for ecological risk was shown for short 
contact time of 5 min.  
Fig. 7-12 shows H/R at each reactor during O3 process. It can be seen that very low H/Rs 
were obtained comparing with other processes, irrespective of O3 dose. Moreover, the H/Rs 
decreased significantly with the increased O3 dose, showing that O3 process will be very 
effective for reducing ecological risk caused by parent PPCPs. However, as mentioned above, 
various intermediates can be formed for the degradation of organic compounds by O3. In this 
study, H/Rs of the intermediates were not considered.  
For O3/UV process (Fig. 7-13), the decrease of H/R during the contact time of 5 min (R1) 
was not so significant, however, the contact time of 10 min (R2) reduced the H/R considerably. 
H/Rs for O3/UV process also decreased gradually the increased O3 dose. Consequently, 
UV/H2O2, O3 and O3/UV processes could reduce total H/Rs of the 30 PPCPs ranging from 3.8 
to 5.0 in tested water by very low level (less than 1.0).  
Therefore, it can be concluded that these processes will play an important role in 
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Fig. 7-12 Variation of H/Rs of the 30 PPCPs by O3 process 





































































O3 2mg/L O3 4mg/L O3 6mg/L
 
Fig. 7-13 Variation of H/Rs of the 30 PPCPs by O3/UV process 
※ O3 consumption : 1.8 mg/L, 3.4 mg/L and 5.3 mg/L for O3 doses of 2 mg/L, 4 mg/L and 6 mg/L, 
respectively. 
 
7.3.5 Propose of appropriate process for water reuse  
Additional concerns have been raised regarding the fate and transport of trace organic 
compounds. These include endocrine disruptors and PPCPs (pharmaceuticals and personal 
care products) that are present in municipal wastewaters. None of these individual compounds 
are regulated for the reclaimed water. Although no illnesses to date have been directly 
connected to the use of reclaimed water, it is recommended to continue with ongoing research 
for these compounds in terms of precautionary principles. The performance of O3, UV/H2O2 
and O3/UV processes for the PPCPs removal was investigated in this study. Based on the 
results from the investigations and previous studies, the applicability of the processes as a 
technology for sewage reuse was evaluated. Effective PPCPs removal was achieved by the 
introduction of less electrical energy comparing to for other pollutants such as MTBE, BTEX 
and atrazine, irrespective of the investigated processes (7.3.1.2). In addition, UV/H2O2, O3 and 
O3/UV processes reduced total H/Rs of the 30 PPCPs in tested water by very low level (7.3.4). 
Therefore, the disinfection effectiveness and the potential of by-product formation are critical 
factors in evaluating the applicability of the investigated processes as a technology of water 
reuse.  
For O3 process, O3 dose of 6 mg/L (O3 consumption : 4.4 mg/L) was necessary for the 
effective removal of the 37 PPCPs detected in secondary effluent. About 4log inactivation of 
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total coliform can be expected under this operational condition (Fig. 7-5). In Japan, total 
coliform in the effluent from wastewater treatment plant must be less than 3,000 /ml. 
Therefore, the removal efficiency of total coliform which the investigated processes should 
achieve for water reuse was calculated from 3,000 /ml. As a result, 3log and 4~5log 
inactivations are necessary to meet the guideline for water reuse of Japan (1,000/100 ml) and 
California Title 22 criteria (Table 7-2), respectively. Consequently, it is expected that O3 dose 
of 6 mg/L can meet the guideline for water reuse of Japan and the water quality required for 
restricted urban and agricultural (non-food crops) reuses in the California Title 22 criteria by 
accomplishing about 4log inactivation of total coliform. On the other hand, the formation 
potential of bromate is likely to be high under O3 dose of 6 mg/L (7.3.3.4). Therefore, the 
combination of UV or H2O2 with O3 process is recommended to suppress bromate formation, 
for direct and indirect potable reuses. In addition, UV/H2O2 process can be a treatment option 
in terms of bromate suppression. 
UV/H2O2 (UV dose : 923 mJ/cm2, H2O2 : 6.2 mg/L) and O3/UV (O3 consumption : 3.4 
mg/L (O3 dose : 4 mg/L), UV : 1,846 mJ/cm2) processes discussed in this chapter can be 
expected to achieve more than 5log inactivation of total coliform (7.3.2.1). Moreover, no 
bromate will be formed during UV/H2O2 process, and the combination of UV with O3 process 
also can suppress the formation of bromate by blocking the reaction of residual O3 with Br 
through the photodegradation of residual O3 (7.3.3). Therefore, the processes can be applied 
for unrestricted urban reuse, agricultural reuse (food crops) and recreational reuse as well as 
restricted urban and agricultural (non-food crops) reuses of sewage water although much more 
energy consumption will be necessary comparing to for O3 process. 
On the other hand, various by-products from the parent PPCPs degradation can be 
formed for all the investigated processes. There are a great variety of PPCPs used for human 
health and, therefore, it is very difficult to investigate the by-products from all the PPCPs. In 
this case, risk assessment for the water treated with the processes will be useful for 
investigating the adverse effects from the by-products. In this study, decrease effect of 
ecological risk before and after treatment was evaluated for the parent PPCPs. As a result, it 
was observed that ecological risk caused by the parent PPCPs could be reduced considerably 
after treatments, irrespective of the applied processes. Therefore, the investigated processes 
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can be used as treatment options for indirect potable reuse, recreational reuse and groundwater 
reuse etc of sewage water in terms of ecological risk decrease for the parent PPCPs, although 
the adverse effect by by-products are still questioned.  
 
Table 7-5 Applicable reuses by the investigated processes 
O3 UV/H2O2 O3/UV 
Items * O3 dose : 6 mg/L 
(O3 consump.:4.4 mg/L) 
* UV dose : 923 mJ/cm2, 
H2O2 : 6.2 mg/L 
* O3 dose : 4 mg/L 
(O3 consump.:3.4 mg/L), 
UV dose : 1,846mJ/cm2 
Energy consumption 
for effective PPCPs removal 
0.09 kWh/m3 0.54 kWh/m3 1.09 kWh/m3 
Disinfection 
effectiveness 
3log inactivation of total 
coliform 
More than 5log inactivation of total coliform 
PPCPs 
by-products 





No bromate formation 
Suppression of bromate 
formation 
Ecological risk Hazardous ratio for 30 PPCPs : less than 0.1 
Applicable reuses 
- Urban and recreational 
reuse (Japan) 
- Restricted urban /  
agricultural reuse (non- 
food crops) (California) 
- Urban and recreational reuse (Japan) 
- Unrestricted and restricted urban / agricultural   





In this chapter, the applicability of O3, UV/H2O2 and O3/UV processes as technologies 
for water reuse considering PPCPs removal was investigated. The PPCPs removal efficiency 
and energy consumption for each process were compared and discussed for this investigation. 
In addition, the formation potential of disinfection by products (DBPs), disinfection 
effectiveness and decrease effect for ecological risk of the investigated processes were also 
discussed. The results are as follows; 
1) Electrical energies required for the effective removal of PPCPs in secondary effluent 
were 0.09 kWh/m3, 0.54 kWh/m3 and 1.09 kWh/m3 for O3 (O3 dose : 6 mg/L, O3 
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consumption : 4.4 mg/L), UV/H2O2 (UV dose : 923 mJ/cm2, H2O2 : 6.2 mg/L) and O3/UV (O3 
dose : 4 mg/L, O3 consumption : 3.4 mg/L, UV dose : 1,846 mJ/cm2) processes, respectively, 
showing that O3 process is the most cost-effective treatment option for the PPCPs removal. 
On the other hand, it is considered that PPCPs removal by the investigated processes requires 
less electrical energy than for other micropollutants such as MTBE, atrazine and 1,4-dioxane.  
2) 4 log inactivation of total coliform was expected to be achieved by O3 process at O3 
dose of 6 mg/L, while more than 5 log inactivation by UV/H2O2 (UV dose : 923 mJ/cm2, 
H2O2 : 6.2 mg/L) and O3/UV (O3 dose : 4 mg/L, UV dose : 1,846 mJ/cm2) processes could be 
achieved. Therefore, in case that the number of total coliform in secondary effluent is 3,000 
/ml, these processes can meet sufficiently the guideline for water reuse of Japan 
(1,000/100ml). On the other hand, O3 process (O3 dose : 6 mg/L) can be used as a treatment 
method for restricted urban reuse and agricultural reuse (non-food crops) requiring the 
number of total coliform of less than 23/100ml. However, in order to obtain the reclaimed 
water for unrestricted urban reuse, agricultural reuse (food crops) and unrestricted/restricted 
recreational reuse considering the effective PPCPs removal, UV/H2O2 and O3/UV processes 
should be applied.  
3) O3 process at O3 dose of 6 mg/L (O3 consumption : 4.4 mg/L) showed the effective 
PPCPs removal, however, the formation of bromate is expected for O3 process using O3 dose 
of more than 4 mg/L (O3 consumption : 3.0 mg/L). In particular, bromate formation will be a 
critical issue when the reclaimed water is used for direct/indirect potable reuses. Therefore, in 
order to suppress the bromate formation as well as achieve the effective PPCPs removal, 
O3/UV process will be appropriate. For O3/UV process, residual O3 will be degraded by UV 
photodegradation, and, therefore, the formation reaction of bromate (reaction of O3 with Br-) 
will be suppressed. UV/H2O2 process will be also a profitable process because no bromate 
will be formed during the process.  
4) The ecological risk evaluation showed that each process could decrease the ecological 
risk caused by parent PPCPs considerably. This means that the investigated processes can play 
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There has been little information that pharmaceuticals and personal care products 
(PPCPs) have any adverse health effects. Nevertheless, water reclamated from secondary 
effluent of wastewater treatment plant as well as drinking water should be free from the 
PPCPs to minimize the unpredictable risk. Therefore, a sufficient removal of PPCPs in 
wastewater treatment plants (WWTPs) known to a main PPCPs source into the aquatic 
environment is inevitable. However, it has not been known that which PPCP is relevant to the 
aquatic environment because a great variety of PPCPs are used for human health and animal 
breed, unlike other micropollutants.  
Indicators for evaluating environmental relevance of a micropollutant include occurrence, 
fate and detection frequency in the aquatic environment, and its ecological toxicity and 
degradability. This study provides information on the degradability of various PPCPs by 
physicochemical processes such as UV-based (UV and UV/H2O2) and O3-based processes (O3, 
O3/H2O2 and O3/UV). Besides, the main achievements of this study are as follows; 1) UV 
doses, O3 doses, the energy consumptions and operating costs required for the effective 
removal of PPCPs were obtained, and 2) considering the disinfection effectiveness, the 
formation potential of by products and the decrease effect of ecological risk by the 
introduction of each process as well as the removal efficiency of PPCPs and energy 
consumption, the removal performance of each process for PPCPs was discussed integratedly. 
These results are available as operating data for the prevention of PPCPs discharge into the 
aquatic environment and water reuse of secondary effluent in WWTPs.  
Main findings from this study are described below by each chapter.  
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In Chapter III, the photodegradation characteristics of PPCPs detected often in aquatic 
environment with UV treatment were examined. Moreover, the effectiveness of H2O2 addition 
for PPCPs degradation during UV treatment was investigated. Finally, UV doses required for 
the effective removal of each PPCP were estimated. This information is useful for expecting 
the removal potential of UV process for various PPCPs in water and wastewater treatment 
plant. The major findings are as follows. 
1) At the UV wavelength of 254nm, molar extinction coefficients of the 30 PPCPs ranged 
from 9 /M/cm (cyclophosphamide) to 19,799 /M/cm (oxytetracycline), indicating that 
photodegradabilites of the PPCPs will be very different according to individual PPCPs.  
2) The concentration decrease of the 30 PPCPs with time followed 1st order kinetics, 
irrespective of UV lamps applied. Degradabilities of the 30 PPCPs were, therefore, classified 
and compared by 1st order rate constants. For UV/Lamp1 that emits at the wavelength of 
254nm, 6 PPCPs including ketoprofen and diclofenac and 14 PPCPs including theophylline, 
cyclophosphamide and DEET were classified as easily-degrading PPCPs (k≥2.6E-03 /sec) and 
slowly-degrading PPCPs (k<6.4E-04 /sec), respectively. On the other hand, 10 PPCPs and 6 
PPCPs belonged to easily-degrading PPCPs and slowly-degrading PPCPs, respectively, for 
UV/Lamp2 that emits at the wavelength of 185nm and 254nm. This result indicates that 
UV/Lamp2 was more effective for degrading PPCPs than UV/Lamp1. This might be due to 
the contribution of OH radicals formed during UV photodegradation of H2O molecular by the 
wavelength of 185nm to the PPCPs degradations. Consequently, the applicability of 
UV/Lamp2 for degrading PPCPs in water was implied.  
3) UV doses of 38 mJ/cm2 to 5,644 mJ/cm2 were needed for 90% degradation of the 30 
PPCPs in secondary effluent. These UV doses are much higher than those required for typical 
disinfection (40 mJ/cm2 ~ 140 mJ/cm2). It can be known that considerable UV dose will be 
required for the effective removal of PPCPs in secondary effluent.  
4) When the 30 PPCPs spiked into secondary effluent were treated with UV/Lamp1/H2O2, 
their degradation rates increased by a factor of about 1.3 comparing with those for UV/Lamp1. 
Especially, H2O2 addition improved significantly degradation rates of the PPCPs such as 
DEET and theophylline, which showed low degradation rates for UV/Lamp1 treatment. 
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Considering that UV alone treatment is not so effective for the degradation of a lot of PPCPs, 
the combination of H2O2 with UV treatment will be a promising alternative treatment option 
for PPCPs removal.  
5) All the PPCPs except 7 PPCPs including cyclophosphamide and 2-QCA (727 mJ/cm2 ~ 
1,695 mJ/cm2) were degraded by more than 90% under UV dose of 691 mJ/cm2 (contact 
time : 30 min) during UV/lamp1/H2O2 treatment. As a consequence, it is considered that 
UV/H2O2 treatment can contribute to the reduction of energy consumption for the effective 
PPCPs removal as well as the improvement of the degradation rates for the investigated 
PPCPs.  
 
The objective of Chapter IV was to investigate the degradation characteristic and the 
removal potential of various PPCPs detected in aquatic environment with O3, O3/UV and 
O3/H2O2 treatments. Additionally, O3 consumption needed for the effective PPCPs 
degradation was estimated. The major findings are as follows. 
1) The degradabilities (pseudo 1st order rate constants) of individual PPCPs increased 
with the increased O3 feed rate (0.15 mg/L/min, 0.3 mg/L/min, 0.6 mg/L/min). However, the 
degradation efficiency (the ratio of pseudo 1st order rate constant (/sec) to the amount of O3 
consumed per the volume of the reactor (mgO3/L)) for the 30 PPCPs was the highest for O3 
feed rate of 0.3 mg/L/min (2.2E-03 L/mgO3·sec). This indicates that the introduction of high 
O3 concentration could not contribute to the improvement of the degradabilites per O3 
consumed although it improved the degradation rates of the PPCPs.  
2) The degradation rate of each PPCP increased considerably by the combination of UV 
with O3 treatment, and the lowest O3 feed rate of 0.15 mg/L/min showed the most efficiency 
PPCPs degradation (6.9E-03 L/mgO3·sec). This means that O3 dose required for the effective 
PPCP removal can be reduced for O3/UV treatment. On the other hand, the degradation rates 
of 14 PPCPs including mefenamic acid, tetracyclines, carbamazepine and cyclophosphamide 
did not improve so much during O3/UV treatment, implying that the PPCPs will react more 
easily with O3 than OH radicals.  
3) For O3/H2O2 treatment, initial H2O2 concentration of 2.3 mg/L and 11.2 mg/L was 
combined with O3 treatment (0.6 mg/L/min). As a result, H2O2 addition increased the 
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degradation rates of 26 PPCPs by factors of 1.1 to 6.5 comparing with for O3 alone treatment. 
However, lower degradation rates showed when initial H2O2 concentration was 11.2 mg/L, 
maybe due to the scavenging effect of O3 and OH radicals by excess H2O2.  
4) Finally, O3 consumptions required for 90% degradation of each PPCP for O3 and 
O3/UV treatment were calculated. For O3 treatment, O3 consumption of 6.3 mg/L was 
necessary for 90% degradation of all the 30 PPCPs spiked into pure water. While, for O3/UV 
treatment, O3 consumption of 4.5 mg/L could achieve 90% degradation of each PPCP. On the 
other hand, comparatively high O3 consumptions of 8.9 mg/L and 7.7 mg/L were required for 
O3 and O3/UV treatments carried out with tested water spiked with the 30 PPCPs, respectively. 
These O3 consumptions resulted from semi-batch experiments (initial dissolved ozone 
concentration in tested water = 0 mg/L), and less O3 consumption will be, therefore, needed 
for real O3 and O3/UV treatment facilities because real treatment facilities are operated by 
supplying continuously O3 gas into O3 and O3/UV reactors.   
 
In Chapter V, the removal performance of UV and UV/H2O2 processes was investigated 
using bench scale plant. Moreover, the appropriate amount of H2O2 addition during UV 
process was investigated for the 90% removal of all the PPCPs detected in secondary effluent. 
Finally, energy consumption and operating costs were estimated for each process considering 
the effective PPCPs removal. The major findings are as follows. 
1) 38 PPCPs were detected in secondary effluent used for tested water in this study. The 
concentration ranged from 1 µg/L to 481 µg/L. As therapeutic classes, 11 antibiotics including 
clarithromycin and levefloxacin, 7 analgesics including ketoprofen and diclofenac and 4 
antiarrhythmic agents such as disopyramide, atenolol, metoprolol and propranolol were 
mainly present. Besides, various PPCPs such as anticonvulsants (carbamazepine, primidone), 
vasodilators (dipyridamole, diltiazem), diuretic (furosemide), antineoplastic agent 
(cyclophosphamide) and peptic ulcer drug (pirenzepine) were also present in secondary 
effluent. The side effects of PPCPs on the aquatic environment and human body have not been 
known yet, however, PPCPs in water environment should be removed in aspect of 
precautionary principles. 
2) Only 17 of 38 PPCPs were removed by more than 90% despite UV dose of 2,768 
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mJ/cm2 (contact time : 15 min) during UV process, showing that considerable UV dose will 
be required for the effective PPCPs removal by UV alone process. This also shows that it will 
be difficult to accomplish good PPCPs removals by typical UV disinfection process (UV 
dose : 40 mJ/cm2 ~ 140 mJ/cm2, contact time : a few secs).  
3) On the other hand, the PPCPs removal by UV alone process improved significantly by 
the combination of H2O2 with UV process. Except naproxen (>89%), 37 PPCPs were removed 
by more than 90% at the operational condition of UV dose of 923 mJ/cm2 (contact time : 5 
min) and initial H2O2 concentration of 6.2 mg/L. As a consequence, the combination of UV 
and H2O2 made it possible to reduce UV dose at least by more than 3 times comparing with 
for UV alone process.  
4) The number of PPCPs removed by more than 90% increased linearly with the 
increased removal efficiency of SUVA, irrespective of applied processes. On the other hand, 
the removal efficiency of SUVA was 52% at at the operational condition of UV dose of 923 
mJ/cm2 and initial H2O2 concentration of 6.2 mg/L. From these results, it was expected that 
SUVA removal of more than 50% ensures the effective removal of various PPCPs by UV or 
UV/H2O2 processes.  
5) Electrical energy required for the effective PPCPs removal by UV/H2O2 process was 
0.54 kW per 1 m3 target water (Operational condition : UV dose : 923 mJ/cm2, H2O2 : 6.2 
mg/L), showing that UV/H2O2 process can reduce energy consumption and operating cost 
considerably, comparing with UV alone process, and, therefore, be utilized as a treatment 
option for water reuse.  
 
In Chapter VI, the removal performance O3-based processes (O3 and O3/UV processes) 
for the PPCPs detected in secondary effluent was investigated using bench-scale experimental 
setup with a treatment capacity of 10 m3/day. Moreover, electrical energy and operating cost 
required for an effective PPCPs removal by the applied processes were estimated. The major 
findings are as follows. 
1) 37 PPCPs were detected in secondary effluent used as tested water in this study. O3 
dose of 6 mg/L (O3 consumption : 4.4 mg/L) was required for 90% removal of all the PPCPs 
except primidone (87%) for O3 process. However, 24 PPCPs including carbamazepine, 
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crotamiton and diclofenac were removed by more than 90% even at a low O3 dose of 2 mg/L 
(O3 consumption : 1.6 mg/L), indicating that O3 process can be used as a technology for the 
effective removal of various PPCPs in secondary effluent.  
2) For O3/UV process, two types of UV lamps (UV21.5W, UV65W) were combined with O3 
doses of 2 mg/L, 4mg/L and 6mg/L, respectively. As a result, all the detected PPCPs were 
removed by more than 90% when UV65W lamps and O3 dose of 6 mg/L (O3 consumption  : 
5.3 mg/L) were combined (Contact time : 10 min, UV dose : 1,846 mJ/cm2). On the other 
hand, all the PPCPs except DEET (89%), primidone (86%), cyclophosphamide (86%) and 
chloramphenicol (>73%) showed removal efficiencies of more than 90% even when UV65W 
lamps and O3 dose of 4 mg/L (O3 consumption : 3.4 mg/L) were combined, showing that a lot 
of PPCPs can be removed effectively under this operational condition.  
3) For O3 and O3/UV65W processes using O3 dose of over 4 mg/L (O3 consumption : over 
3.4 mg/L), more than 30 PPCPs showed the removal efficiency of more than 90% when 
SUVA decreased by more than 48%. Similarly to UV-based processes, it was thought that 
about 50% decrease in SUVA could ensure the effective PPCPs removal.  
4) Electrical energy consumed for the effective PPCPs removal was 0.09 kWh/m3 for O3 
process (O3 dose : 6 mg/L). Whereas, O3/UV process (O3 dose : 4 mg/L, UV dose : 1,846 
mJ/cm2) needed comparatively high electrical energy of 1.09 kWh/m3. Consequently, it can be 
known that O3 process is more cost-effective process than O3/UV process in the removal 
performance of PPCPs. 
5) For O3 process, the formation of bromate regulated in drinking water as well as the 
removal performance of PPCPs should be also taken into consideration. Although O3/UV 
process needs high energy consumption, the process has several advantages such as the 
suppression of bromate formation and the additional disinfection effect by UV. It is, therefore, 
thought that O3/UV process cannot be excluded in applying as technology for water reuse.  
 
In Chapter VII, the applicability as a technology for the reclamation of secondary effluent 
of O3, UV/H2O2 and O3/UV processes was discussed based on the energy consumption, the 
formation potential of disinfection by products (DBPs), disinfection effectiveness and 
decrease effect for ecological risk. The main results obtained in this chapter are as follows; 
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1) Electrical energies required for the effective removal of PPCPs in secondary effluent 
were 0.09 kWh/m3, 0.54 kWh/m3 and 1.09 kWh/m3 for O3 (O3 dose : 6 mg/L, O3 
consumption : 4.4 mg/L), UV/H2O2 (UV dose : 923 mJ/cm2, H2O2 : 6.2 mg/L) and O3/UV (O3 
dose : 4 mg/L, O3 consumption : 3.4 mg/L, UV dose : 1,846 mJ/cm2) processes, respectively, 
showing that O3 process is the most cost-effective treatment option for the PPCPs removal. 
On the other hand, it is considered that PPCPs removal by the investigated processes requires 
less electrical energy than for other micropollutants such as MTBE, atrazine and 1,4-dioxane.  
2) 4 log inactivation of total coliform was expected to be achieved by O3 process at O3 
dose of 6 mg/L, while more than 5 log inactivation by UV/H2O2 (UV dose : 923 mJ/cm2, 
H2O2 : 6.2 mg/L) and O3/UV (O3 dose : 4 mg/L, UV dose : 1,846 mJ/cm2) processes could be 
achieved. Therefore, in case that the number of total coliform in secondary effluent is 3,000 
/ml, these processes can meet sufficiently the guideline for water reuse of Japan 
(1,000/100ml). On the other hand, O3 process (O3 dose : 6 mg/L) can be used as a treatment 
method for restricted urban reuse and agricultural reuse (non-food crops) requiring the 
number of total coliform of less than 23/100ml. However, in order to obtain the reclaimed 
water for unrestricted urban reuse, agricultural reuse (food crops) and unrestricted/restricted 
recreational reuse considering the effective PPCPs removal, UV/H2O2 and O3/UV processes 
should be applied.  
3) O3 process at O3 dose of 6 mg/L (O3 consumption : 4.4 mg/L) showed the effective 
PPCPs removal, however, the formation of bromate is expected for O3 process using O3 dose 
of more than 4 mg/L (O3 consumption : 3.0 mg/L). In particular, bromate formation will be a 
critical issue when the reclaimed water is used for direct/indirect potable reuses. Therefore, in 
order to suppress the bromate formation as well as achieve the effective PPCPs removal, 
O3/UV process will be appropriate. For O3/UV process, residual O3 will be degraded by UV 
photodegradation, and, therefore, the formation reaction of bromate (reaction of O3 with Br-) 
will be suppressed. UV/H2O2 process will be also a profitable process because no bromate 
will be formed during the process.  
4) The ecological risk evaluation showed that each process could decrease the ecological 
risk caused by parent PPCPs considerably. This means that the investigated processes can play 
an important role in reducing unpredictable side effects caused by PPCPs in the aquatic 
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environment. 
8.2 Recommendations for future research 
1) This study was performed for the effective removal of PPCPs in secondary effluent of 
WWTPs, a main PPCPs source into the aquatic environment, by UV-based and O3-based 
processes. However, there are almost no studies for the effluent from hospital wastewater 
treatment plant where higher concentration of PPCPs is likely to be present. In aspect of the 
control of the point source for PPCPs, it will be also desirable to conduct this kind of 
investigation. 
2) This study focused on the removal of parent PPCPs, however, various by products can 
be formed during degradation of parent PPCPs by physicochemical processes, especially O3 
treatment, due to its selective reactivity on compounds. Moreover, the evaluation on the 
decrease effect of ecological risk after physicochemical treatment processes was also 
conducted only based on the concentration decrease of parent PPCPs. In order to evaluate the 
applicability of physicochemical processes for the PPCPs removal, it will be necessary to 
know more about the formation potential of by-products after the treatments and the 
ecological risk of by-products formed.  
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